<SEC-DOCUMENT>0000950103-25-013457.txt : 20251021
<SEC-HEADER>0000950103-25-013457.hdr.sgml : 20251021
<ACCEPTANCE-DATETIME>20251021160720
ACCESSION NUMBER:		0000950103-25-013457
CONFORMED SUBMISSION TYPE:	424B2
PUBLIC DOCUMENT COUNT:		19
FILED AS OF DATE:		20251021
DATE AS OF CHANGE:		20251021

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			BARCLAYS BANK PLC
		CENTRAL INDEX KEY:			0000312070
		STANDARD INDUSTRIAL CLASSIFICATION:	COMMERCIAL BANKS, NEC [6029]
		ORGANIZATION NAME:           	02 Finance
		EIN:				000000000
		STATE OF INCORPORATION:			X0
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		424B2
		SEC ACT:		1933 Act
		SEC FILE NUMBER:	333-287303
		FILM NUMBER:		251407119

	BUSINESS ADDRESS:	
		STREET 1:		1 CHURCHILL PLACE
		STREET 2:		CANARY WHARF
		CITY:			LONDON
		STATE:			X0
		ZIP:			E14 5HP
		BUSINESS PHONE:		0044-20-3555-4619

	MAIL ADDRESS:	
		STREET 1:		1 CHURCHILL PLACE
		STREET 2:		CANARY WHARF
		CITY:			LONDON
		STATE:			X0
		ZIP:			E14 5HP

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	BARCLAYS BANK PLC /ENG/
		DATE OF NAME CHANGE:	19990402

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	BARCLAYS BANK INTERNATIONAL LTD
		DATE OF NAME CHANGE:	19850313
</SEC-HEADER>
<DOCUMENT>
<TYPE>424B2
<SEQUENCE>1
<FILENAME>dp236095_424b2-7903wfps.htm
<DESCRIPTION>FORM 424B2
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="margin: 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font-size: 10pt; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD ROWSPAN="2" STYLE="width: 49%">
    <P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">PRICING SUPPLEMENT dated October 17, 2025</P>
    <P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">(To the Prospectus dated May 15, 2025,</P>
    <P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">the Prospectus Supplement dated May 15, 2025,</P>
    <P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">the Product Supplement No. WF-1 dated May 20, 2025 and</P>
    <P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">the Underlying Supplement dated May 15, 2025)</P></TD>
    <TD STYLE="width: 51%">
    <P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: right">Filed Pursuant to Rule 424(b)(2)</P>
    <P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: right">Registration Statement No. 333-287303</P></TD></TR>
  <TR>
    <TD STYLE="font: 10pt Arial, Helvetica, Sans-Serif; text-align: center"><FONT STYLE="font-size: 10pt"><IMG SRC="image_001.jpg" ALT="barclays PLC logo" STYLE="height: 29px; width: 121px"></FONT></TD></TR>
  </TABLE>
<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font-size: 10pt; border-collapse: collapse">
  <TR STYLE="vertical-align: top; background-color: #EDEFEE">
    <TD STYLE="width: 100%">
    <P STYLE="color: #BB0826; font: bold 18pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify">Barclays Bank PLC</P>
    <P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: left; color: #BB0826">Global Medium-Term Notes, Series
A</P></TD></TR>
  <TR STYLE="vertical-align: top; background-color: #D5D9D8">
    <TD>
    <P STYLE="color: #BB0826; font: bold 11pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">$6,962,000 Market Linked Securities&mdash;Callable
with Contingent Coupon with Daily Observation and Contingent Downside</P>
    <P STYLE="color: #BB0826; font: bold 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">Principal at Risk Securities Linked to the
Lowest Performing of the Nasdaq-100 Index<SUP>&reg;</SUP>, the Russell 2000<SUP>&reg;</SUP> Index and the S&amp;P 500<SUP>&reg;</SUP>
Index due April 22, 2030</P></TD></TR>
  </TABLE>
<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font-size: 10pt; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="font: 10pt Arial, Helvetica, Sans-Serif; background-color: rgb(94,138,180); width: 3%; text-align: center; color: white"><FONT STYLE="font-family: Wingdings">n</FONT></TD>
    <TD STYLE="padding-right: 6pt; background-color: rgb(94,138,180); width: 97%; font: 10pt Arial, Helvetica, Sans-Serif; text-align: justify; text-indent: 0in; color: white"><FONT STYLE="font-size: 10pt">Linked to the lowest performing of the Nasdaq-100 Index<SUP>&reg;</SUP>, the Russell 2000<SUP>&reg;</SUP> Index and the S&amp;P 500<SUP>&reg;</SUP> Index (each referred to as an &ldquo;<U>Index</U>&rdquo;)</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="font: 10pt Arial, Helvetica, Sans-Serif; background-color: rgb(94,138,180); text-align: center; color: white"><FONT STYLE="font-family: Wingdings">n</FONT></TD>
    <TD STYLE="padding-right: 6pt; background-color: rgb(94,138,180); font: 10pt Arial, Helvetica, Sans-Serif; text-align: justify; text-indent: 0in; color: white"><FONT STYLE="font-size: 10pt">The securities are redeemable debt securities of Barclays Bank PLC that, unlike ordinary debt securities, do not provide for fixed payments of interest and do not repay a fixed amount of principal at stated maturity. Whether the securities pay a contingent coupon and, if the securities are not redeemed prior to stated maturity, whether you receive the principal amount of your securities at stated maturity will depend in each case on the performance of the lowest performing Index as described below. The lowest performing Index on any eligible trading day during an observation period (including on the final calculation day) is the Index that has the lowest performance factor on that day, calculated for each Index as the closing level of that Index on that day <I>divided by</I> its starting level.</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="font: 10pt Arial, Helvetica, Sans-Serif; background-color: rgb(94,138,180); text-align: center; color: white"><FONT STYLE="font-family: Wingdings">n</FONT></TD>
    <TD STYLE="padding-right: 6pt; background-color: rgb(94,138,180); font: 10pt Arial, Helvetica, Sans-Serif; text-align: justify; text-indent: 0in; color: white"><FONT STYLE="font-size: 10pt"><B>Contingent Coupon.</B> The securities will pay a contingent coupon with respect to each quarterly observation period until the earlier of stated maturity or early redemption if the closing level of the lowest performing Index on <B>each eligible trading day during such observation period</B> is greater than or equal to its coupon threshold level. However, if the closing level of the lowest performing Index on <B>any eligible trading day during an observation period </B>is less than its coupon threshold level, you will not receive any contingent coupon with respect to that observation period. <B>This will be the case even if the closing level of the lowest performing Index is greater than or equal to its coupon threshold level on one or more other eligible trading days during that observation period, and even if the better performing Indices perform favorably</B>. If the closing level of at least one Index is less than its coupon threshold level on one or more eligible trading days during each observation period, you will not receive any contingent coupons throughout the entire term of the securities. The contingent coupon rate is 10.60% per annum.</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="font: 10pt Arial, Helvetica, Sans-Serif; background-color: rgb(94,138,180); text-align: center; color: white"><FONT STYLE="font-family: Wingdings">n</FONT></TD>
    <TD STYLE="padding-right: 6pt; background-color: rgb(94,138,180); font: 10pt Arial, Helvetica, Sans-Serif; text-align: justify; text-indent: 0in; color: white"><FONT STYLE="font-size: 10pt"><B>Optional Redemption.</B> The issuer may, at its option, redeem the securities on any contingent coupon payment date beginning approximately three months after their issue date. If the issuer elects to redeem the securities prior to maturity, you will receive the principal amount plus any contingent coupon payment otherwise due.</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="font: 10pt Arial, Helvetica, Sans-Serif; background-color: rgb(94,138,180); text-align: center; color: white"><FONT STYLE="font-family: Wingdings">n</FONT></TD>
    <TD STYLE="padding-right: 6pt; background-color: rgb(94,138,180); font: 10pt Arial, Helvetica, Sans-Serif; text-align: justify; text-indent: 0in; color: white"><FONT STYLE="font-size: 10pt"><B>Potential Loss of Principal. </B>If the issuer does not redeem the securities prior to stated maturity, you will receive the principal amount at stated maturity if the closing level of the lowest performing Index on the final calculation day is greater than or equal to its downside threshold level. If the closing level of the lowest performing Index on the final calculation day is less than its downside threshold level, you will lose more than 40%, and possibly all, of the principal amount of your securities.</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="font: 10pt Arial, Helvetica, Sans-Serif; background-color: rgb(94,138,180); text-align: center; color: white"><FONT STYLE="font-family: Wingdings">n</FONT></TD>
    <TD STYLE="padding-right: 6pt; background-color: rgb(94,138,180); font: 10pt Arial, Helvetica, Sans-Serif; text-align: justify; text-indent: 0in; color: white"><FONT STYLE="font-size: 10pt">The coupon threshold level of each Index is equal to 70% of its starting level, and the downside threshold level of each Index is equal to 60% of its starting level.</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="font: 10pt Arial, Helvetica, Sans-Serif; background-color: rgb(94,138,180); text-align: center; color: white"><FONT STYLE="font-family: Wingdings">n</FONT></TD>
    <TD STYLE="padding-right: 6pt; background-color: rgb(94,138,180); font: 10pt Arial, Helvetica, Sans-Serif; text-align: justify; text-indent: 0in; color: white"><FONT STYLE="font-size: 10pt">You will not participate in any appreciation of any Index.</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="font: 10pt Arial, Helvetica, Sans-Serif; background-color: rgb(94,138,180); text-align: center; color: white"><FONT STYLE="font-family: Wingdings">n</FONT></TD>
    <TD STYLE="padding-right: 6pt; background-color: rgb(94,138,180); font: 10pt Arial, Helvetica, Sans-Serif; text-align: justify; text-indent: 0in; color: white"><FONT STYLE="font-size: 10pt">Your return on the securities will depend <B>solely</B> on the performance of the Index that is the lowest performing Index on each eligible trading day during the observation periods, including on the final calculation day. You will not benefit in any way from the performance of the better performing Indices. Therefore, you will be adversely affected if <B>any Index</B> performs poorly, even if the other Indices perform favorably.</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="font: 10pt Arial, Helvetica, Sans-Serif; background-color: rgb(94,138,180); text-align: center; color: white"><FONT STYLE="font-family: Wingdings">n</FONT></TD>
    <TD STYLE="padding-right: 6pt; background-color: rgb(94,138,180); font: 10pt Arial, Helvetica, Sans-Serif; text-align: justify; text-indent: 0in; color: white"><FONT STYLE="font-size: 10pt">Any payment on the securities, including any repayment of principal, is subject to the creditworthiness of Barclays Bank PLC and is not guaranteed by any third party. If Barclays Bank PLC were to default on its payment obligations or become subject to the exercise of any U.K. Bail-in Power (as described on page PS-7 of this pricing supplement) by the relevant U.K. resolution authority, you might not receive any amounts owed to you under the securities. See &ldquo;Selected Risk Considerations&rdquo; and &ldquo;Consent to U.K. Bail-in Power&rdquo; in this pricing supplement and &ldquo;Risk Factors&rdquo; in the accompanying prospectus supplement.</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="font: 10pt Arial, Helvetica, Sans-Serif; background-color: rgb(94,138,180); text-align: center; color: white"><FONT STYLE="font-family: Wingdings">n</FONT></TD>
    <TD STYLE="padding-right: 6pt; background-color: rgb(94,138,180); font: 10pt Arial, Helvetica, Sans-Serif; text-align: justify; text-indent: 0in; color: white"><FONT STYLE="font-size: 10pt">No fixed periodic interest payments or dividends</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="font: 10pt Arial, Helvetica, Sans-Serif; background-color: rgb(94,138,180); text-align: center; color: white"><FONT STYLE="font-family: Wingdings">n</FONT></TD>
    <TD STYLE="padding-right: 6pt; background-color: rgb(94,138,180); font: 10pt Arial, Helvetica, Sans-Serif; text-align: justify; text-indent: 0in; color: white"><FONT STYLE="font-size: 10pt">No exchange listing; designed to be held to maturity</FONT></TD></TR>
  </TABLE>
<P STYLE="font: bold 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify">See &ldquo;Additional Information about the
Issuer and the Securities&rdquo; on page PS-5 of this pricing supplement. The securities will have the terms specified in the prospectus
dated May 15, 2025, the prospectus supplement dated May 15, 2025, the product supplement no. WF-1 dated May 20, 2025 and the underlying
supplement dated May 15, 2025, as supplemented or superseded by this pricing supplement.</P>

<P STYLE="font: bold 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify">The securities have complex features and
investing in the securities involves risks not associated with an investment in conventional debt securities. See &ldquo;Selected Risk
Considerations&rdquo; on page PS-12 herein, &ldquo;Risk Factors&rdquo; beginning on page PS-3 of the product supplement and &ldquo;Risk
Factors&rdquo; beginning on page S-9 of the prospectus supplement.</P>

<P STYLE="font: bold 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify">The securities constitute our unsecured and
unsubordinated obligations. The securities are not deposit liabilities of Barclays Bank PLC and are not covered by the U.K. Financial
Services Compensation Scheme or insured by the U.S. Federal Deposit Insurance Corporation or any other governmental agency or deposit
insurance agency of the United States, the United Kingdom or any other jurisdiction.</P>

<P STYLE="font: bold 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify">Neither the U.S. Securities and Exchange
Commission (the &ldquo;<U>SEC</U>&rdquo;) nor any state securities commission has approved or disapproved of these securities or determined
that this pricing supplement is truthful or complete. Any representation to the contrary is a criminal offense.</P>

<P STYLE="font: bold 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify">We may use this pricing supplement in the
initial sale of the securities. In addition, Barclays Capital Inc. or any other of our affiliates may use this pricing supplement in
market resale transactions in any of the securities after their initial sale. Unless we or our agent informs you otherwise in the confirmation
of sale, this pricing supplement is being used in a market resale transaction.</P>

<P STYLE="font: bold 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify">Notwithstanding and to the exclusion of any
other term of the securities or any other agreements, arrangements or understandings between Barclays Bank PLC and any holder or beneficial
owner of the securities (or the trustee on behalf of the holders of the securities), by acquiring the securities, each holder or beneficial
owner of the securities acknowledges, accepts, agrees to be bound by, and consents to the exercise of, any U.K. Bail-in Power by the
relevant U.K. resolution authority. See &ldquo;Consent to U.K. Bail-in Power&rdquo; on page PS-7 of this pricing supplement.</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; border-collapse: collapse; font-size: 10pt">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 17%; font-family: Arial, Helvetica, Sans-Serif; text-align: justify; font-weight: bold">&nbsp;</TD>
    <TD STYLE="width: 29%; border-bottom: Black 1pt solid; font-family: Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-size: 10pt"><B>Original Offering Price<SUP>(1)</SUP></B></FONT></TD>
    <TD STYLE="width: 27%; border-bottom: Black 1pt solid; font-family: Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-size: 10pt"><B>Agent Discount<SUP>(2), (3)</SUP></B></FONT></TD>
    <TD STYLE="width: 27%; border-bottom: Black 1pt solid; font-family: Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-size: 10pt"><B>Proceeds to Barclays Bank PLC</B></FONT></TD></TR>
  <TR STYLE="vertical-align: top; background-color: #E0E3E2">
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-size: 10pt"><B>Per Security</B></FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-size: 10pt">$1,000.00</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-size: 10pt">$12.75</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-size: 10pt">$987.25</FONT></TD></TR>
  <TR STYLE="vertical-align: top; background-color: #E0E3E2">
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-size: 10pt"><B>Total</B></FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-size: 10pt">$6,962,000.00</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-size: 10pt">$88,765.50</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-size: 10pt">$6,873,234.50</FONT></TD></TR>
  </TABLE>
<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.2in"><FONT STYLE="background-color: white"><SUP>(1)</SUP></FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="background-color: white">Our estimated value of the securities on the pricing date, based
on our internal pricing models, is $974.20 per security. The estimated value is less than the original offering price of the securities.
See &ldquo;Additional Information Regarding Our Estimated Value of the Securities&rdquo; on page PS-6 of this pricing supplement.</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.2in"><FONT STYLE="background-color: white"><SUP>(2)</SUP></FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="background-color: white">Wells Fargo Securities, LLC (&ldquo;WFS&rdquo;) and Barclays Capital
Inc. are the agents for the distribution of the securities and are acting as principal. The agent will receive an underwriting discount
of $12.75 per security. Barclays Capital Inc. will sell the securities to WFS at the original offering price of the securities less a
concession of $12.75 per security. WFS may provide dealers, which may include Wells Fargo Advisors (&ldquo;WFA&rdquo;) (the trade name
of the retail brokerage business of WFS&rsquo;s affiliates, Wells Fargo Clearing Services, LLC and Wells Fargo Advisors Financial Network,
LLC), with a selling concession of $10.00 per security. In addition to the concession allowed to WFA, WFS may pay $0.75 per security of
the agent&rsquo;s discount to WFA as a distribution expense fee for each security sold by WFA. See &ldquo;Terms of the Securities&mdash;Supplemental
Plan of Distribution&rdquo; in this pricing supplement for further information.</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.2in"><FONT STYLE="background-color: white"><SUP>(3)</SUP></FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="background-color: white">In respect of certain securities sold in this offering, Barclays
Capital Inc. may pay a fee of up to $1.00 per security to selected securities dealers in consideration for marketing and other services
in connection with the distribution of the securities to other securities dealers.</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; border-collapse: collapse; font-size: 10pt">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 50%; font: bold 12pt Arial, Helvetica, Sans-Serif; text-align: justify">Wells Fargo Securities</TD>
    <TD STYLE="width: 50%; font: bold 12pt Arial, Helvetica, Sans-Serif; text-align: right">Barclays Capital Inc.</TD></TR>
  </TABLE>

<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="font: 18pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; color: #BB0826"><B>Market Linked Securities&mdash;Callable with Contingent Coupon with Daily Observation and Contingent Downside</B></P><P STYLE="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; color: #BB0826"><B>Principal at Risk Securities Linked to the Lowest Performing of the Nasdaq-100 Index<SUP>&reg;</SUP>, the Russell 2000<SUP>&reg;</SUP> Index and the S&amp;P 500<SUP>&reg;</SUP> Index due April 22, 2030</B></P></DIV>
    <!-- Field: /Page -->

<P STYLE="color: white; font: bold 12pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: center; background-color: #4F81BD">Terms
of the Securities</P>



<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; border-collapse: collapse; font-size: 10pt">
  <TR>
    <TD STYLE="width: 25%; border: white 1pt solid; background-color: #D9D9D6; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt; color: black"><B>Issuer:</B></FONT></TD>
    <TD STYLE="vertical-align: top; width: 75%; font-family: Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-size: 10pt">Barclays Bank PLC</FONT></TD></TR>
  <TR>
    <TD STYLE="border-right: white 1pt solid; border-left: white 1pt solid; background-color: #D9D9D6; font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="vertical-align: top; font-family: Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-size: 10pt">The Nasdaq-100 Index<SUP>&reg;</SUP> (the &ldquo;<U>NDX Index</U>&rdquo;), the Russell 2000<SUP>&reg;</SUP> Index (the &ldquo;<U>RTY Index</U>&rdquo;) and the S&amp;P 500<SUP>&reg;</SUP> Index (the &ldquo;<U>SPX Index</U>&rdquo;) (each referred to as an &ldquo;<U>Index</U>,&rdquo; and collectively as the &ldquo;<U>Indices</U>&rdquo;)</FONT></TD></TR>
  </TABLE>
<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR>
    <TD STYLE="width: 25%; border-left: white 1pt solid; border-right: Black 1pt solid; background-color: #D9D9D6">&nbsp;</TD>
    <TD STYLE="vertical-align: top; width: 15%; border-top: Black 1pt solid; border-right: Black 1pt solid; border-bottom: Black 1pt solid; text-align: center"><FONT STYLE="font-size: 10pt"><B>Market Measure</B></FONT></TD>
    <TD STYLE="vertical-align: top; width: 17%; border-top: Black 1pt solid; border-right: Black 1pt solid; border-bottom: Black 1pt solid; text-align: center"><FONT STYLE="font-size: 10pt"><B>Bloomberg Ticker Symbol</B></FONT></TD>
    <TD STYLE="vertical-align: top; width: 11%; border-top: Black 1pt solid; border-right: Black 1pt solid; border-bottom: Black 1pt solid; text-align: center"><FONT STYLE="font-size: 10pt"><B>Starting Level<SUP>(a)</SUP></B></FONT></TD>
    <TD STYLE="vertical-align: top; width: 16%; border-top: Black 1pt solid; border-right: Black 1pt solid; border-bottom: Black 1pt solid; text-align: center"><FONT STYLE="font-size: 10pt"><B>Coupon Threshold Level<SUP>(b)</SUP></B></FONT></TD>
    <TD STYLE="vertical-align: top; width: 16%; border-top: Black 1pt solid; border-right: Black 1pt solid; border-bottom: Black 1pt solid; text-align: center"><FONT STYLE="font-size: 10pt"><B>Downside Threshold Level<SUP>(c)</SUP></B></FONT></TD></TR>
  <TR>
    <TD STYLE="border-right: Black 1pt solid; border-left: white 1pt solid; background-color: #D9D9D6"><FONT STYLE="font-size: 10pt"><B>Market Measures<SUP>1</SUP>:</B></FONT></TD>
    <TD STYLE="vertical-align: top; border-right: Black 1pt solid; border-bottom: Black 1pt solid; text-align: center"><FONT STYLE="font-size: 10pt">NDX Index</FONT></TD>
    <TD STYLE="vertical-align: top; border-right: Black 1pt solid; border-bottom: Black 1pt solid; text-align: center"><FONT STYLE="font-size: 10pt">NDX&lt;Index&gt;</FONT></TD>
    <TD STYLE="vertical-align: top; border-right: Black 1pt solid; border-bottom: Black 1pt solid; text-align: center"><FONT STYLE="font-size: 10pt">24,817.95</FONT></TD>
    <TD STYLE="vertical-align: top; border-right: Black 1pt solid; border-bottom: Black 1pt solid; text-align: center"><FONT STYLE="font-size: 10pt">17,372.565</FONT></TD>
    <TD STYLE="vertical-align: top; border-right: Black 1pt solid; border-bottom: Black 1pt solid; text-align: center"><FONT STYLE="font-size: 10pt">14,890.77</FONT></TD></TR>
  <TR>
    <TD STYLE="border-right: Black 1pt solid; border-left: white 1pt solid; background-color: #D9D9D6">&nbsp;</TD>
    <TD STYLE="vertical-align: top; border-right: Black 1pt solid; border-bottom: Black 1pt solid; text-align: center"><FONT STYLE="font-size: 10pt">RTY Index</FONT></TD>
    <TD STYLE="vertical-align: top; border-right: Black 1pt solid; border-bottom: Black 1pt solid; text-align: center"><FONT STYLE="font-size: 10pt">RTY&lt;Index&gt;</FONT></TD>
    <TD STYLE="vertical-align: top; border-right: Black 1pt solid; border-bottom: Black 1pt solid; text-align: center"><FONT STYLE="font-size: 10pt">2,452.173</FONT></TD>
    <TD STYLE="vertical-align: top; border-right: Black 1pt solid; border-bottom: Black 1pt solid; text-align: center"><FONT STYLE="font-size: 10pt">1,716.5211</FONT></TD>
    <TD STYLE="vertical-align: top; border-right: Black 1pt solid; border-bottom: Black 1pt solid; text-align: center"><FONT STYLE="font-size: 10pt">1,471.3038</FONT></TD></TR>
  <TR>
    <TD STYLE="border-right: Black 1pt solid; border-left: white 1pt solid; background-color: #D9D9D6">&nbsp;</TD>
    <TD STYLE="vertical-align: top; border-right: Black 1pt solid; border-bottom: Black 1pt solid; text-align: center"><FONT STYLE="font-size: 10pt">SPX Index</FONT></TD>
    <TD STYLE="vertical-align: top; border-right: Black 1pt solid; border-bottom: Black 1pt solid; text-align: center"><FONT STYLE="font-size: 10pt">SPX&lt;Index&gt;</FONT></TD>
    <TD STYLE="vertical-align: top; border-right: Black 1pt solid; border-bottom: Black 1pt solid; text-align: center"><FONT STYLE="font-size: 10pt">6,664.01</FONT></TD>
    <TD STYLE="vertical-align: top; border-right: Black 1pt solid; border-bottom: Black 1pt solid; text-align: center"><FONT STYLE="font-size: 10pt">4,664.807</FONT></TD>
    <TD STYLE="vertical-align: top; border-right: Black 1pt solid; border-bottom: Black 1pt solid; text-align: center"><FONT STYLE="font-size: 10pt">3,998.406</FONT></TD></TR>
  </TABLE>
<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; border-collapse: collapse">
  <TR>
    <TD STYLE="width: 25%; border-right: white 1pt solid; border-bottom: white 1pt solid; border-left: white 1pt solid; background-color: #D9D9D6">&nbsp;</TD>
    <TD STYLE="vertical-align: top; width: 75%">
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><SUP>(a)</SUP> With respect to each Index, the
    closing level of that Index on the pricing date</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><SUP>(b)</SUP> With respect to each Index, 70%
    of its starting level</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><SUP>(c)</SUP> With respect to each Index,
60% of its starting level</P></TD></TR>
  <TR>
    <TD STYLE="border-right: white 1pt solid; border-bottom: white 1pt solid; border-left: white 1pt solid; background-color: #D9D9D6"><FONT STYLE="font-size: 10pt"><B>Pricing Date:</B></FONT></TD>
    <TD STYLE="vertical-align: top; text-align: justify"><FONT STYLE="font-size: 10pt">October 17, 2025</FONT></TD></TR>
  <TR>
    <TD STYLE="border-right: white 1pt solid; border-bottom: white 1pt solid; border-left: white 1pt solid; background-color: #D9D9D6"><FONT STYLE="font-size: 10pt"><B>Issue Date:</B></FONT></TD>
    <TD STYLE="vertical-align: top; text-align: justify"><FONT STYLE="font-size: 10pt">October 22, 2025</FONT></TD></TR>
  <TR>
    <TD STYLE="border-right: white 1pt solid; border-bottom: white 1pt solid; border-left: white 1pt solid; background-color: #D9D9D6"><FONT STYLE="font-size: 10pt"><B>Final Calculation Day<SUP>2</SUP>:</B></FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">April 17, 2030</FONT></TD></TR>
  <TR>
    <TD STYLE="border-right: white 1pt solid; border-bottom: white 1pt solid; border-left: white 1pt solid; background-color: #D9D9D6"><FONT STYLE="font-size: 10pt"><B>Stated Maturity Date<SUP>2</SUP>:</B></FONT></TD>
    <TD STYLE="vertical-align: top; text-align: justify"><FONT STYLE="font-size: 10pt">April 22, 2030</FONT></TD></TR>
  <TR>
    <TD STYLE="border-right: white 1pt solid; border-bottom: white 1pt solid; border-left: white 1pt solid; background-color: #D9D9D6"><FONT STYLE="font-size: 10pt"><B>Principal Amount:</B></FONT></TD>
    <TD STYLE="vertical-align: top; text-align: justify"><FONT STYLE="font-size: 10pt">$1,000 per security. References in this pricing supplement to a &ldquo;<U>security</U>&rdquo; are to a security with a principal amount of $1,000.</FONT></TD></TR>
  <TR>
    <TD STYLE="border-right: white 1pt solid; border-bottom: white 1pt solid; border-left: white 1pt solid; background-color: #D9D9D6"><FONT STYLE="font-size: 10pt"><B>Contingent Coupon Payment:</B></FONT></TD>
    <TD>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">With respect to each observation period, you will
    receive on the related contingent coupon payment date a contingent coupon payment at a per annum rate equal to the contingent coupon rate
    if the closing level of the lowest performing Index on each eligible trading day during such observation period is greater than or equal
    to its coupon threshold level.</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Each &ldquo;<U>contingent coupon payment</U>,&rdquo;
    if any, will be calculated per security as follows:</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">($1,000 &times; contingent coupon rate) / 4</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Any contingent coupon payments will be rounded
    to the nearest cent, with one-half cent rounded upward.</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>If the closing level of the lowest performing
    Index on any eligible trading day during an observation period is less than its coupon threshold level, you will not receive any contingent
    coupon payment on the related contingent coupon payment date. If the closing level of at least one Index is less than its coupon threshold
    level on one or more eligible trading days during each observation period, you will not receive any contingent coupon payments over the
    term of the securities.</B></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Any return on the securities will be limited
to the sum of your contingent coupon payments, if any, even if the closing level of the lowest performing Index on any observation period
end-date significantly exceeds its starting level. You will not participate in any appreciation of any Index.</B></P></TD></TR>
  <TR>
    <TD STYLE="border-right: white 1pt solid; border-bottom: white 1pt solid; border-left: white 1pt solid; background-color: #D9D9D6"><FONT STYLE="font-size: 10pt"><B>Contingent Coupon Payment Dates<SUP>2</SUP>:</B></FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">Quarterly, on the third business day following each observation period end-date, <I>provided</I> that the contingent coupon payment date with respect to the final observation period will be the stated maturity date. If an observation period end-date is postponed with respect to one or more Indices, the related contingent coupon payment date will be three business days after the latest observation period end-date as postponed.</FONT></TD></TR>
  <TR>
    <TD STYLE="border-right: white 1pt solid; border-bottom: white 1pt solid; border-left: white 1pt solid; background-color: #D9D9D6"><FONT STYLE="font-size: 10pt"><B>Contingent Coupon Rate:</B></FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">The &ldquo;<U>contingent coupon rate</U>&rdquo; is 10.60% per annum. </FONT></TD></TR>
  </TABLE>

<!-- Field: Page; Sequence: 2; Options: NewSection; Value: 2 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">PS-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="font: 18pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; color: #BB0826"><B>Market Linked Securities&mdash;Callable with Contingent Coupon with Daily Observation and Contingent Downside</B></P><P STYLE="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; color: #BB0826"><B>Principal at Risk Securities Linked to the Lowest Performing of the Nasdaq-100 Index<SUP>&reg;</SUP>, the Russell 2000<SUP>&reg;</SUP> Index and the S&amp;P 500<SUP>&reg;</SUP> Index due April 22, 2030</B></P></DIV>
    <!-- Field: /Page -->

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; border-collapse: collapse">
  <TR>
    <TD STYLE="width: 25%; border: white 1pt solid; background-color: #D9D9D6"><FONT STYLE="font-size: 10pt"><B>Optional Redemption:</B></FONT></TD>
    <TD STYLE="width: 75%">
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">We may, at our option, redeem the securities,
    in whole but not in part, on any optional redemption date. If we elect to redeem the securities prior to stated maturity, you will be
    entitled to receive on the applicable optional redemption date a cash payment per security in U.S. dollars equal to the principal amount
    plus any contingent coupon payment otherwise due.</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">If we elect to redeem the securities on an optional
    redemption date, we will give notice to the trustee on or before the observation period end-date immediately preceding that optional redemption
    date. Any redemption of the securities will be at our option and will not automatically occur based on the performance of any Index.</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">If the securities are redeemed, they will
cease to be outstanding on the applicable optional redemption date and you will have no further rights under the securities after that
date.</P></TD></TR>
  <TR>
    <TD STYLE="border-right: white 1pt solid; border-bottom: white 1pt solid; border-left: white 1pt solid; background-color: #D9D9D6"><FONT STYLE="font-size: 10pt"><B>Observation Periods: </B></FONT></TD>
    <TD>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Each observation period will consist of each day
    that is a trading day for at least one Index (each such day, an &ldquo;<U>eligible trading day</U>&rdquo;) from but excluding an observation
    period end-date to and including the following observation period end-date, <I>provided</I> that the first observation period will consist
    of each eligible trading day from but excluding the pricing date to and including the first observation period end-date.</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">If a market disruption event or non-trading
day occurs with respect to an Index on any eligible trading day during an observation period (other than an observation period end-date),
that Index will be disregarded on that eligible trading day for purposes of determining whether a contingent coupon payment is payable
with respect to such observation period. For the avoidance of doubt, any such eligible trading day for any Index not affected by a market
disruption event or non-trading day on that eligible trading day will remain a valid day for purposes of determining whether a contingent
coupon payment is payable with respect to such observation period, even if that day is not a trading day for any other Index or a market
disruption event has occurred with respect to any other Index on that day.</P></TD></TR>
  <TR>
    <TD STYLE="border-right: white 1pt solid; border-bottom: white 1pt solid; border-left: white 1pt solid; background-color: #D9D9D6"><FONT STYLE="font-size: 10pt"><B>Observation Period End-Dates<SUP>2</SUP>:</B></FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">Quarterly, on the 17th day of each January, April, July and October, commencing January 2026 and ending April 2030, <I>provided</I> that the April 2030 observation period end-date will be the final calculation day</FONT></TD></TR>
  <TR>
    <TD STYLE="border-right: white 1pt solid; border-bottom: white 1pt solid; border-left: white 1pt solid; background-color: #D9D9D6"><FONT STYLE="font-size: 10pt"><B>Optional Redemption Dates<SUP>2</SUP>:</B></FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">Quarterly, beginning approximately three months after the issue date, on the contingent coupon payment dates following each observation period end-date scheduled to occur from January 2026 to January 2030, inclusive</FONT></TD></TR>
  <TR>
    <TD STYLE="border-right: white 1.5pt solid; border-bottom: white 1.5pt solid; border-left: white 1.5pt solid; background-color: #D9D9D6"><FONT STYLE="font-size: 10pt"><B>Maturity Payment Amount:</B></FONT></TD>
    <TD STYLE="vertical-align: bottom">
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">If we do not redeem the securities prior to the
    stated maturity date, you will be entitled to receive on the stated maturity date a cash payment per security in U.S. dollars equal to
    the maturity payment amount (in addition to any contingent coupon payment otherwise due). The &ldquo;<U>maturity payment amount</U>&rdquo;
    per security will equal:</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 18.75pt; text-align: justify; text-indent: -9pt"><FONT STYLE="font-family: Symbol">&#183;&#9;</FONT>if
    the ending level of the lowest performing Index on the final calculation day is greater than or equal to its downside threshold level:
    $1,000; or</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 18.75pt; text-align: justify; text-indent: -9pt">&nbsp;</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 18.75pt; text-align: justify; text-indent: -9pt"><FONT STYLE="font-family: Symbol">&#183;&#9;</FONT>if
    the ending level of the lowest performing Index on the final calculation day is less than its downside threshold level:</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 18.75pt; text-align: justify; text-indent: -9pt">&nbsp;</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 19.45pt; text-align: center; text-indent: -12.25pt">$1,000 &times;
    performance factor of the lowest performing Index on the final calculation day</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 19.45pt; text-align: center; text-indent: -12.25pt">&nbsp;</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>If we do not redeem the securities prior to
    stated maturity and the ending level of the lowest performing Index on the final calculation day is less than its downside threshold level,
    you will lose more than 40%, and possibly all, of the principal amount of your securities at stated maturity.</B></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Any payment on the securities, including
any repayment of principal, is subject to the creditworthiness of Barclays Bank PLC and is not guaranteed by any third party. If Barclays
Bank PLC were to default on its payment obligations or become subject to the exercise of any U.K. Bail-in Power by the relevant U.K.
resolution authority, you might not receive any amounts owed to you under the securities.</B></P></TD></TR>
  <TR>
    <TD STYLE="border-right: white 1.5pt solid; border-bottom: white 1.5pt solid; border-left: white 1.5pt solid; background-color: #D9D9D6"><FONT STYLE="font-size: 10pt"><B>Lowest Performing Index:</B></FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">For any eligible trading day during an observation period (including the final calculation day), the &ldquo;<U>lowest performing Index</U>&rdquo; will be the Index with the lowest performance factor on that eligible trading day and that has not been disregarded due to a market disruption event or non-trading day in accordance with &ldquo;&mdash;Observation Periods&rdquo; above. For the avoidance of doubt, if any eligible trading day is a valid day for only one Index, then that Index will be the lowest performing Index on that eligible trading day.</FONT></TD></TR>
  </TABLE>

<!-- Field: Page; Sequence: 3; Value: 2 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">PS-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="font: 18pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; color: #BB0826"><B>Market Linked Securities&mdash;Callable with Contingent Coupon with Daily Observation and Contingent Downside</B></P><P STYLE="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; color: #BB0826"><B>Principal at Risk Securities Linked to the Lowest Performing of the Nasdaq-100 Index<SUP>&reg;</SUP>, the Russell 2000<SUP>&reg;</SUP> Index and the S&amp;P 500<SUP>&reg;</SUP> Index due April 22, 2030</B></P></DIV>
    <!-- Field: /Page -->

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; border-collapse: collapse">
  <TR>
    <TD STYLE="width: 25%; border: white 1.5pt solid; background-color: #D9D9D6"><FONT STYLE="font-size: 10pt"><B>Performance Factor:</B></FONT></TD>
    <TD STYLE="width: 75%; text-align: justify"><FONT STYLE="font-size: 10pt">With respect to an Index on any eligible trading day during an observation period, its closing level on such day <I>divided by</I> its starting level.</FONT></TD></TR>
  <TR>
    <TD STYLE="border-right: white 1.5pt solid; border-bottom: white 1.5pt solid; border-left: white 1.5pt solid; background-color: #D9D9D6; text-align: justify"><FONT STYLE="font-size: 10pt"><B>Closing Level<SUP>1</SUP>:</B></FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">With respect to each Index, &ldquo;<U>closing level</U>&rdquo; has the meaning set forth under &ldquo;General Terms of the Securities&mdash;Certain Terms for Securities Linked to an Index&mdash;Certain Definitions&rdquo; in the product supplement.</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="border-right: white 1.5pt solid; border-bottom: white 1.5pt solid; border-left: white 1.5pt solid; background-color: #D9D9D6"><FONT STYLE="font-size: 10pt"><B>Ending Level:</B></FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">The &ldquo;<U>ending level</U>&rdquo; of an Index will be its closing level on the final calculation day.</FONT></TD></TR>
  <TR>
    <TD STYLE="border-right: white 1.5pt solid; border-bottom: white 1.5pt solid; border-left: white 1.5pt solid; background-color: #D9D9D6"><FONT STYLE="font-size: 10pt"><B>Additional Terms:</B></FONT></TD>
    <TD STYLE="vertical-align: top; text-align: justify"><FONT STYLE="font-size: 10pt">Terms used in this pricing supplement, but not defined herein, will have the meanings ascribed to them in the product supplement, <I>provided</I> that terms used in this pricing supplement, but not defined herein or in the product supplement, will have the meanings ascribed to them in the prospectus supplement.</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="border-right: white 1.5pt solid; border-bottom: white 1.5pt solid; border-left: white 1.5pt solid; background-color: #D9D9D6"><FONT STYLE="font-size: 10pt"><B>Calculation Agent:</B></FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">Barclays Bank PLC</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="border-right: white 1.5pt solid; border-bottom: white 1.5pt solid; border-left: white 1.5pt solid; background-color: #D9D9D6"><FONT STYLE="font-size: 10pt"><B>Tax Considerations:</B></FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">For a discussion of the tax considerations relating to ownership and disposition of the securities, see &ldquo;Tax Considerations.&rdquo;</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="border-right: white 1.5pt solid; border-bottom: white 1.5pt solid; border-left: white 1.5pt solid; background-color: #D9D9D6"><FONT STYLE="font-size: 10pt"><B>Denominations:</B></FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">$1,000 and any integral multiple of $1,000</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="border-right: white 1.5pt solid; border-bottom: white 1.5pt solid; border-left: white 1.5pt solid; background-color: #D9D9D6"><FONT STYLE="font-size: 10pt"><B>CUSIP / ISIN:</B></FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">06746EGR0 / US06746EGR09</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="border-right: white 1.5pt solid; border-bottom: white 1.5pt solid; border-left: white 1.5pt solid; background-color: #D9D9D6"><FONT STYLE="font-size: 10pt"><B>Supplemental Plan of Distribution:</B></FONT></TD>
    <TD>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Wells Fargo Securities, LLC (&ldquo;WFS&rdquo;)
    and Barclays Capital Inc. will act as agents for the securities. The agent will receive an underwriting discount of $12.75 per security.
    Barclays Capital Inc. will sell the securities to WFS at the original offering price of the securities less a concession of $12.75 per
    security. WFS may provide dealers, which may include Wells Fargo Advisors (&ldquo;WFA&rdquo;) (the trade name of the retail brokerage
    business of WFS&rsquo;s affiliates, Wells Fargo Clearing Services, LLC and Wells Fargo Advisors Financial Network, LLC), with a selling
    concession of $10.00 per security. In addition to the concession allowed to WFA, WFS may pay $0.75 per security of the agent&rsquo;s discount
    to WFA as a distribution expense fee for each security sold by WFA.</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">In addition, in respect of certain securities
    sold in this offering, Barclays may pay a fee of up to $1.00 per security to selected securities dealers in consideration for marketing
    and other services in connection with the distribution of the securities to other securities dealers.</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Barclays Bank PLC or its affiliate will enter
into swap agreements or related hedge transactions with one of its other affiliates or unaffiliated counterparties in connection with
the sale of the securities. If WFS, Barclays Capital Inc. or an affiliate of either agent participating as a dealer in the distribution
of the securities conducts hedging activities for Barclays Bank PLC in connection with the securities, such agent or participating dealer
will expect to realize a projected profit from such hedging activities, and this projected profit will be in addition to any discount,
concession or fee received in connection with the sale of the securities to you. This additional projected profit may create a further
incentive for the agents or participating dealers to sell the securities to you.</P></TD></TR>
  </TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>


<P STYLE="margin: 0"></P>

<!-- Field: Rule-Page --><DIV ALIGN="LEFT" STYLE="margin-top: 3pt; margin-bottom: 3pt"><DIV STYLE="border-top: Black 1pt solid; font-size: 1pt; width: 15%">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->




<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><SUP>1</SUP> If an Index is discontinued or if
the sponsor of an Index fails to publish that Index, the calculation agent may select a successor index or, if no successor index is
available, will calculate the value to be used as the closing level of that Index. In addition, the calculation agent will calculate
the value to be used as the closing level of an Index in the event of certain changes in or modifications to that Index. For more information,
see &ldquo;General Terms of the Securities&mdash;Certain Terms for Securities Linked to an Index&mdash;Adjustments to an Index&rdquo;
and &ldquo;&mdash;Discontinuance of an Index&rdquo; in the accompanying product supplement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><SUP>2</SUP> If any observation period end-date
is not a trading day with respect to any Index, that observation period end-date for each Index will be postponed to the next succeeding
day that is a trading day with respect to each Index. An observation period end-date will also be postponed for any Index if a market
disruption event occurs with respect to that Index on that observation period end-date as described under &ldquo;General Terms of the
Securities&mdash;Consequences of a Market Disruption Event; Postponement of a Calculation Day&mdash;Securities Linked to Multiple Market
Measures&rdquo; in the accompanying product supplement. In addition, the stated maturity date will be postponed if that day is not a business
day or if the final calculation day is postponed as described under &ldquo;General Terms of the Securities&mdash;Payment Dates&rdquo;
in the accompanying product supplement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>


<!-- Field: Page; Sequence: 4; Value: 2 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">PS-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="font: 18pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; color: #BB0826"><B>Market Linked Securities&mdash;Callable with Contingent Coupon with Daily Observation and Contingent Downside</B></P><P STYLE="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; color: #BB0826"><B>Principal at Risk Securities Linked to the Lowest Performing of the Nasdaq-100 Index<SUP>&reg;</SUP>, the Russell 2000<SUP>&reg;</SUP> Index and the S&amp;P 500<SUP>&reg;</SUP> Index due April 22, 2030</B></P></DIV>
    <!-- Field: /Page -->

<P STYLE="color: white; font: bold 12pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: center; background-color: #4F81BD">Additional
Information about the Issuer and the Securities</P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">You should read this pricing supplement together
with the prospectus dated May 15, 2025, as supplemented by the prospectus supplement dated May 15, 2025 relating to our Global Medium-Term
Notes, Series A, of which these securities are a part, the product supplement no. WF-1 dated May 20, 2025 and the underlying supplement
dated May 15, 2025. This pricing supplement, together with the documents listed below, contains the terms of the securities and supersedes
all prior or contemporaneous oral statements as well as any other written materials including preliminary or indicative pricing terms,
correspondence, trade ideas, structures for implementation, sample structures, brochures or other educational materials of ours. You should
carefully consider, among other things, the matters set forth under &ldquo;Risk Factors&rdquo; in the prospectus supplement and &ldquo;Selected
Risk Considerations&rdquo; in this pricing supplement, as the securities involve risks not associated with conventional debt securities.
We urge you to consult your investment, legal, tax, accounting and other advisors before you invest in the securities.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">To the extent the information or terms in this
pricing supplement are different from or inconsistent with the information or terms in the prospectus, prospectus supplement, product
supplement or underlying supplement, the information and terms in this pricing supplement will control. To the extent the information
or terms in the product supplement are different from or inconsistent with the information or terms in the prospectus or prospectus supplement,
the information and terms in the product supplement will control.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">You may access these documents on the SEC website
at www.sec.gov as follows (or if such address has changed, by reviewing our filings for the relevant date on the SEC website):</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&#183;</FONT></TD><TD>Prospectus dated May 15, 2025:<BR>
<A HREF="http://www.sec.gov/Archives/edgar/data/312070/000119312525120720/d925982d424b2.htm">http://www.sec.gov/Archives/edgar/data/312070/000119312525120720/d925982d424b2.htm</A></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&#183;</FONT></TD><TD>Prospectus Supplement dated May 15, 2025:<BR>
<A HREF="http://www.sec.gov/Archives/edgar/data/312070/000095010325006051/dp228678_424b2-prosupp.htm">http://www.sec.gov/Archives/edgar/data/312070/000095010325006051/dp228678_424b2-prosupp.htm</A></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&#183;</FONT></TD><TD>Product Supplement No. WF-1 dated May 20, 2025:<BR>
<A HREF="http://www.sec.gov/Archives/edgar/data/312070/000095010325006260/dp229046_424b2-wf1.htm">http://www.sec.gov/Archives/edgar/data/312070/000095010325006260/dp229046_424b2-wf1.htm</A></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&#183;</FONT></TD><TD>Underlying <FONT STYLE="font-size: 10pt">Supplement</FONT> dated May 15, 2025:<BR>
<FONT STYLE="font-family: Georgia, Times, Serif; font-size: 10pt"><A HREF="http://www.sec.gov/Archives/edgar/data/312070/000095010325006053/dp228705_424b2-underl.htm"></FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">http://www.sec.gov/Archives/edgar/data/312070/000095010325006053/dp228705_424b2-underl.htm</FONT><FONT STYLE="font-family: Georgia, Times, Serif; font-size: 10pt"></A></FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Our SEC file number is 1-10257. As used in this
pricing supplement, &ldquo;we,&rdquo; &ldquo;us&rdquo; and &ldquo;our&rdquo; refer to Barclays Bank PLC.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>


<!-- Field: Page; Sequence: 5; Value: 2 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">PS-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->5<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="font: 18pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; color: #BB0826"><B>Market Linked Securities&mdash;Callable with Contingent Coupon with Daily Observation and Contingent Downside</B></P><P STYLE="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; color: #BB0826"><B>Principal at Risk Securities Linked to the Lowest Performing of the Nasdaq-100 Index<SUP>&reg;</SUP>, the Russell 2000<SUP>&reg;</SUP> Index and the S&amp;P 500<SUP>&reg;</SUP> Index due April 22, 2030</B></P></DIV>
    <!-- Field: /Page -->

<P STYLE="color: white; font: bold 12pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: center; background-color: #4F81BD">Additional
Information Regarding Our Estimated Value of the Securities</P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Our internal pricing models take into account
a number of variables and are based on a number of subjective assumptions, which may or may not materialize, typically including volatility,
interest rates and our internal funding rates. Our internal funding rates (which are our internally published borrowing rates based on
variables, such as market benchmarks, our appetite for borrowing and our existing obligations coming to maturity) may vary from the levels
at which our benchmark debt securities trade in the secondary market. Our estimated value on the pricing date is based on our internal
funding rates. Our estimated value of the securities might be lower if such valuation were based on the levels at which our benchmark
debt securities trade in the secondary market.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Our estimated value of the securities on the pricing
date is less than the original offering price of the securities. The difference between the original offering price of the securities
and our estimated value of the securities results from several factors, including any sales commissions to be paid to Barclays Capital
Inc. or another affiliate of ours, any selling concessions, discounts, commissions or fees to be allowed or paid to non-affiliated intermediaries,
the estimated profit that we or any of our affiliates expect to earn in connection with structuring the securities, the estimated cost
that we may incur in hedging our obligations under the securities, and estimated development and other costs that we may incur in connection
with the securities.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Our estimated value on the pricing date is not
a prediction of the price at which the securities may trade in the secondary market, nor will it be the price at which Barclays Capital
Inc. may buy or sell the securities in the secondary market. Subject to normal market and funding conditions, Barclays Capital Inc. or
another affiliate of ours intends to offer to purchase the securities in the secondary market but it is not obligated to do so.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Assuming that all relevant factors remain constant
after the pricing date, the price at which Barclays Capital Inc. may initially buy or sell the securities in the secondary market, if
any, and the value that we may initially use for customer account statements, if we provide any customer account statements at all, may
exceed our estimated value on the pricing date for a temporary period expected to be approximately five months after the initial issue
date of the securities because, in our discretion, we may elect to effectively reimburse to investors a portion of the estimated cost
of hedging our obligations under the securities and other costs in connection with the securities that we will no longer expect to incur
over the term of the securities. We made such discretionary election and determined this temporary reimbursement period on the basis of
a number of factors, which may include the tenor of the securities and/or any agreement we may have with the distributors of the securities.
The amount of our estimated costs that we effectively reimburse to investors in this way may not be allocated ratably throughout the reimbursement
period, and we may discontinue such reimbursement at any time or revise the duration of the reimbursement period after the initial issue
date of the securities based on changes in market conditions and other factors that cannot be predicted.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>We urge you to read the &ldquo;Selected Risk
Considerations&rdquo; beginning on page PS-12 of this pricing supplement.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>


<!-- Field: Page; Sequence: 6; Value: 2 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">PS-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->6<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="font: 18pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; color: #BB0826"><B>Market Linked Securities&mdash;Callable with Contingent Coupon with Daily Observation and Contingent Downside</B></P><P STYLE="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; color: #BB0826"><B>Principal at Risk Securities Linked to the Lowest Performing of the Nasdaq-100 Index<SUP>&reg;</SUP>, the Russell 2000<SUP>&reg;</SUP> Index and the S&amp;P 500<SUP>&reg;</SUP> Index due April 22, 2030</B></P></DIV>
    <!-- Field: /Page -->

<P STYLE="color: white; font: bold 12pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: center; background-color: #4F81BD">Consent
to U.K. Bail-in Power</P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Notwithstanding and to the exclusion of any
other term of the securities or any other agreements, arrangements or understandings between us and any holder or beneficial owner of
the securities (or the trustee on behalf of the holders of the securities), by acquiring the securities, each holder or beneficial owner
of the securities acknowledges, accepts, agrees to be bound by and consents to the exercise of, any U.K. Bail-in Power by the relevant
U.K. resolution authority.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Under the U.K. Banking Act 2009, as amended, the
relevant U.K. resolution authority may exercise a U.K. Bail-in Power in circumstances in which the relevant U.K. resolution authority
is satisfied that the resolution conditions are met. These conditions include that a U.K. bank or investment firm is failing or is likely
to fail to satisfy the Financial Services and Markets Act 2000 (the &ldquo;<U>FSMA</U>&rdquo;) threshold conditions for authorization
to carry on certain regulated activities (within the meaning of section 55B FSMA) or, in the case of a U.K. banking group company that
is a European Economic Area (&ldquo;<U>EEA</U>&rdquo;) or third country institution or investment firm, that the relevant EEA or third
country relevant authority is satisfied that the resolution conditions are met in respect of that entity.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The U.K. Bail-in Power includes any write-down,
conversion, transfer, modification and/or suspension power, which allows for (i) the reduction or cancellation of all, or a portion, of
the principal amount of, or interest on, or any other amounts payable on, the securities; (ii) the conversion of all, or a portion, of
the principal amount of, or interest on, or any other amounts payable on, the securities into shares or other securities or other obligations
of Barclays Bank PLC or another person (and the issue to, or conferral on, the holder or beneficial owner of the securities of such shares,
securities or obligations); (iii) the cancellation of the securities and/or (iv) the amendment or alteration of the maturity of the securities,
or the amendment of the amount of interest or any other amounts due on the securities, or the dates on which interest or any other amounts
become payable, including by suspending payment for a temporary period; which U.K. Bail-in Power may be exercised by means of a variation
of the terms of the securities solely to give effect to the exercise by the relevant U.K. resolution authority of such U.K. Bail-in Power.
Each holder and beneficial owner of the securities further acknowledges and agrees that the rights of the holders or beneficial owners
of the securities are subject to, and will be varied, if necessary, solely to give effect to, the exercise of any U.K. Bail-in Power by
the relevant U.K. resolution authority. For the avoidance of doubt, this consent and acknowledgment is not a waiver of any rights holders
or beneficial owners of the securities may have at law if and to the extent that any U.K. Bail-in Power is exercised by the relevant U.K.
resolution authority in breach of laws applicable in England.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">For more information, please see &ldquo;Selected
Risk Considerations&mdash;Risks Relating to the Issuer&mdash;You May Lose Some or All of Your Investment If Any U.K. Bail-in Power Is
Exercised by the Relevant U.K. Resolution Authority&rdquo; in this pricing supplement as well as &ldquo;U.K. Bail-in Power,&rdquo; &ldquo;Risk
Factors&mdash;Risks Relating to the Securities Generally&mdash;Regulatory action in the event a bank or investment firm in the Group is
failing or likely to fail, including the exercise by the relevant U.K. resolution authority of a variety of statutory resolution powers,
could materially adversely affect the value of any securities&rdquo; and &ldquo;Risk Factors&mdash;Risks Relating to the Securities Generally&mdash;Under
the terms of the securities, you have agreed to be bound by the exercise of any U.K. Bail-in Power by the relevant U.K. resolution authority&rdquo;
in the accompanying prospectus supplement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>


<!-- Field: Page; Sequence: 7; Value: 2 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">PS-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->7<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="font: 18pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; color: #BB0826"><B>Market Linked Securities&mdash;Callable with Contingent Coupon with Daily Observation and Contingent Downside</B></P><P STYLE="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; color: #BB0826"><B>Principal at Risk Securities Linked to the Lowest Performing of the Nasdaq-100 Index<SUP>&reg;</SUP>, the Russell 2000<SUP>&reg;</SUP> Index and the S&amp;P 500<SUP>&reg;</SUP> Index due April 22, 2030</B></P></DIV>
    <!-- Field: /Page -->

<P STYLE="color: white; font: bold 12pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: center; background-color: #4F81BD">Investor
Considerations</P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>The securities are not appropriate for all
investors. The securities <I>may</I> be an appropriate investment for you if all of the following statements are true:</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&#183;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">You do not seek an investment that produces fixed periodic interest or coupon
payments or other non-contingent sources of current income.</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&#183;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">You do not anticipate that the ending level of the lowest performing Index
on the final calculation day will be less than its downside threshold level, and you are willing and able to accept the risk that, if
it is, you will lose more than 40%, and possibly all, of the principal amount of your securities at stated maturity.</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&#183;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">You are willing and able to accept that you will not receive a contingent
coupon payment with respect to an observation period if the closing level of the lowest performing Index on any eligible trading day during
that observation period is less than its coupon threshold level, even if the closing level of the lowest performing Index is greater than
or equal to its coupon threshold level on one or more other eligible trading days during that observation period.</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&#183;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">You do not anticipate that the closing level of the lowest performing Index
will be less than its coupon threshold level on any eligible trading day during the observation periods, and you are willing and able
to accept the risk that, if it is, you may receive few or no contingent coupon payments over the term of the securities.</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&#183;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">You are willing and able to accept the individual market risk of each Index
and you understand that poor performance by any Index over the term of the securities may negatively affect your return and will not be
offset or mitigated by any positive performance by the other Indices.</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&#183;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">You are willing and able to forgo participation in any appreciation of any
Index, and you understand that any return on your investment will be limited to the contingent coupon payments that may be payable on
the securities.</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&#183;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">You are willing and able to accept the risks associated with an investment
linked to the performance of the lowest performing Index, as explained in more detail in the &#8220;Selected Risk Considerations&#8221;
section of this pricing supplement.</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&#183;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">You understand and accept that you will not be entitled to receive dividends
or distributions that may be paid to holders of the securities composing the Indices, nor will you have any voting rights with respect
to the securities composing the Indices.</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&#183;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">You are willing and able to accept the risk that we may redeem the securities
prior to stated maturity at our option beginning approximately three months after their issue date, that it is more likely that we will
redeem the securities when it would otherwise be advantageous for you to continue to hold the securities and that you may not be able
to reinvest your money in an alternative investment with comparable risk and yield.</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&#183;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">You do not seek an investment for which there will be an active secondary
market and you are willing and able to hold the securities to stated maturity if we do not redeem the securities.</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&#183;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">You are willing and able to assume our credit risk for all payments on the
securities.</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&#183;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">You are willing and able to consent to the exercise of any U.K. Bail-in
Power by any relevant U.K. resolution authority.</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>The securities may <I>not</I> be an appropriate
investment for you if <I>any</I> of the following statements are true:</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&#183;</FONT></TD><TD STYLE="text-align: justify">You seek an investment that produces fixed periodic interest or coupon payments or other non-contingent
sources of current income.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&#183;</FONT></TD><TD STYLE="text-align: justify">You seek an investment that provides for the full repayment of principal at stated maturity.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&#183;</FONT></TD><TD STYLE="text-align: justify">You anticipate that the ending level of the lowest performing Index on the final calculation day will
be less than its downside threshold level, or you are unwilling or unable to accept the risk that, if it is, you will lose more than 40%,
and possibly all, of the principal amount of your securities at stated maturity.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&#183;</FONT></TD><TD STYLE="text-align: justify">You anticipate that the closing level of the lowest performing Index will be less than its coupon threshold
level on one or more eligible trading days during the observation periods, or you are unwilling or unable to accept the risk that, if
it is, you may receive few or no contingent coupon payments over the term of the securities.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>


<!-- Field: Page; Sequence: 8; Value: 2 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">PS-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->8<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="font: 18pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; color: #BB0826"><B>Market Linked Securities&mdash;Callable with Contingent Coupon with Daily Observation and Contingent Downside</B></P><P STYLE="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; color: #BB0826"><B>Principal at Risk Securities Linked to the Lowest Performing of the Nasdaq-100 Index<SUP>&reg;</SUP>, the Russell 2000<SUP>&reg;</SUP> Index and the S&amp;P 500<SUP>&reg;</SUP> Index due April 22, 2030</B></P></DIV>
    <!-- Field: /Page -->

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&#183;</FONT></TD><TD STYLE="text-align: justify">You are unwilling or unable to accept the individual market risk of each Index or the risk that poor performance
by any Index over the term of the securities may negatively affect your return and will not be offset or mitigated by any positive performance
by the other Indices.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&#183;</FONT></TD><TD STYLE="text-align: justify">You seek exposure to any upside performance of the Indices or you seek an investment with a return that
is not limited to the contingent coupon payments that may be payable on the securities.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&#183;</FONT></TD><TD STYLE="text-align: justify">You are unwilling or unable to accept the risks associated with an investment linked to the performance
of the lowest performing Index, as explained in more detail in the &#8220;Selected Risk Considerations&#8221; section of this pricing
supplement.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&#183;</FONT></TD><TD STYLE="text-align: justify">You seek an investment that entitles you to dividends or distributions on, or voting rights related to,
the securities composing the Indices.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&#183;</FONT></TD><TD STYLE="text-align: justify">You are unwilling or unable to accept the risk that we may redeem the securities prior to stated maturity
at our option.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&#183;</FONT></TD><TD STYLE="text-align: justify">You seek an investment for which there will be an active secondary market and/or you are unwilling or
unable to hold the securities to stated maturity if they are not redeemed.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&#183;</FONT></TD><TD STYLE="text-align: justify">You are unwilling or unable to assume our credit risk for all payments on the securities.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&#183;</FONT></TD><TD STYLE="text-align: justify">You are unwilling or unable to consent to the exercise of any U.K. Bail-in Power by any relevant U.K.
resolution authority.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>The considerations identified above are not
exhaustive. Whether or not the securities are an appropriate investment for you will depend on your individual circumstances, and you
should reach an investment decision only after you and your investment, legal, tax, accounting and other advisors have carefully considered
the appropriateness of an investment in the securities in light of your particular circumstances. You should also review carefully the
&ldquo;Selected Risk Considerations&rdquo; beginning on page PS-12 of this pricing supplement and the &ldquo;Risk Factors&rdquo; beginning
on page PS-3 of the accompanying product supplement and the &ldquo;Risk Factors&rdquo; beginning on page S-9 of the accompanying prospectus
supplement for risks related to an investment in the securities. For more information about the Indices, please see the sections titled
&ldquo;The Nasdaq-100 Index<SUP>&reg;</SUP>,&rdquo; &ldquo;The Russell 2000<SUP>&reg;</SUP> Index&rdquo; and &ldquo;The S&amp;P 500<SUP>&reg;</SUP>
Index&rdquo; below.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>


<!-- Field: Page; Sequence: 9; Value: 2 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">PS-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->9<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="font: 18pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; color: #BB0826"><B>Market Linked Securities&mdash;Callable with Contingent Coupon with Daily Observation and Contingent Downside</B></P><P STYLE="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; color: #BB0826"><B>Principal at Risk Securities Linked to the Lowest Performing of the Nasdaq-100 Index<SUP>&reg;</SUP>, the Russell 2000<SUP>&reg;</SUP> Index and the S&amp;P 500<SUP>&reg;</SUP> Index due April 22, 2030</B></P></DIV>
    <!-- Field: /Page -->

<P STYLE="color: white; font: bold 12pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: center; background-color: #4F81BD">Determining
Payment on a Contingent Coupon Payment Date and at Maturity</P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Unless we have previously redeemed the securities
at our option, on each contingent coupon payment date prior to the stated maturity date, whether you receive a contingent coupon payment
will be determined based on the closing level of the lowest performing Index on each eligible trading day during the related observation
period.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Step 1</B>: Determine which Index is the lowest
performing Index on each eligible trading day during the related observation period. The lowest performing Index on any eligible trading
day during an observation period is the Index that has the lowest performance factor on that date, calculated for each Index as the closing
level of that Index on that date divided by its starting level.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Step 2</B>: Determine whether a contingent
coupon payment is paid on the applicable contingent coupon payment date prior to the stated maturity date, based on the closing level
of the lowest performing Index on each eligible trading day during the relevant observation period, as follows:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&nbsp;<IMG SRC="image_006.jpg" ALT=""></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">On the stated maturity date, if we have not previously
redeemed the securities at our option, you will receive a cash payment per security (the maturity payment amount) calculated as described
below.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Step 1</B>: Determine which Index is the lowest
performing Index on the final calculation day. The lowest performing Index on the final calculation day is the Index that has the lowest
performance factor on the final calculation day, calculated for each Index as its ending level divided by its starting level.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Step 2</B>: Calculate the maturity payment
amount based on the ending level of the lowest performing Index on the final calculation day, as follows:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&nbsp;<IMG SRC="image_007.jpg" ALT=""></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>


<!-- Field: Page; Sequence: 10; Value: 2 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">PS-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->10<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="font: 18pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; color: #BB0826"><B>Market Linked Securities&mdash;Callable with Contingent Coupon with Daily Observation and Contingent Downside</B></P><P STYLE="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; color: #BB0826"><B>Principal at Risk Securities Linked to the Lowest Performing of the Nasdaq-100 Index<SUP>&reg;</SUP>, the Russell 2000<SUP>&reg;</SUP> Index and the S&amp;P 500<SUP>&reg;</SUP> Index due April 22, 2030</B></P></DIV>
    <!-- Field: /Page -->

<P STYLE="color: white; font: bold 12pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: center; background-color: #4F81BD">Hypothetical
Payout Profile</P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The following profile illustrates the potential
maturity payment amount on the securities (excluding any contingent coupon payment otherwise due) for a range of hypothetical performances
of the lowest performing Index on the final calculation day from its starting level to its ending level, assuming the securities have
not been redeemed prior to the stated maturity date. As this profile illustrates, in no event will you have a positive rate of return
based solely on the maturity payment amount received at maturity; any positive return will be based solely on the contingent coupon payments,
if any, received during the term of the securities. This graph has been prepared for purposes of illustration only. Your actual return
will depend on the actual ending level of the lowest performing Index on the final calculation day and whether you hold your securities
to stated maturity. The performance of the better performing Indices is not relevant to your return on the securities.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Georgia, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><IMG SRC="image_002.jpg" ALT="" STYLE="height: 372px; width: 552px"></B></FONT></P>

<P STYLE="font: 10pt Georgia, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>


<!-- Field: Page; Sequence: 11; Value: 2 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">PS-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->11<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="font: 18pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; color: #BB0826"><B>Market Linked Securities&mdash;Callable with Contingent Coupon with Daily Observation and Contingent Downside</B></P><P STYLE="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; color: #BB0826"><B>Principal at Risk Securities Linked to the Lowest Performing of the Nasdaq-100 Index<SUP>&reg;</SUP>, the Russell 2000<SUP>&reg;</SUP> Index and the S&amp;P 500<SUP>&reg;</SUP> Index due April 22, 2030</B></P></DIV>
    <!-- Field: /Page -->

<P STYLE="color: white; font: bold 12pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: center; background-color: #4F81BD">Selected
Risk Considerations</P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">An investment in the securities involves significant
risks. Investing in the securities is not equivalent to investing directly in any or all of the Indices or their components. Some of the
risks that apply to an investment in the securities are summarized below, but we urge you to read the more detailed explanation of risks
relating to the securities generally in the &ldquo;Risk Factors&rdquo; sections of the product supplement and prospectus supplement. You
should not purchase the securities unless you understand and can bear the risks of investing in the securities.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Risks Relating to the Securities Generally</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&#183;</FONT></TD><TD STYLE="text-align: justify"><B>If We Do Not Redeem The Securities Prior To Stated Maturity, You May Lose Some Or All Of The Principal
Amount Of Your Securities At Stated Maturity</B> &#8212; We will not repay you a fixed amount on your securities at stated maturity. If
we do not exercise our right to redeem the securities prior to stated maturity, you will receive a maturity payment amount that will be
equal to or less than the principal amount, depending on the ending level of the lowest performing Index on the final calculation day.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; text-indent: 0in">If the ending level
of the lowest performing Index on the final calculation day is less than its downside threshold level, the maturity payment amount will
be less than the principal amount and you will have full downside exposure to the decrease in the level of the lowest performing Index
from its starting level. The downside threshold level for each Index is 60% of its starting level. For example, if we do not redeem the
securities prior to stated maturity and the lowest performing Index on the final calculation day has declined by 40.1% from its starting
level to its ending level, you will not receive any benefit of the contingent downside protection feature and you will lose 40.1% of the
principal amount. As a result, you will not receive any protection if the level of the lowest performing Index on the final calculation
day declines significantly and you may lose some, and possibly all, of the principal amount of your securities at stated maturity, even
if the level of the lowest performing Index is greater than or equal to its starting level or its downside threshold level at certain
times during the term of the securities.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; text-indent: 0in">Even if the ending
level of the lowest performing Index on the final calculation day is greater than its downside threshold level, the maturity payment amount
will not exceed the principal amount, and your yield on the securities, taking into account any contingent coupon payments you may have
received during the term of the securities, may be less than the yield you would earn if you bought a traditional interest-bearing debt
security of Barclays Bank PLC or another issuer with a similar credit rating.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; text-indent: 0in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&#183;</FONT></TD><TD STYLE="text-align: justify"><B>The Securities Do Not Provide For Fixed Payments Of Interest And You May Receive No Coupon Payments
On One Or More Contingent Coupon Payment Dates, Or Even Throughout The Entire Term Of The Securities</B> &#8212; On each contingent coupon
payment date you will receive a contingent coupon payment if the closing level of the lowest performing Index on each eligible trading
day during the related observation period is greater than or equal to its coupon threshold level. If the closing level of the lowest performing
Index on any eligible trading day during the related observation period is less than its coupon threshold level, you will not receive
any contingent coupon payment on the related contingent coupon payment date, and if the closing level of at least one Index is less than
its coupon threshold level on one or more eligible trading days during each observation period over the term of the securities, you will
not receive any contingent coupon payments over the entire term of the securities.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&#183;</FONT></TD><TD STYLE="text-align: justify"><B>Whether You Receive A Contingent Coupon Payment On A Contingent Coupon Payment Date Will Depend On
The Closing Level Of The Lowest Performing Index On Each Eligible Trading Day During The Related Observation Period </B>&#8212; Whether
you receive a contingent coupon payment on any contingent coupon payment date will be determined at the end of the related observation
period, based on the closing level of the lowest performing Index on each eligible trading day during that observation period. If any
eligible trading day during an observation period is a valid day for only one Index due to a market disruption event or non-trading day
for the other Indices, then that Index will be the lowest performing Index on that eligible trading day. Therefore, if the closing level
of any one of the Indices is less than its coupon threshold level on any eligible trading day during an observation period, you will not
receive a contingent coupon payment with respect to that observation period. This will be the case even if the closing level of the lowest
performing Index is greater than or equal to its coupon threshold level on one or more other eligible trading days during that observation
period, and even if the better performing Indices perform favorably.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&#183;</FONT></TD><TD STYLE="text-align: justify"><B>The Securities Are Subject To The Full Risks Of Each Index And Will Be Negatively Affected If Any Index
Performs Poorly, Even If The Other Indices Perform Favorably </B>&#8212; You are subject to the full risks of each Index. If any Index
performs poorly, you will be negatively affected, even if the other Indices perform favorably. The securities are not linked to a basket
composed of the Indices, where the better performance of some Indices could offset the poor performance of others. Instead, you are subject
to the full risks of whichever Index is the lowest performing Index on each eligible trading day during each observation period. As a
result, the securities are riskier than an alternative investment linked to only one of the Indices or linked to a basket composed of
each Index. You should not invest in the securities unless you understand and are willing to accept the full downside risks of each Index.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&#183;</FONT></TD><TD STYLE="text-align: justify"><B>You May Be Fully Exposed To The Decline In The Lowest Performing Index On The Final Calculation Day
From Its Starting Level, But Will Not Participate In Any Positive Performance Of Any Index</B> &#8212; Even though you will be fully</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>


<!-- Field: Page; Sequence: 12; Value: 2 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">PS-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->12<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="font: 18pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; color: #BB0826"><B>Market Linked Securities&mdash;Callable with Contingent Coupon with Daily Observation and Contingent Downside</B></P><P STYLE="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; color: #BB0826"><B>Principal at Risk Securities Linked to the Lowest Performing of the Nasdaq-100 Index<SUP>&reg;</SUP>, the Russell 2000<SUP>&reg;</SUP> Index and the S&amp;P 500<SUP>&reg;</SUP> Index due April 22, 2030</B></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify">exposed to a decline in the level of
the lowest performing Index on the final calculation day if its ending level is below its downside threshold level, you will not participate
in any increase in the level of any Index over the term of the securities. Your maximum possible return on the securities will be limited
to the sum of the contingent coupon payments you receive, if any. Consequently, your return on the securities may be significantly less
than the return you could achieve on an alternative investment that provides for participation in an increase in the level of any or each
Index.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&#183;</FONT></TD><TD STYLE="text-align: justify"><B>Your Return On The Securities Will Depend Solely On The Performance Of The Index That Is The Lowest
Performing Index On Each Eligible Trading Day During The Observation Periods, Including The Final Calculation Day, And You Will Not Benefit
In Any Way From The Performance Of The Better Performing Indices</B> &#8212; Your return on the securities will depend solely on the performance
of the Index that is the lowest performing Index on each eligible trading day during the observation periods, including on the final calculation
day. Although it is necessary for each Index to close at or above its coupon threshold level on each eligible trading during the relevant
observation period in order for you to receive a contingent coupon payment and at or above its downside threshold level on the final calculation
day for you to be repaid the principal amount of your securities at maturity, you will not benefit in any way from the performance of
the better performing Indices. The securities may underperform an alternative investment linked to a basket composed of the Indices, since
in such case the performance of the better performing Indices would be blended with the performance of the lowest performing Index, resulting
in a better return than the return of the lowest performing Index alone.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&#183;</FONT></TD><TD STYLE="text-align: justify"><B>Higher Contingent Coupon Rates Are Associated With Greater Risk</B> &#8212; The securities offer contingent
coupon payments at a higher rate, if paid, than the fixed rate we would pay on conventional debt securities of the same maturity. These
higher potential contingent coupon payments are associated with greater levels of expected risk as of the pricing date as compared to
conventional debt securities, including the risk that you may not receive a contingent coupon payment on one or more, or any, contingent
coupon payment dates and the risk that you may lose a substantial portion, and possibly all, of the principal amount at maturity. The
volatility of the Indices and the correlation among the Indices are important factors affecting this risk. Volatility is a measure of
the degree of variation in the levels of the Indices over a period of time. Volatility can be measured in a variety of ways, including
on a historical basis or on an expected basis as implied by option prices in the market. The correlation of a pair of Indices represents
a statistical measurement of the degree to which the returns of those Indices are similar to each other over a given period in terms of
timing and direction. Greater expected volatility of the Indices or lower expected correlation among the Indices as of the pricing date
may result in a higher contingent coupon rate, but it also represents a greater expected likelihood as of the pricing date that the closing
level of at least one Index will be less than its coupon threshold level on one or more eligible trading days during one or more observation
periods, such that you will not receive one or more, or any, contingent coupon payments during the term of the securities, and that the
closing level of at least one Index will be less than its downside threshold level on the final calculation day such that you will lose
a substantial portion, and possibly all, of the principal amount at maturity. In general, the higher the contingent coupon rate is relative
to the fixed rate we would pay on conventional debt securities, the greater the expected risk that you will not receive one or more, or
any, contingent coupon payments during the term of the securities and that you will lose a substantial portion, and possibly all, of the
principal amount at maturity.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&#183;</FONT></TD><TD STYLE="text-align: justify"><B>Our Redemption Right May Limit Your Potential To Receive Contingent Coupon Payments</B> &#8212; We
may, at our option, redeem the securities on any optional redemption date. Although exercise of the redemption right will be within our
sole discretion, we will be more likely to redeem the securities at a time when the lowest performing Index is performing favorably from
your perspective&#8212;in other words, at a time when, if the securities were to remain outstanding, it is more likely that you would
have continued to receive contingent coupon payments and been repaid the principal amount at maturity. Therefore, our redemption right
is likely to limit your potential to receive contingent coupon payments if the lowest performing Index is performing favorably from your
perspective. On the other hand, we will be less likely to redeem the securities at a time when the lowest performing Index is performing
unfavorably from your perspective&#8212;in other words, you are more likely to continue to hold the securities at a time when it is less
likely that you will continue to receive contingent coupon payments and it is less likely that you will be repaid the principal amount
at maturity.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; text-indent: 0in">If we exercise our
redemption right, the term of the securities may be reduced to as short as approximately three months. There is no guarantee that you
would be able to reinvest the proceeds from an investment in the securities at a comparable return for a similar level of risk in the
event we redeem the securities prior to maturity.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; text-indent: 0in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&#183;</FONT></TD><TD STYLE="text-align: justify"><B>You Will Be Subject To Risks Resulting From The Relationship Between The Indices</B> &#8212; The correlation
of a pair of Indices represents a statistical measurement of the degree to which the returns of those Indices are similar to each other
over a given period in terms of timing and direction. By investing in the securities, you assume the risk that the returns of the Indices
will not be correlated. The less correlated the Indices, the more likely it is that any one of the Indices will be performing poorly at
any time over the term of the securities. All that is necessary for the securities to perform poorly is for one of the Indices to perform
poorly; the performance of the better performing Indices is not relevant to your return on the securities. It is impossible to predict
what the relationship between the Indices will be over the term of the securities. The Indices may represent different equity markets,
and those equity markets may not perform similarly over the term of the securities.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>


<!-- Field: Page; Sequence: 13; Value: 2 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">PS-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->13<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="font: 18pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; color: #BB0826"><B>Market Linked Securities&mdash;Callable with Contingent Coupon with Daily Observation and Contingent Downside</B></P><P STYLE="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; color: #BB0826"><B>Principal at Risk Securities Linked to the Lowest Performing of the Nasdaq-100 Index<SUP>&reg;</SUP>, the Russell 2000<SUP>&reg;</SUP> Index and the S&amp;P 500<SUP>&reg;</SUP> Index due April 22, 2030</B></P></DIV>
    <!-- Field: /Page -->

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&#183;</FONT></TD><TD STYLE="text-align: justify"><B>Any Payment On The Securities Will Be Determined Based On The Closing Levels Of The Indices On The
Dates Specified</B> &#8212; Any payment on the securities will be determined based on the closing levels of the Indices on the dates specified.
You will not benefit from any more favorable values of the Indices determined at any other time.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&#183;</FONT></TD><TD STYLE="text-align: justify"><B>Owning The Securities Is Not The Same As Owning The Securities Composing Any Or All Of The Indices</B>
&#8212; The return on your securities may not reflect the return you would realize if you actually owned the securities composing any
or all of the Indices. For instance, as a holder of the securities, you will not have voting rights or rights to receive cash dividends
or other distributions or any other rights that holders of the securities composing any Index would have.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&#183;</FONT></TD><TD STYLE="text-align: justify"><B>No Assurance That The Investment View Implicit In The Securities Will Be Successful</B> &#8212; It
is impossible to predict whether and the extent to which the level of any Index will rise or fall. There can be no assurance that the
level of any Index will not close below its coupon threshold level on any eligible trading day during an observation period or below its
downside threshold level on the final calculation day. The level of each Index will be influenced by complex and interrelated political,
economic, financial and other factors that affect that Index and the securities composing that Index. You should be willing to accept
the downside risks associated with equities in general and each Index in particular, and the risk of losing a significant portion or all
of the principal amount.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&#183;</FONT></TD><TD STYLE="text-align: justify"><B>Tax Treatment &#8212; </B>Significant aspects of the tax treatment of the securities are uncertain.
You should consult your tax advisor about your tax situation. See &#8220;Tax Considerations&#8221; below.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Risks Relating to the Issuer</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&#183;</FONT></TD><TD STYLE="text-align: justify"><B>The Securities Are Subject To The Credit Risk Of Barclays Bank PLC</B> &#8212; The securities are unsecured
and unsubordinated debt obligations of the issuer, Barclays Bank PLC, and are not, either directly or indirectly, an obligation of any
third party. Any payment to be made on the securities, including any repayment of principal, is subject to the ability of Barclays Bank
PLC to satisfy its obligations as they come due and is not guaranteed by any third party. As a result, the actual and perceived creditworthiness
of Barclays Bank PLC may affect the market value of the securities and, in the event Barclays Bank PLC were to default on its obligations,
you might not receive any amount owed to you under the terms of the securities.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&#183;</FONT></TD><TD STYLE="text-align: justify"><B>You May Lose Some Or All Of Your Investment If Any U.K. Bail-In Power Is Exercised By The Relevant
U.K. Resolution Authority &#8212; </B>Notwithstanding and to the exclusion of any other term of the securities or any other agreements,
arrangements or understandings between Barclays Bank PLC and any holder or beneficial owner of the securities (or the trustee on behalf
of the holders of the securities), by acquiring the securities, each holder or beneficial owner of the securities acknowledges, accepts,
agrees to be bound by, and consents to the exercise of, any U.K. Bail-in Power by the relevant U.K. resolution authority as set forth
under &#8220;Consent to U.K. Bail-in Power&#8221; in this pricing supplement. Accordingly, any U.K. Bail-in Power may be exercised in
such a manner as to result in you and other holders and beneficial owners of the securities losing all or a part of the value of your
investment in the securities or receiving a different security from the securities, which may be worth significantly less than the securities
and which may have significantly fewer protections than those typically afforded to debt securities. Moreover, the relevant U.K. resolution
authority may exercise the U.K. Bail-in Power without providing any advance notice to, or requiring the consent of, the holders and beneficial
owners of the securities. The exercise of any U.K. Bail-in Power by the relevant U.K. resolution authority with respect to the securities
will not be a default or an Event of Default (as each term is defined in the senior debt securities indenture) and the trustee will not
be liable for any action that the trustee takes, or abstains from taking, in either case, in accordance with the exercise of the U.K.
Bail-in Power by the relevant U.K. resolution authority with respect to the securities. See &#8220;Consent to U.K. Bail-in Power&#8221;
in this pricing supplement as well as &#8220;U.K. Bail-in Power,&#8221; &#8220;Risk Factors&#8212;Risks Relating to the Securities Generally&#8212;Regulatory
action in the event a bank or investment firm in the Group is failing or likely to fail, including the exercise by the relevant U.K. resolution
authority of a variety of statutory resolution powers, could materially adversely affect the value of any securities&#8221; and &#8220;Risk
Factors&#8212;Risks Relating to the Securities Generally&#8212;Under the terms of the securities, you have agreed to be bound by the exercise
of any U.K. Bail-in Power by the relevant U.K. resolution authority&#8221; in the accompanying prospectus supplement.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Risks Relating to the Indices</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&#183;</FONT></TD><TD STYLE="text-align: justify"><B>There Are Risks Associated With Investments In Securities Linked To The Value Of Non-U.S. Equity Securities
With Respect To The NDX Index</B> &#8212; Some of the equity securities composing the NDX Index are issued by non-U.S. companies. Investments
in securities linked to the value of such non-U.S. equity securities involve risks associated with the home countries of the issuers of
those non-U.S. equity securities. The prices of securities in non-U.S. markets may be affected by political, economic, financial and social
factors in those countries, or global regions, including changes in government, economic and fiscal policies and currency exchange laws.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&#183;</FONT></TD><TD STYLE="text-align: justify"><B>The Securities Are Subject To Small-Capitalization Companies Risk With Respect To The RTY Index</B>
&#8212; The RTY Index tracks companies that are considered small-capitalization companies. These companies often have greater stock price
volatility, lower trading volume and less liquidity than large-capitalization companies, and therefore securities linked to the RTY Index
may be more</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>


<!-- Field: Page; Sequence: 14; Value: 2 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">PS-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->14<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="font: 18pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; color: #BB0826"><B>Market Linked Securities&mdash;Callable with Contingent Coupon with Daily Observation and Contingent Downside</B></P><P STYLE="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; color: #BB0826"><B>Principal at Risk Securities Linked to the Lowest Performing of the Nasdaq-100 Index<SUP>&reg;</SUP>, the Russell 2000<SUP>&reg;</SUP> Index and the S&amp;P 500<SUP>&reg;</SUP> Index due April 22, 2030</B></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; text-indent: 0in">volatile than an
investment linked to an index with component stocks issued by large-capitalization companies. Stock prices of small-capitalization companies
are also more vulnerable than those of large-capitalization companies to adverse business and economic developments. In addition, small-capitalization
companies are typically less stable financially than large-capitalization companies and may depend on a small number of key personnel,
making them more vulnerable to loss of personnel. Small-capitalization companies are often subject to less analyst coverage and may be
in early, and less predictable, periods of their corporate existences. Such companies tend to have smaller revenues, less diverse product
lines, smaller shares of their product or service markets, fewer financial resources and less competitive strengths than large-capitalization
companies and are more susceptible to adverse developments related to their products.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; text-indent: 0in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&#183;</FONT></TD><TD STYLE="text-align: justify"><B>Each Index Reflects The Price Return Of The Securities Composing That Index, Not The Total Return</B>
&#8212; The return on the securities is based on the performance of the Indices, which reflects changes in the market prices of the securities
composing each Index. Each Index is not a &#8220;total <FONT STYLE="background-color: white">return</FONT>&#8221; index that, in addition
to reflecting those price returns, would also reflect dividends paid on the securities composing the applicable Index. Accordingly, the
return on the securities will not include such a total return feature.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&#183;</FONT></TD><TD STYLE="text-align: justify"><B>We Cannot Control Actions Of Any Of The Unaffiliated Companies Whose Securities Are Included As Components
Of The Indices </B>&#8212; Actions by any company whose securities are components of an Index may have an adverse effect on the price
of its security, the closing level of such Index on any eligible trading day during the observation periods, the ending level of such
Index and the value of the securities. These unaffiliated companies will not be involved in the offering of the securities and will have
no obligations with respect to the <FONT STYLE="background-color: white">securities</FONT>, including any obligation to take <FONT STYLE="background-color: white">our</FONT>
or your interests into consideration for any reason. These companies will not <FONT STYLE="background-color: white">receive</FONT> any
of the proceeds of the offering of the securities and will not be responsible for, and will not have participated in, the determination
of the timing of, prices for, or quantities of, the securities to be issued. These companies will not be involved with the administration,
marketing or trading of the securities and will have no obligations with respect to any amounts to be paid to you on the securities.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&#183;</FONT></TD><TD STYLE="text-align: justify"><B>We And Our Affiliates Have No Affiliation With Any Index Sponsor And Have Not Independently Verified
Their Public Disclosure Of Information </B>&#8212; We, our affiliates and WFS and its affiliates are not affiliated in any way with any
index sponsor and have no ability to control or predict their actions, including any errors in or discontinuation of disclosure regarding
the methods or policies relating to the calculation of <FONT STYLE="background-color: white">the</FONT> applicable Index. We have derived
the information about each Index contained in this pricing <FONT STYLE="background-color: white">supplement</FONT> and the accompanying
underlying supplement from publicly available information, without independent verification. You, as an investor in the securities, should
make your own investigation into each Index and the index sponsors. The index sponsors will not be involved in the offering of the securities
made hereby in any way, and the index sponsors do not have any obligation to consider your interests as an owner of the securities in
taking any actions that might affect the value of the securities.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&#183;</FONT></TD><TD STYLE="text-align: justify"><B>Adjustments To The Indices Could Adversely Affect The Value Of The Securities And The Amount You Will
Receive At Maturity</B> &#8212; The sponsor of an Index (an &#8220;<U>index sponso</U>r&#8221;) may add, delete, substitute or adjust
the securities composing that Index or make other methodological <FONT STYLE="background-color: white">changes</FONT> to that Index that
could affect its performance. The calculation agent will calculate the value to be used as the closing level of an Index in the event
of certain material changes in or modifications to that Index. In addition, an index sponsor may also discontinue or suspend calculation
or publication of that Index at any time. Under these circumstances, the calculation agent may select a successor index that the calculation
agent determines to be comparable to the discontinued index or, if no successor index is available, the calculation agent will determine
the value to be used as the closing level of that Index. Any of these actions could adversely affect the level of the relevant Index and,
consequently, the value of the securities. See &#8220;General Terms of the Securities&#8212;Certain Terms for Securities Linked to an
Index&#8212;Adjustments to an Index&#8221; and &#8220;&#8212;Discontinuance of an Index&#8221; in the accompanying product supplement.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&#183;</FONT></TD><TD STYLE="text-align: justify"><B>The Historical Performance Of The Indices Is Not An Indication Of Their Future Performance &#8212;</B>
The historical performance of the Indices should not be taken as an indication of the future performance of the Indices. It is impossible
to predict whether the closing levels of the Indices will fall or rise during the term of the securities, in particular in the environment
in the last several years, which has been characterized by volatility across a wide range of asset classes. Past fluctuations and trends
in the levels of the Indices are not necessarily indicative of fluctuations or trends that may occur in the future.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Risks Relating to Conflicts of Interest</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&#183;</FONT></TD><TD STYLE="text-align: justify"><B>Potentially Inconsistent Research, Opinions Or Recommendations By Barclays Capital Inc., WFS Or Their
Respective Affiliates</B> &#8212; Barclays Capital Inc., WFS or their respective affiliates may publish research from time to time on
financial markets and other matters that may influence the value of the securities or express opinions or provide recommendations that
are inconsistent with purchasing or holding the securities. Any research, opinions or recommendations expressed by Barclays Capital Inc.,
WFA or their respective affiliates may not be consistent with each other and may be modified from time to time without notice. You should
make your own independent investigation of each Index and the merits of investing in the securities.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&#183;</FONT></TD><TD STYLE="text-align: justify"><B>We, Our Affiliates And Any Other Agent And/Or Participating Dealer May Engage In Various Activities
Or Make Determinations That Could Materially Affect Your Securities In Various Ways And Create Conflicts Of Interest </B>&#8212;</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>


<!-- Field: Page; Sequence: 15; Value: 2 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">PS-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->15<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="font: 18pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; color: #BB0826"><B>Market Linked Securities&mdash;Callable with Contingent Coupon with Daily Observation and Contingent Downside</B></P><P STYLE="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; color: #BB0826"><B>Principal at Risk Securities Linked to the Lowest Performing of the Nasdaq-100 Index<SUP>&reg;</SUP>, the Russell 2000<SUP>&reg;</SUP> Index and the S&amp;P 500<SUP>&reg;</SUP> Index due April 22, 2030</B></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; text-indent: 0in">We, our affiliates,
WFS and any dealer participating in the distribution of the securities (a &ldquo;<U>participating dealer</U>&rdquo;) may play a variety
of roles in connection with the issuance of the securities, as described below. In performing these roles, our economic interests and
the economic interests of our affiliates, WFS and any participating dealer are potentially adverse to your interests as an investor in
the securities.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; text-indent: 0in">In connection with
our normal business activities and in connection with hedging our obligations under the securities, we and our affiliates make markets
in and trade various financial instruments or products for our accounts and for the account of our clients and otherwise provide investment
banking and other financial services with respect to these financial instruments and products. These financial instruments and products
may include securities, derivative instruments or assets that may relate to the Indices or their components. In any such market making,
trading and hedging activity, investment banking and other financial services, we or our affiliates may take positions or take actions
that are inconsistent with, or adverse to, the investment objectives of the holders of the securities. We and our affiliates have no obligation
to take the needs of any buyer, seller or holder of the securities into account in conducting these activities. Such market making, trading
and hedging activity, investment banking and other financial services may negatively impact the value of the securities. Participating
dealers may also engage in such activities that may negatively impact the value of the securities.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; text-indent: 0in">In addition, the
role played by Barclays Capital Inc., as the agent for the securities, could present significant conflicts of interest with the role of
Barclays Bank PLC, as issuer of the securities. For example, Barclays Capital Inc. or its representatives may derive compensation or financial
benefit from the distribution of the securities and such compensation or financial benefit may serve as an incentive to sell the securities
instead of other investments. Furthermore, we and our affiliates establish the offering price of the securities for initial sale to the
public, and the offering price is not based upon any independent verification or valuation.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; text-indent: 0in">Furthermore, if any
dealer participating in the distribution of the securities or any of its affiliates conducts hedging activities for us in connection with
the securities, that participating dealer or its affiliates will expect to realize a projected profit from such hedging activities, and
this projected profit will be in addition to any selling concession and/or any fee that the participating dealer realizes for the sale
of the securities to you. This additional projected profit may create a further incentive for the participating dealer to sell the securities
to you.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; text-indent: 0in">In addition to the
activities described above, Barclays Bank PLC will also act as the calculation agent for the securities. As calculation agent, we will
determine any levels of the Indices and make any other determinations necessary to calculate any payments on the securities. In making
these determinations, we may be required to make discretionary judgments, including those described in the accompanying product supplement
and under &ldquo;&mdash;Risks Relating to the Indices&rdquo; above. In making these discretionary judgments, our economic interests are
potentially adverse to your interests as an investor in the securities, and any of these determinations may adversely affect any payments
on the securities. Absent manifest error, all determinations of the calculation agent will be final and binding, without any liability
on the part of the calculation agent. You will not be entitled to any compensation from Barclays Bank PLC for any loss suffered as a result
of any determinations made by the calculation agent with respect to the securities.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><B>Risks Relating to the Estimated
Value of the Securities and the Secondary Market </B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&#183;</FONT></TD><TD STYLE="text-align: justify"><B>The Securities Will Not Be Listed On Any Securities Exchange And We Do Not Expect A Trading Market
For The Securities To Develop</B> &#8212; The securities will not be listed on any securities exchange. Barclays Capital Inc. and other
affiliates of Barclays Bank PLC intend to make a secondary market for the securities but are not required to do so, and may discontinue
any such secondary market making at any time, without notice. Even if there is a secondary market, it may not provide enough liquidity
to allow you to trade or sell the securities easily. Because other dealers are not likely to make a secondary market for the securities,
the price at which you may be able to trade your securities is likely to depend on the price, if any, at which Barclays Capital Inc. and
other affiliates of Barclays Bank PLC are willing to buy the securities. The securities are not designed to be short-term trading instruments.
Accordingly, you should be willing and able to hold your securities to maturity.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&#183;</FONT></TD><TD STYLE="text-align: justify"><B>The Value Of The Securities Prior To Maturity Will Be Affected By Numerous Factors, Some Of Which Are
Related In Complex Ways</B> &#8212; Structured notes, including the securities, can be thought of as securities that combine a debt instrument
with one or more options or other derivative instruments. As a result, the factors that influence the values of debt instruments and options
or other derivative instruments will also influence the terms and features of the securities at issuance and their value in the secondary
market. Accordingly, in addition to the levels of the Indices on any day, the value of the securities will be affected by a number of
economic and market factors that may either offset or magnify each other, including:</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&#183;</FONT></TD><TD STYLE="text-align: justify">the expected volatility of the Indices;</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&#183;</FONT></TD><TD STYLE="text-align: justify">correlation (or lack of correlation) of the Indices;</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&#183;</FONT></TD><TD STYLE="text-align: justify">the time to maturity of the securities;</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&#183;</FONT></TD><TD STYLE="text-align: justify">the market prices of, and dividend rates on, the securities composing the Indices;</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>


<!-- Field: Page; Sequence: 16; Value: 2 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">PS-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->16<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="font: 18pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; color: #BB0826"><B>Market Linked Securities&mdash;Callable with Contingent Coupon with Daily Observation and Contingent Downside</B></P><P STYLE="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; color: #BB0826"><B>Principal at Risk Securities Linked to the Lowest Performing of the Nasdaq-100 Index<SUP>&reg;</SUP>, the Russell 2000<SUP>&reg;</SUP> Index and the S&amp;P 500<SUP>&reg;</SUP> Index due April 22, 2030</B></P></DIV>
    <!-- Field: /Page -->

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&#183;</FONT></TD><TD STYLE="text-align: justify">interest and yield rates in the market generally;</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&#183;</FONT></TD><TD STYLE="text-align: justify">supply and demand for the securities;</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&#183;</FONT></TD><TD STYLE="text-align: justify">a variety of economic, financial, political, regulatory and judicial events; and</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&#183;</FONT></TD><TD STYLE="text-align: justify">our creditworthiness, including actual or anticipated downgrades in our credit ratings.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&#183;</FONT></TD><TD STYLE="text-align: justify"><B>The Estimated Value Of Your Securities Is Lower Than The Original Offering Price Of Your Securities</B>
&#8212; The estimated value of your securities on the pricing date is lower than the original offering price of your securities. The difference
between the original offering price of your securities and the estimated value of the securities is a result of certain factors, such
as any sales commissions, selling concessions, discounts, commissions or fees to be allowed or paid to Barclays Capital Inc., another
affiliate of ours, WFS or its affiliates or other non-affiliated intermediaries, the estimated profit that we or any of our affiliates
expect to earn in connection with structuring the securities, the estimated cost that we may incur in hedging our obligations under the
securities, and estimated development and other costs that we may incur in connection with the securities.&#9;</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&#183;</FONT></TD><TD STYLE="text-align: justify"><B>The Estimated Value Of Your Securities Might Be Lower If Such Estimated Value Were Based On The Levels
At Which Our Debt Securities Trade In The Secondary Market</B> &#8212; The estimated value of your securities on the pricing date is based
on a number of variables, including our internal funding rates. Our internal funding rates may vary from the levels at which our benchmark
debt securities trade in the secondary market. As a result of this difference, the estimated value referenced above might be lower if
such estimated value were based on the levels at which our benchmark debt securities trade in the secondary market.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&#183;</FONT></TD><TD STYLE="text-align: justify"><B>The Estimated Value Of The Securities Is Based On Our Internal Pricing Models, Which May Prove To Be
Inaccurate And May Be Different From The Pricing Models Of Other Financial Institutions</B> &#8212; The estimated value of your securities
on the pricing date is based on our internal pricing models, which take into account a number of variables and are based on a number of
subjective assumptions, which may or may not materialize. These variables and assumptions are not evaluated or verified on an independent
basis. Further, our pricing models may be different from other financial institutions&#8217; pricing models and the methodologies used
by us to estimate the value of the securities may not be consistent with those of other financial institutions that may be purchasers
or sellers of securities in the secondary market. As a result, the secondary market price of your securities may be materially different
from the estimated value of the securities determined by reference to our internal pricing models.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&#183;</FONT></TD><TD STYLE="text-align: justify"><B>The Estimated Value Of Your Securities Is Not A Prediction Of The Prices At Which You May Sell Your
Securities In The Secondary Market, If Any, And Such Secondary Market Prices, If Any, Will Likely Be Lower Than The Original Offering
Price Of Your Securities And May Be Lower Than The Estimated Value Of Your Securities</B> &#8212; The estimated value of the securities
will not be a prediction of the prices at which Barclays Capital Inc., other affiliates of ours or third parties may be willing to purchase
the securities from you in secondary market transactions (if they are willing to purchase, which they are not obligated to do). The price
at which you may be able to sell your securities in the secondary market at any time will be influenced by many factors that cannot be
predicted, such as market conditions, and any bid and ask spread for similar sized trades, and may be substantially less than our estimated
value of the securities. Further, as secondary market prices of your securities take into account the levels at which our debt securities
trade in the secondary market, and do not take into account our various costs related to the securities such as fees, commissions, discounts,
and the costs of hedging our obligations under the securities, secondary market prices of your securities will likely be lower than the
original offering price of your securities. As a result, the price at which Barclays Capital Inc., other affiliates of ours or third parties
may be willing to purchase the securities from you in secondary market transactions, if any, will likely be lower than the price you paid
for your securities, and any sale prior to the stated maturity date could result in a substantial loss to you.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&#183;</FONT></TD><TD STYLE="text-align: justify"><B>The Temporary Price At Which We May Initially Buy The Securities In The Secondary Market And The Value
We May Initially Use For Customer Account Statements, If We Provide Any Customer Account Statements At All, May Not Be Indicative Of Future
Prices Of Your Securities</B> &#8212; Assuming that all relevant factors remain constant after the pricing date, the price at which Barclays
Capital Inc. may initially buy or sell the securities in the secondary market (if Barclays Capital Inc. makes a market in the securities,
which it is not obligated to do) and the value that we may initially use for customer account statements, if we provide any customer account
statements at all, may exceed our estimated value of the securities on the pricing date, as well as the secondary market value of the
securities, for a temporary period after the initial issue date of the securities. The price at which Barclays Capital Inc. may initially
buy or sell the securities in the secondary market and the value that we may initially use for customer account statements may not be
indicative of future prices of your securities.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>


<!-- Field: Page; Sequence: 17; Value: 2 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">PS-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->17<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="font: 18pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; color: #BB0826"><B>Market Linked Securities&mdash;Callable with Contingent Coupon with Daily Observation and Contingent Downside</B></P><P STYLE="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; color: #BB0826"><B>Principal at Risk Securities Linked to the Lowest Performing of the Nasdaq-100 Index<SUP>&reg;</SUP>, the Russell 2000<SUP>&reg;</SUP> Index and the S&amp;P 500<SUP>&reg;</SUP> Index due April 22, 2030</B></P></DIV>
    <!-- Field: /Page -->

<P STYLE="color: white; font: bold 12pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: center; background-color: #4F81BD">Hypothetical
Returns</P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>If we redeem the securities prior to stated
maturity:</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">If we redeem the securities prior to stated maturity,
you will receive the principal amount of your securities plus any contingent coupon payment otherwise due on the applicable optional redemption
date. In the event we redeem the securities prior to stated maturity, your total return on the securities will equal any contingent coupon
payments received prior to the optional redemption date and any contingent coupon payment received on the optional redemption date.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>If we do not redeem the securities prior to
stated maturity:</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">If we do not redeem the securities prior to stated
maturity, the following table illustrates, for a range of hypothetical performance factors of the lowest performing Index on the final
calculation day, the hypothetical maturity payment amount payable at stated maturity per security (excluding any contingent coupon payment
otherwise due). The performance factor of the lowest performing Index on the final calculation day is calculated as its ending level divided
by its starting level.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" ALIGN="CENTER" STYLE="font: 10pt Times New Roman, Times, Serif; width: 45%; border-collapse: collapse">
  <TR>
    <TD STYLE="width: 50%; border: Black 1pt solid; text-align: center"><FONT STYLE="font-size: 10pt"><B>Hypothetical performance factor of lowest performing Index on final calculation day</B></FONT></TD>
    <TD STYLE="width: 50%; border-top: Black 1pt solid; border-right: Black 1pt solid; border-bottom: Black 1pt solid; text-align: center"><FONT STYLE="font-size: 10pt"><B>Hypothetical maturity payment amount per security</B></FONT></TD></TR>
  <TR>
    <TD STYLE="white-space: nowrap; border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid; text-align: center"><FONT STYLE="font-size: 10pt">175.00%</FONT></TD>
    <TD STYLE="white-space: nowrap; border-bottom: Black 1pt solid; border-right: Black 1pt solid; text-align: center"><FONT STYLE="font-size: 10pt">$1,000.00</FONT></TD></TR>
  <TR>
    <TD STYLE="white-space: nowrap; border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid; text-align: center"><FONT STYLE="font-size: 10pt">150.00%</FONT></TD>
    <TD STYLE="white-space: nowrap; border-bottom: Black 1pt solid; border-right: Black 1pt solid; text-align: center"><FONT STYLE="font-size: 10pt">$1,000.00</FONT></TD></TR>
  <TR>
    <TD STYLE="white-space: nowrap; border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid; text-align: center"><FONT STYLE="font-size: 10pt">140.00%</FONT></TD>
    <TD STYLE="white-space: nowrap; border-bottom: Black 1pt solid; border-right: Black 1pt solid; text-align: center"><FONT STYLE="font-size: 10pt">$1,000.00</FONT></TD></TR>
  <TR>
    <TD STYLE="white-space: nowrap; border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid; text-align: center"><FONT STYLE="font-size: 10pt">130.00%</FONT></TD>
    <TD STYLE="white-space: nowrap; border-bottom: Black 1pt solid; border-right: Black 1pt solid; text-align: center"><FONT STYLE="font-size: 10pt">$1,000.00</FONT></TD></TR>
  <TR>
    <TD STYLE="white-space: nowrap; border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid; text-align: center"><FONT STYLE="font-size: 10pt">120.00%</FONT></TD>
    <TD STYLE="white-space: nowrap; border-bottom: Black 1pt solid; border-right: Black 1pt solid; text-align: center"><FONT STYLE="font-size: 10pt">$1,000.00</FONT></TD></TR>
  <TR>
    <TD STYLE="white-space: nowrap; border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid; text-align: center"><FONT STYLE="font-size: 10pt">110.00%</FONT></TD>
    <TD STYLE="white-space: nowrap; border-bottom: Black 1pt solid; border-right: Black 1pt solid; text-align: center"><FONT STYLE="font-size: 10pt">$1,000.00</FONT></TD></TR>
  <TR STYLE="background-color: #CCCCCC">
    <TD STYLE="white-space: nowrap; border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid; text-align: center"><FONT STYLE="font-size: 10pt">100.00%</FONT></TD>
    <TD STYLE="white-space: nowrap; border-bottom: Black 1pt solid; border-right: Black 1pt solid; text-align: center"><FONT STYLE="font-size: 10pt">$1,000.00</FONT></TD></TR>
  <TR>
    <TD STYLE="white-space: nowrap; border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid; text-align: center"><FONT STYLE="font-size: 10pt">90.00%</FONT></TD>
    <TD STYLE="white-space: nowrap; border-bottom: Black 1pt solid; border-right: Black 1pt solid; text-align: center"><FONT STYLE="font-size: 10pt">$1,000.00</FONT></TD></TR>
  <TR>
    <TD STYLE="white-space: nowrap; border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid; text-align: center"><FONT STYLE="font-size: 10pt">80.00%</FONT></TD>
    <TD STYLE="white-space: nowrap; border-bottom: Black 1pt solid; border-right: Black 1pt solid; text-align: center"><FONT STYLE="font-size: 10pt">$1,000.00</FONT></TD></TR>
  <TR>
    <TD STYLE="white-space: nowrap; border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid; text-align: center"><FONT STYLE="font-size: 10pt">70.00%</FONT></TD>
    <TD STYLE="white-space: nowrap; border-bottom: Black 1pt solid; border-right: Black 1pt solid; text-align: center"><FONT STYLE="font-size: 10pt">$1,000.00</FONT></TD></TR>
  <TR STYLE="background-color: #CCCCCC">
    <TD STYLE="white-space: nowrap; border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid; text-align: center"><FONT STYLE="font-size: 10pt">60.00%</FONT></TD>
    <TD STYLE="white-space: nowrap; border-bottom: Black 1pt solid; border-right: Black 1pt solid; text-align: center"><FONT STYLE="font-size: 10pt">$1,000.00</FONT></TD></TR>
  <TR>
    <TD STYLE="white-space: nowrap; border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid; text-align: center"><FONT STYLE="font-size: 10pt">59.00%</FONT></TD>
    <TD STYLE="white-space: nowrap; border-bottom: Black 1pt solid; border-right: Black 1pt solid; text-align: center"><FONT STYLE="font-size: 10pt">$590.00</FONT></TD></TR>
  <TR>
    <TD STYLE="white-space: nowrap; border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid; text-align: center"><FONT STYLE="font-size: 10pt">50.00%</FONT></TD>
    <TD STYLE="white-space: nowrap; border-bottom: Black 1pt solid; border-right: Black 1pt solid; text-align: center"><FONT STYLE="font-size: 10pt">$500.00</FONT></TD></TR>
  <TR>
    <TD STYLE="white-space: nowrap; border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid; text-align: center"><FONT STYLE="font-size: 10pt">40.00%</FONT></TD>
    <TD STYLE="white-space: nowrap; border-bottom: Black 1pt solid; border-right: Black 1pt solid; text-align: center"><FONT STYLE="font-size: 10pt">$400.00</FONT></TD></TR>
  <TR>
    <TD STYLE="white-space: nowrap; border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid; text-align: center"><FONT STYLE="font-size: 10pt">25.00%</FONT></TD>
    <TD STYLE="white-space: nowrap; border-bottom: Black 1pt solid; border-right: Black 1pt solid; text-align: center"><FONT STYLE="font-size: 10pt">$250.00</FONT></TD></TR>
  <TR>
    <TD STYLE="white-space: nowrap; border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid; text-align: center"><FONT STYLE="font-size: 10pt">0.00%</FONT></TD>
    <TD STYLE="white-space: nowrap; border-bottom: Black 1pt solid; border-right: Black 1pt solid; text-align: center"><FONT STYLE="font-size: 10pt">$0.00</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The above figures do not take into account contingent
coupon payments, if any, received during the term of the securities. As evidenced above, in no event will you have a positive rate of
return based solely on the maturity payment amount received at maturity (excluding any contingent coupon payment otherwise due); any positive
return will be based solely on the contingent coupon payments, if any, received during the term of the securities.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The above figures are for purposes of illustration
only and may have been rounded for ease of analysis. If we do not redeem the securities prior to stated maturity, the actual amount you
will receive at stated maturity will depend on the actual ending level of the lowest performing Index on the final calculation day. The
performance of the better performing Indices is not relevant to your return on the securities.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>


<!-- Field: Page; Sequence: 18; Value: 2 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">PS-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->18<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="font: 18pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; color: #BB0826"><B>Market Linked Securities&mdash;Callable with Contingent Coupon with Daily Observation and Contingent Downside</B></P><P STYLE="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; color: #BB0826"><B>Principal at Risk Securities Linked to the Lowest Performing of the Nasdaq-100 Index<SUP>&reg;</SUP>, the Russell 2000<SUP>&reg;</SUP> Index and the S&amp;P 500<SUP>&reg;</SUP> Index due April 22, 2030</B></P></DIV>
    <!-- Field: /Page -->

<P STYLE="color: white; font: bold 12pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: center; background-color: #4F81BD">Hypothetical
Contingent Coupon Payments</P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Set forth below are examples that illustrate how
to determine whether a contingent coupon payment will be paid on a contingent coupon payment date. The examples do not reflect any specific
contingent coupon payment date. The following examples assume the hypothetical starting level, coupon threshold level and closing levels
for each Index indicated in the examples. The terms used for purposes of these hypothetical examples do not represent any actual starting
level or coupon threshold level. The hypothetical starting level of 100.00 for each Index has been chosen for illustrative purposes only
and does not represent the actual starting level for any Index. The actual starting level and coupon threshold level for each Index are
set forth under &ldquo;Terms of the Securities&rdquo; above. For historical closing levels of the Indices, see the historical information
set forth under the sections titled &ldquo;The Nasdaq-100 Index<SUP>&reg;</SUP>,&rdquo; &ldquo;The Russell 2000<SUP>&reg;</SUP> Index&rdquo;
and &ldquo;The S&amp;P 500<SUP>&reg;</SUP> Index&rdquo; below. These examples are for purposes of illustration only and the values used
in the examples may have been rounded for ease of analysis. If we were to redeem the securities on the relevant contingent coupon payment
date in either of the examples below, you would receive the principal amount on the contingent coupon payment date in addition to the
contingent coupon payment, if any, and would not receive any further payments.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Example 1.&nbsp;The closing level of the lowest
performing Index on each eligible trading day during the relevant observation period is greater than or equal to its coupon threshold
level. As a result, investors receive a contingent coupon payment on the applicable contingent coupon payment date.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR>
    <TD STYLE="vertical-align: bottom; width: 55%; border: Black 1pt solid">&nbsp;</TD>
    <TD STYLE="width: 15%; border-top: Black 1pt solid; border-right: Black 1pt solid; border-bottom: Black 1pt solid; text-align: center"><FONT STYLE="font-size: 10pt"><B>NDX Index</B></FONT></TD>
    <TD STYLE="width: 15%; border-top: Black 1pt solid; border-right: Black 1pt solid; border-bottom: Black 1pt solid; text-align: center"><FONT STYLE="font-size: 10pt"><B>RTY Index</B></FONT></TD>
    <TD STYLE="vertical-align: bottom; width: 15%; border-top: Black 1pt solid; border-right: Black 1pt solid; border-bottom: Black 1pt solid; text-align: center"><FONT STYLE="font-size: 10pt"><B>SPX Index</B></FONT></TD></TR>
  <TR STYLE="background-color: white">
    <TD STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid; font-size: 12pt"><FONT STYLE="font-size: 10pt"><B>Hypothetical starting level:</B></FONT></TD>
    <TD STYLE="vertical-align: bottom; border-right: Black 1pt solid; border-bottom: Black 1pt solid; text-align: center"><FONT STYLE="font-size: 10pt">100.00</FONT></TD>
    <TD STYLE="vertical-align: bottom; border-right: Black 1pt solid; border-bottom: Black 1pt solid; text-align: center"><FONT STYLE="font-size: 10pt">100.000</FONT></TD>
    <TD STYLE="vertical-align: bottom; border-right: Black 1pt solid; border-bottom: Black 1pt solid; text-align: center"><FONT STYLE="font-size: 10pt">100.00</FONT></TD></TR>
  <TR STYLE="background-color: white">
    <TD STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid; font-size: 12pt"><FONT STYLE="font-size: 10pt"><B>Hypothetical lowest closing level during observation period:</B></FONT></TD>
    <TD STYLE="vertical-align: bottom; border-right: Black 1pt solid; border-bottom: Black 1pt solid; text-align: center"><FONT STYLE="font-size: 10pt">95.00</FONT></TD>
    <TD STYLE="vertical-align: bottom; border-right: Black 1pt solid; border-bottom: Black 1pt solid; text-align: center"><FONT STYLE="font-size: 10pt">115.000</FONT></TD>
    <TD STYLE="vertical-align: bottom; border-right: Black 1pt solid; border-bottom: Black 1pt solid; text-align: center"><FONT STYLE="font-size: 10pt">90.00</FONT></TD></TR>
  <TR STYLE="background-color: white">
    <TD STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid; font-size: 12pt"><FONT STYLE="font-size: 10pt"><B>Hypothetical coupon threshold level: </B></FONT></TD>
    <TD STYLE="vertical-align: bottom; border-right: Black 1pt solid; border-bottom: Black 1pt solid; text-align: center"><FONT STYLE="font-size: 10pt">70.00</FONT></TD>
    <TD STYLE="vertical-align: bottom; border-right: Black 1pt solid; border-bottom: Black 1pt solid; text-align: center"><FONT STYLE="font-size: 10pt">70.000</FONT></TD>
    <TD STYLE="vertical-align: bottom; border-right: Black 1pt solid; border-bottom: Black 1pt solid; text-align: center"><FONT STYLE="font-size: 10pt">70.00</FONT></TD></TR>
  <TR STYLE="background-color: white">
    <TD STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid; font-size: 12pt"><FONT STYLE="font-size: 10pt"><B>Lowest performance factor during observation period (lowest closing level during observation period <I>divided by</I> starting level):</B></FONT></TD>
    <TD STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid; text-align: center"><FONT STYLE="font-size: 10pt">95.00%</FONT></TD>
    <TD STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid; text-align: center"><FONT STYLE="font-size: 10pt">115.00%</FONT></TD>
    <TD STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid; text-align: center"><FONT STYLE="font-size: 10pt">90.00%</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 12.2pt; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 12.2pt; text-align: justify"><U>Step 1</U>: Determine whether the
closing level of the lowest performing Index on any eligible trading day during the relevant observation period was less than its hypothetical
coupon threshold level.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 12.2pt; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 27pt; text-align: justify">In this example, the closing level of
each Index on each eligible trading day during the relevant observation period is greater than its hypothetical coupon threshold level.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 27pt; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 12.2pt; text-align: justify"><U>Step 2</U>: Determine whether a
contingent coupon payment will be paid on the applicable contingent coupon payment date.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 12.2pt; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 27pt; text-align: justify">Since the hypothetical closing level
of the lowest performing Index on each eligible trading day during the relevant observation period is greater than or equal to its hypothetical
coupon threshold level, you would receive a contingent coupon payment on the applicable contingent coupon payment date. The contingent
coupon payment would be equal to $26.50 per security, determined as follows: (i) $1,000 <I>multiplied by</I> 10.60% per annum <I>divided
by</I> (ii) 4, rounded to the nearest cent.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 27pt; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Example 2. The closing level of the lowest
performing Index on at least one eligible trading day during the relevant observation period is less than its coupon threshold level.
As a result, investors do not receive a contingent coupon payment on the applicable contingent coupon payment date.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="background-color: white">
    <TD STYLE="vertical-align: bottom; width: 55%; border: Black 1pt solid">&nbsp;</TD>
    <TD STYLE="width: 15%; border-top: Black 1pt solid; border-right: Black 1pt solid; border-bottom: Black 1pt solid; text-align: center"><FONT STYLE="font-size: 10pt"><B>NDX Index</B></FONT></TD>
    <TD STYLE="width: 15%; border-top: Black 1pt solid; border-right: Black 1pt solid; border-bottom: Black 1pt solid; text-align: center"><FONT STYLE="font-size: 10pt"><B>RTY Index</B></FONT></TD>
    <TD STYLE="vertical-align: bottom; width: 15%; border-top: Black 1pt solid; border-right: Black 1pt solid; border-bottom: Black 1pt solid; text-align: center"><FONT STYLE="font-size: 10pt"><B>SPX Index</B></FONT></TD></TR>
  <TR STYLE="background-color: white">
    <TD STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid; font-size: 12pt"><FONT STYLE="font-size: 10pt"><B>Hypothetical starting level:</B></FONT></TD>
    <TD STYLE="vertical-align: bottom; border-right: Black 1pt solid; border-bottom: Black 1pt solid; text-align: center"><FONT STYLE="font-size: 10pt">100.00</FONT></TD>
    <TD STYLE="vertical-align: bottom; border-right: Black 1pt solid; border-bottom: Black 1pt solid; text-align: center"><FONT STYLE="font-size: 10pt">100.000</FONT></TD>
    <TD STYLE="vertical-align: bottom; border-right: Black 1pt solid; border-bottom: Black 1pt solid; text-align: center"><FONT STYLE="font-size: 10pt">100.00</FONT></TD></TR>
  <TR STYLE="background-color: white">
    <TD STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid; font-size: 12pt"><FONT STYLE="font-size: 10pt"><B>Hypothetical lowest closing level during observation period:</B></FONT></TD>
    <TD STYLE="vertical-align: bottom; border-right: Black 1pt solid; border-bottom: Black 1pt solid; text-align: center"><FONT STYLE="font-size: 10pt">125.00</FONT></TD>
    <TD STYLE="vertical-align: bottom; border-right: Black 1pt solid; border-bottom: Black 1pt solid; text-align: center"><FONT STYLE="font-size: 10pt">55.000</FONT></TD>
    <TD STYLE="vertical-align: bottom; border-right: Black 1pt solid; border-bottom: Black 1pt solid; text-align: center"><FONT STYLE="font-size: 10pt">105.00</FONT></TD></TR>
  <TR STYLE="background-color: white">
    <TD STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid; font-size: 12pt"><FONT STYLE="font-size: 10pt"><B>Hypothetical coupon threshold level: </B></FONT></TD>
    <TD STYLE="vertical-align: bottom; border-right: Black 1pt solid; border-bottom: Black 1pt solid; text-align: center"><FONT STYLE="font-size: 10pt">70.00</FONT></TD>
    <TD STYLE="vertical-align: bottom; border-right: Black 1pt solid; border-bottom: Black 1pt solid; text-align: center"><FONT STYLE="font-size: 10pt">70.000</FONT></TD>
    <TD STYLE="vertical-align: bottom; border-right: Black 1pt solid; border-bottom: Black 1pt solid; text-align: center"><FONT STYLE="font-size: 10pt">70.00</FONT></TD></TR>
  <TR STYLE="background-color: white">
    <TD STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid; font-size: 12pt"><FONT STYLE="font-size: 10pt"><B>Lowest performance factor during observation period (lowest closing level during observation period <I>divided by</I> starting level):</B></FONT></TD>
    <TD STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid; text-align: center"><FONT STYLE="font-size: 10pt">125.00%</FONT></TD>
    <TD STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid; text-align: center"><FONT STYLE="font-size: 10pt">55.00%</FONT></TD>
    <TD STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid; text-align: center"><FONT STYLE="font-size: 10pt">105.00%</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 12.2pt; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 12.2pt; text-align: justify"><U>Step 1</U>: Determine whether the
closing level of the lowest performing Index on any eligible trading day during the relevant observation period was less than its hypothetical
coupon threshold level.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 12.2pt; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 27pt; text-align: justify">In this example, the closing level of
the RTY Index on at least one eligible trading day during the relevant observation period was less than its hypothetical coupon threshold
level.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 27pt; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 12.2pt; text-align: justify"><U>Step 2</U>: Determine whether a
contingent coupon payment will be paid on the applicable contingent coupon payment date.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 12.2pt; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 27pt; text-align: justify">Since the hypothetical closing level
of the lowest performing Index on at least one eligible trading day during the relevant observation period is less than its hypothetical
coupon threshold level, you would not receive a contingent coupon payment on the applicable contingent coupon payment date. This is the
case even though the closing levels of the better performing Indices were</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 27pt; text-align: justify">&nbsp;</P>


<!-- Field: Page; Sequence: 19; Value: 2 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">PS-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->19<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="font: 18pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; color: #BB0826"><B>Market Linked Securities&mdash;Callable with Contingent Coupon with Daily Observation and Contingent Downside</B></P><P STYLE="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; color: #BB0826"><B>Principal at Risk Securities Linked to the Lowest Performing of the Nasdaq-100 Index<SUP>&reg;</SUP>, the Russell 2000<SUP>&reg;</SUP> Index and the S&amp;P 500<SUP>&reg;</SUP> Index due April 22, 2030</B></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 27pt; text-align: justify">each greater than their respective hypothetical
coupon threshold levels on every eligible trading day during the relevant observation period, and would be the case even if the closing
level of the RTY Index was greater than or equal to its hypothetical coupon threshold level on every other eligible trading day during
the relevant observation period.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 27pt; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 27pt; text-align: justify">As this example illustrates, whether
you receive a contingent coupon payment on a contingent coupon payment date will depend solely on the closing level of the lowest performing
Index on each eligible trading day during the relevant observation period. Therefore, if the closing level of any one of the Indices is
less than its coupon threshold level on any eligible trading day during an observation period, you will not receive a contingent coupon
payment with respect to that observation period. This will be the case even if the closing level of the lowest performing Index is greater
than or equal to its coupon threshold level on every other eligible trading day during that observation period, and even if the better
performing Indices perform favorably. The performance of the better performing Indices is not relevant to your return on the securities.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 27pt; text-align: justify">&nbsp;</P>


<!-- Field: Page; Sequence: 20; Value: 2 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">PS-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->20<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="font: 18pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; color: #BB0826"><B>Market Linked Securities&mdash;Callable with Contingent Coupon with Daily Observation and Contingent Downside</B></P><P STYLE="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; color: #BB0826"><B>Principal at Risk Securities Linked to the Lowest Performing of the Nasdaq-100 Index<SUP>&reg;</SUP>, the Russell 2000<SUP>&reg;</SUP> Index and the S&amp;P 500<SUP>&reg;</SUP> Index due April 22, 2030</B></P></DIV>
    <!-- Field: /Page -->

<P STYLE="color: white; font: bold 12pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: center; background-color: #4F81BD">Hypothetical
Maturity Payment Amount</P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Set forth below are examples of calculations of
the maturity payment amount payable at stated maturity, assuming that the securities are not redeemed at our option prior to stated maturity
and assuming the hypothetical starting level, coupon threshold level, downside threshold level, closing levels and ending levels for each
Index indicated in the examples. The terms used for purposes of these hypothetical examples do not represent any actual starting level,
coupon threshold level or downside threshold level. The hypothetical starting level of 100.00 for each Index has been chosen for illustrative
purposes only and does not represent the actual starting level for any Index. The actual starting level, coupon threshold level and downside
threshold level for each Index are set forth under &ldquo;Terms of the Securities&rdquo; above. For historical closing levels of the Indices,
see the historical information set forth under the sections titled &ldquo;The Nasdaq-100 Index<SUP>&reg;</SUP>,&rdquo; &ldquo;The Russell
2000<SUP>&reg;</SUP> Index&rdquo; and &ldquo;The S&amp;P 500<SUP>&reg;</SUP> Index&rdquo; below. These examples are for purposes of illustration
only and the values used in the examples may have been rounded for ease of analysis.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Example 1.&nbsp;The closing level of the lowest
performing Index on each eligible trading day during the final observation period is greater than or equal to its coupon threshold level,
and the ending level of the lowest performing Index on the final calculation day is greater than its starting level. As a result, the
maturity payment amount is equal to the principal amount of your securities at maturity and you receive a final contingent coupon payment.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; background-color: white; border-collapse: collapse">
  <TR>
    <TD STYLE="vertical-align: bottom; width: 55%; border: Black 1pt solid">&nbsp;</TD>
    <TD STYLE="width: 15%; border-top: Black 1pt solid; border-right: Black 1pt solid; border-bottom: Black 1pt solid; text-align: center"><FONT STYLE="font-size: 10pt"><B>NDX Index</B></FONT></TD>
    <TD STYLE="width: 15%; border-top: Black 1pt solid; border-right: Black 1pt solid; border-bottom: Black 1pt solid; text-align: center"><FONT STYLE="font-size: 10pt"><B>RTY Index</B></FONT></TD>
    <TD STYLE="vertical-align: bottom; width: 15%; border-top: Black 1pt solid; border-right: Black 1pt solid; border-bottom: Black 1pt solid; text-align: center"><FONT STYLE="font-size: 10pt"><B>SPX Index</B></FONT></TD></TR>
  <TR>
    <TD STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid; font-size: 12pt"><FONT STYLE="font-size: 10pt"><B>Hypothetical starting level:</B></FONT></TD>
    <TD STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid; text-align: center"><FONT STYLE="font-size: 10pt">100.00</FONT></TD>
    <TD STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid; text-align: center"><FONT STYLE="font-size: 10pt">100.000</FONT></TD>
    <TD STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid; text-align: center"><FONT STYLE="font-size: 10pt">100.00</FONT></TD></TR>
  <TR>
    <TD STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid; font-size: 12pt"><FONT STYLE="font-size: 10pt"><B>Hypothetical lowest closing level during final observation period:</B></FONT></TD>
    <TD STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid; text-align: center"><FONT STYLE="font-size: 10pt">95.00</FONT></TD>
    <TD STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid; text-align: center"><FONT STYLE="font-size: 10pt">80.000</FONT></TD>
    <TD STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid; text-align: center"><FONT STYLE="font-size: 10pt">90.00</FONT></TD></TR>
  <TR>
    <TD STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid; font-size: 12pt"><FONT STYLE="font-size: 10pt"><B>Hypothetical ending level:</B></FONT></TD>
    <TD STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid; text-align: center"><FONT STYLE="font-size: 10pt">135.00</FONT></TD>
    <TD STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid; text-align: center"><FONT STYLE="font-size: 10pt">145.000</FONT></TD>
    <TD STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid; text-align: center"><FONT STYLE="font-size: 10pt">125.00</FONT></TD></TR>
  <TR>
    <TD STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid; font-size: 12pt"><FONT STYLE="font-size: 10pt"><B>Hypothetical coupon threshold level:</B></FONT></TD>
    <TD STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid; text-align: center"><FONT STYLE="font-size: 10pt">70.00</FONT></TD>
    <TD STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid; text-align: center"><FONT STYLE="font-size: 10pt">70.000</FONT></TD>
    <TD STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid; text-align: center"><FONT STYLE="font-size: 10pt">70.00</FONT></TD></TR>
  <TR>
    <TD STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid; font-size: 12pt"><FONT STYLE="font-size: 10pt"><B>Hypothetical downside threshold level:</B></FONT></TD>
    <TD STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid; text-align: center"><FONT STYLE="font-size: 10pt">60.00</FONT></TD>
    <TD STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid; text-align: center"><FONT STYLE="font-size: 10pt">60.000</FONT></TD>
    <TD STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid; text-align: center"><FONT STYLE="font-size: 10pt">60.00</FONT></TD></TR>
  <TR>
    <TD STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid; font-size: 12pt"><FONT STYLE="font-size: 10pt"><B>Lowest performance factor during final observation period (lowest closing level during final observation period <I>divided by</I> starting level):</B></FONT></TD>
    <TD STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid; text-align: center"><FONT STYLE="font-size: 10pt">95.00%</FONT></TD>
    <TD STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid; text-align: center"><FONT STYLE="font-size: 10pt">80.00%</FONT></TD>
    <TD STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid; text-align: center"><FONT STYLE="font-size: 10pt">90.00%</FONT></TD></TR>
  <TR>
    <TD STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid; font-size: 12pt"><FONT STYLE="font-size: 10pt"><B>Performance factor on final calculation day (ending level <I>divided by</I> starting level): </B></FONT></TD>
    <TD STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid; text-align: center"><FONT STYLE="font-size: 10pt">135.00%</FONT></TD>
    <TD STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid; text-align: center"><FONT STYLE="font-size: 10pt">145.00%</FONT></TD>
    <TD STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid; text-align: center"><FONT STYLE="font-size: 10pt">125.00%</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 12.2pt; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 12.2pt; text-align: justify"><U>Step 1</U>: Determine which Index
is the lowest performing Index on the final calculation day.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 12.2pt; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 27pt; text-align: justify">In this example, the SPX Index has the
lowest performance factor on the final calculation day and is, therefore, the lowest performing Index on the final calculation day.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 27pt; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 12.2pt; text-align: justify"><U>Step 2</U>: Determine the maturity
payment amount based on the ending level of the lowest performing Index on the final calculation day.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 12.2pt; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 27pt; text-align: justify">Since the hypothetical ending level of
the lowest performing Index on the final calculation day is greater than its hypothetical downside threshold level, the maturity payment
amount would equal the principal amount. Although the hypothetical ending level of the lowest performing Index on the final calculation
day is significantly greater than its hypothetical starting level in this scenario, the maturity payment amount will not exceed the principal
amount.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 27pt; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 12.2pt; text-align: justify">In addition to any contingent coupon
payments received prior to the stated maturity date, on the stated maturity date you would receive $1,000.00 per security as well as the
contingent coupon payment otherwise due because the hypothetical closing level of the lowest performing Index on each eligible trading
day during the final observation period was greater than its hypothetical coupon threshold level.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 12.2pt; text-align: justify">&nbsp;</P>


<!-- Field: Page; Sequence: 21; Value: 2 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">PS-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->21<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="font: 18pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; color: #BB0826"><B>Market Linked Securities&mdash;Callable with Contingent Coupon with Daily Observation and Contingent Downside</B></P><P STYLE="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; color: #BB0826"><B>Principal at Risk Securities Linked to the Lowest Performing of the Nasdaq-100 Index<SUP>&reg;</SUP>, the Russell 2000<SUP>&reg;</SUP> Index and the S&amp;P 500<SUP>&reg;</SUP> Index due April 22, 2030</B></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Example 2. The closing level of the lowest
performing Index on at least one eligible trading day during the final observation period is less than its coupon threshold level, and
the ending level of the lowest performing Index on the final calculation day is less than its starting level but greater than its downside
threshold level. As a result, the maturity payment amount is equal to the principal amount of your securities at maturity but you will
not receive a final contingent coupon payment.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; background-color: white; border-collapse: collapse">
  <TR>
    <TD STYLE="vertical-align: bottom; width: 55%; border: Black 1pt solid">&nbsp;</TD>
    <TD STYLE="width: 15%; border-top: Black 1pt solid; border-right: Black 1pt solid; border-bottom: Black 1pt solid; text-align: center"><FONT STYLE="font-size: 10pt"><B>NDX Index</B></FONT></TD>
    <TD STYLE="width: 15%; border-top: Black 1pt solid; border-right: Black 1pt solid; border-bottom: Black 1pt solid; text-align: center"><FONT STYLE="font-size: 10pt"><B>RTY Index</B></FONT></TD>
    <TD STYLE="vertical-align: bottom; width: 15%; border-top: Black 1pt solid; border-right: Black 1pt solid; border-bottom: Black 1pt solid; text-align: center"><FONT STYLE="font-size: 10pt"><B>SPX Index</B></FONT></TD></TR>
  <TR>
    <TD STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid; font-size: 12pt"><FONT STYLE="font-size: 10pt"><B>Hypothetical starting level:</B></FONT></TD>
    <TD STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid; text-align: center"><FONT STYLE="font-size: 10pt">100.00</FONT></TD>
    <TD STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid; text-align: center"><FONT STYLE="font-size: 10pt">100.000</FONT></TD>
    <TD STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid; text-align: center"><FONT STYLE="font-size: 10pt">100.00</FONT></TD></TR>
  <TR>
    <TD STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid; font-size: 12pt"><FONT STYLE="font-size: 10pt"><B>Hypothetical lowest closing level during final observation period:</B></FONT></TD>
    <TD STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid; text-align: center"><FONT STYLE="font-size: 10pt">95.00</FONT></TD>
    <TD STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid; text-align: center"><FONT STYLE="font-size: 10pt">45.000</FONT></TD>
    <TD STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid; text-align: center"><FONT STYLE="font-size: 10pt">105.00</FONT></TD></TR>
  <TR>
    <TD STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid; font-size: 12pt"><FONT STYLE="font-size: 10pt"><B>Hypothetical ending level:</B></FONT></TD>
    <TD STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid; text-align: center"><FONT STYLE="font-size: 10pt">115.00</FONT></TD>
    <TD STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid; text-align: center"><FONT STYLE="font-size: 10pt">90.000</FONT></TD>
    <TD STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid; text-align: center"><FONT STYLE="font-size: 10pt">110.00</FONT></TD></TR>
  <TR>
    <TD STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid; font-size: 12pt"><FONT STYLE="font-size: 10pt"><B>Hypothetical coupon threshold level:</B></FONT></TD>
    <TD STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid; text-align: center"><FONT STYLE="font-size: 10pt">70.00</FONT></TD>
    <TD STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid; text-align: center"><FONT STYLE="font-size: 10pt">70.000</FONT></TD>
    <TD STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid; text-align: center"><FONT STYLE="font-size: 10pt">70.00</FONT></TD></TR>
  <TR>
    <TD STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid; font-size: 12pt"><FONT STYLE="font-size: 10pt"><B>Hypothetical downside threshold level:</B></FONT></TD>
    <TD STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid; text-align: center"><FONT STYLE="font-size: 10pt">60.00</FONT></TD>
    <TD STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid; text-align: center"><FONT STYLE="font-size: 10pt">60.000</FONT></TD>
    <TD STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid; text-align: center"><FONT STYLE="font-size: 10pt">60.00</FONT></TD></TR>
  <TR>
    <TD STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid; font-size: 12pt"><FONT STYLE="font-size: 10pt"><B>Lowest performance factor during final observation period (lowest closing level during final observation period <I>divided by</I> starting level):</B></FONT></TD>
    <TD STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid; text-align: center"><FONT STYLE="font-size: 10pt">95.00%</FONT></TD>
    <TD STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid; text-align: center"><FONT STYLE="font-size: 10pt">45.00%</FONT></TD>
    <TD STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid; text-align: center"><FONT STYLE="font-size: 10pt">105.00%</FONT></TD></TR>
  <TR>
    <TD STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid; font-size: 12pt"><FONT STYLE="font-size: 10pt"><B>Performance factor on final calculation day (ending level <I>divided by</I> starting level): </B></FONT></TD>
    <TD STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid; text-align: center"><FONT STYLE="font-size: 10pt">115.00%</FONT></TD>
    <TD STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid; text-align: center"><FONT STYLE="font-size: 10pt">90.00%</FONT></TD>
    <TD STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid; text-align: center"><FONT STYLE="font-size: 10pt">110.00%</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 12.2pt; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 12.2pt; text-align: justify"><U>Step 1</U>: Determine which Index
is the lowest performing Index on the final calculation day.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 12.2pt; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 27pt; text-align: justify">In this example, the RTY Index has the
lowest performance factor on the final calculation day and is, therefore, the lowest performing Index on the final calculation day.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 27pt; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 12.2pt; text-align: justify"><U>Step 2</U>: Determine the maturity
payment amount based on the ending level of the lowest performing Index on the final calculation day.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 12.2pt; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 27pt; text-align: justify">Since the hypothetical ending level of
the lowest performing Index on the final calculation day is greater than its hypothetical downside threshold level, you would be repaid
the principal amount of your securities at maturity.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 27pt; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 12pt; text-align: justify">In addition to any contingent coupon
payments received during the term of the securities, on the stated maturity date you would receive $1,000.00 per security, but no final
contingent coupon payment since the hypothetical closing level of the lowest performing Index on at least one eligible trading day during
the final observation period was less than its hypothetical coupon threshold level. This is the case even though the closing levels of
the better performing Indices were greater than their respective hypothetical coupon threshold levels on every eligible trading day during
the relevant observation period, and even though the ending level of the RTY Index was greater than its hypothetical coupon threshold
level.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 12pt; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Example 3.&nbsp;The ending level of the lowest
performing Index on the final calculation day is less than its coupon threshold level and its downside threshold level, the maturity payment
amount is less than the principal amount of your securities at maturity and you do not receive a contingent coupon payment at maturity.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; background-color: white; border-collapse: collapse">
  <TR>
    <TD STYLE="vertical-align: bottom; width: 55%; border: Black 1pt solid">&nbsp;</TD>
    <TD STYLE="width: 15%; border-top: Black 1pt solid; border-right: Black 1pt solid; border-bottom: Black 1pt solid; text-align: center"><FONT STYLE="font-size: 10pt"><B>NDX Index</B></FONT></TD>
    <TD STYLE="width: 15%; border-top: Black 1pt solid; border-right: Black 1pt solid; border-bottom: Black 1pt solid; text-align: center"><FONT STYLE="font-size: 10pt"><B>RTY Index</B></FONT></TD>
    <TD STYLE="vertical-align: bottom; width: 15%; border-top: Black 1pt solid; border-right: Black 1pt solid; border-bottom: Black 1pt solid; text-align: center"><FONT STYLE="font-size: 10pt"><B>SPX Index</B></FONT></TD></TR>
  <TR>
    <TD STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid; font-size: 12pt"><FONT STYLE="font-size: 10pt"><B>Hypothetical starting level:</B></FONT></TD>
    <TD STYLE="vertical-align: bottom; border-right: Black 1pt solid; border-bottom: Black 1pt solid; text-align: center"><FONT STYLE="font-size: 10pt">100.00</FONT></TD>
    <TD STYLE="vertical-align: bottom; border-right: Black 1pt solid; border-bottom: Black 1pt solid; text-align: center"><FONT STYLE="font-size: 10pt">100.000</FONT></TD>
    <TD STYLE="vertical-align: bottom; border-right: Black 1pt solid; border-bottom: Black 1pt solid; text-align: center"><FONT STYLE="font-size: 10pt">100.00</FONT></TD></TR>
  <TR>
    <TD STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid; font-size: 12pt"><FONT STYLE="font-size: 10pt"><B>Hypothetical lowest closing level during final observation period:</B></FONT></TD>
    <TD STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid; text-align: center"><FONT STYLE="font-size: 10pt">45.00</FONT></TD>
    <TD STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid; text-align: center"><FONT STYLE="font-size: 10pt">105.000</FONT></TD>
    <TD STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid; text-align: center"><FONT STYLE="font-size: 10pt">85.00</FONT></TD></TR>
  <TR>
    <TD STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid; font-size: 12pt"><FONT STYLE="font-size: 10pt"><B>Hypothetical ending level:</B></FONT></TD>
    <TD STYLE="vertical-align: bottom; border-right: Black 1pt solid; border-bottom: Black 1pt solid; text-align: center"><FONT STYLE="font-size: 10pt">45.00</FONT></TD>
    <TD STYLE="vertical-align: bottom; border-right: Black 1pt solid; border-bottom: Black 1pt solid; text-align: center"><FONT STYLE="font-size: 10pt">120.000</FONT></TD>
    <TD STYLE="vertical-align: bottom; border-right: Black 1pt solid; border-bottom: Black 1pt solid; text-align: center"><FONT STYLE="font-size: 10pt">90.00</FONT></TD></TR>
  <TR>
    <TD STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid; font-size: 12pt"><FONT STYLE="font-size: 10pt"><B>Hypothetical coupon threshold level:</B></FONT></TD>
    <TD STYLE="vertical-align: bottom; border-right: Black 1pt solid; border-bottom: Black 1pt solid; text-align: center"><FONT STYLE="font-size: 10pt">70.00</FONT></TD>
    <TD STYLE="vertical-align: bottom; border-right: Black 1pt solid; border-bottom: Black 1pt solid; text-align: center"><FONT STYLE="font-size: 10pt">70.000</FONT></TD>
    <TD STYLE="vertical-align: bottom; border-right: Black 1pt solid; border-bottom: Black 1pt solid; text-align: center"><FONT STYLE="font-size: 10pt">70.00</FONT></TD></TR>
  <TR>
    <TD STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid; font-size: 12pt"><FONT STYLE="font-size: 10pt"><B>Hypothetical downside threshold level:</B></FONT></TD>
    <TD STYLE="vertical-align: bottom; border-right: Black 1pt solid; border-bottom: Black 1pt solid; text-align: center"><FONT STYLE="font-size: 10pt">60.00</FONT></TD>
    <TD STYLE="vertical-align: bottom; border-right: Black 1pt solid; border-bottom: Black 1pt solid; text-align: center"><FONT STYLE="font-size: 10pt">60.000</FONT></TD>
    <TD STYLE="vertical-align: bottom; border-right: Black 1pt solid; border-bottom: Black 1pt solid; text-align: center"><FONT STYLE="font-size: 10pt">60.00</FONT></TD></TR>
  <TR>
    <TD STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid; font-size: 12pt"><FONT STYLE="font-size: 10pt"><B>Lowest performance factor during final observation period (lowest closing level during final observation period <I>divided by</I> starting level):</B></FONT></TD>
    <TD STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid; text-align: center"><FONT STYLE="font-size: 10pt">45.00%</FONT></TD>
    <TD STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid; text-align: center"><FONT STYLE="font-size: 10pt">105.00%</FONT></TD>
    <TD STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid; text-align: center"><FONT STYLE="font-size: 10pt">85.00%</FONT></TD></TR>
  <TR>
    <TD STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid; font-size: 12pt"><FONT STYLE="font-size: 10pt"><B>Performance factor on final calculation day (ending level <I>divided by</I> starting level): </B></FONT></TD>
    <TD STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid; text-align: center"><FONT STYLE="font-size: 10pt">45.00%</FONT></TD>
    <TD STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid; text-align: center"><FONT STYLE="font-size: 10pt">120.00%</FONT></TD>
    <TD STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid; text-align: center"><FONT STYLE="font-size: 10pt">90.00%</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 12.2pt; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 12.2pt; text-align: justify"><U>Step 1</U>: Determine which Index
is the lowest performing Index on the final calculation day.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 12.2pt; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 27pt; text-align: justify">In this example, the NDX Index has the
lowest performance factor on the final calculation day and is, therefore, the lowest performing Index on the final calculation day.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 27pt; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 12.2pt; text-align: justify"><U>Step 2</U>: Determine the maturity
payment amount based on the ending level of the lowest performing Index on the final calculation day.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 12.2pt; text-align: justify">&nbsp;</P>


<!-- Field: Page; Sequence: 22; Value: 2 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">PS-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->22<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="font: 18pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; color: #BB0826"><B>Market Linked Securities&mdash;Callable with Contingent Coupon with Daily Observation and Contingent Downside</B></P><P STYLE="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; color: #BB0826"><B>Principal at Risk Securities Linked to the Lowest Performing of the Nasdaq-100 Index<SUP>&reg;</SUP>, the Russell 2000<SUP>&reg;</SUP> Index and the S&amp;P 500<SUP>&reg;</SUP> Index due April 22, 2030</B></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 27pt; text-align: justify">Since the hypothetical ending level of
the lowest performing Index on the final calculation day is less than its hypothetical downside threshold level, you would lose a portion
of the principal amount of your securities and receive the maturity payment amount equal to $450.00 per security, calculated as follows:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 27pt; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">$1,000 &times; performance factor of the lowest
performing Index on the final calculation day</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">= $1,000 &times; 45.00%</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">= $450.00</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 13.5pt; text-align: justify">In addition to any contingent coupon
payments received prior to the stated maturity date, on the stated maturity date you would receive $450.00 per security, but no contingent
coupon payment because the hypothetical closing level of the lowest performing Index on at least one eligible trading day during the final
observation period was less than its hypothetical coupon threshold level.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 13.5pt; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">These examples illustrate that you will not participate
in any appreciation of any Index, but will be fully exposed to a decrease in the lowest performing Index if the ending level of the lowest
performing Index on the final calculation day is less than its downside threshold level, even if the ending levels of the other Indices
have appreciated or have not declined below their respective downside threshold levels.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">To the extent that the starting level, coupon
threshold level, downside threshold level and ending level of the lowest performing Index on the final calculation day differ from the
values assumed above, the results indicated above would be different.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>


<!-- Field: Page; Sequence: 23; Value: 2 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">PS-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->23<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="font: 18pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; color: #BB0826"><B>Market Linked Securities&mdash;Callable with Contingent Coupon with Daily Observation and Contingent Downside</B></P><P STYLE="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; color: #BB0826"><B>Principal at Risk Securities Linked to the Lowest Performing of the Nasdaq-100 Index<SUP>&reg;</SUP>, the Russell 2000<SUP>&reg;</SUP> Index and the S&amp;P 500<SUP>&reg;</SUP> Index due April 22, 2030</B></P></DIV>
    <!-- Field: /Page -->

<P STYLE="color: white; font: bold 12pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: center; background-color: #4F81BD">The
Nasdaq-100 Index<SUP>&reg;</SUP></P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The NDX Index is a modified market capitalization-weighted
index that is designed to measure the performance of 100 of the largest non-financial companies listed on The Nasdaq Stock Market. For
more information about the NDX Index, see &ldquo;Indices&mdash;The Nasdaq-100 Index<SUP>&reg;</SUP>&rdquo; in the accompanying underlying
supplement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0">Historical Information</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">We obtained the closing levels of the NDX Index
displayed in the graph below from Bloomberg Professional<SUP>&reg;</SUP> service (&ldquo;<U>Bloomberg</U>&rdquo;) without independent
verification. The historical performance of the NDX Index should not be taken as an indication of the future performance of the NDX Index.
Future performance of the NDX Index may differ significantly from historical performance, and no assurance can be given as to the closing
levels of the NDX Index during the term of the securities, including on any eligible trading day during an observation period or on the
final calculation day. We cannot give you assurance that the performance of the NDX Index will not result in a loss on your initial investment.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The following graph sets forth daily closing levels
of the NDX Index for the period from January 1, 2020 to October 17, 2025. The closing level on October 17, 2025 was 24,817.95.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 100%; font-family: Georgia, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><IMG SRC="image_003.jpg" ALT="" STYLE="height: 322px; width: 614px"></B></FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="font-family: Georgia, Times, Serif; text-align: center">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="font-family: Georgia, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">* The dotted lines indicate the coupon threshold level and the downside threshold level of 70% and 60%, respectively, of the starting level of the NDX Index.</FONT></TD></TR>
  </TABLE>
<P STYLE="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 9.35pt; text-align: center">&nbsp;</P>

<P STYLE="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 9.35pt; text-align: center">PAST PERFORMANCE IS NOT
INDICATIVE OF FUTURE RESULTS.</P>

<P STYLE="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 9.35pt; text-align: center">&nbsp;</P>


<!-- Field: Page; Sequence: 24; Value: 2 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">PS-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->24<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="font: 18pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; color: #BB0826"><B>Market Linked Securities&mdash;Callable with Contingent Coupon with Daily Observation and Contingent Downside</B></P><P STYLE="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; color: #BB0826"><B>Principal at Risk Securities Linked to the Lowest Performing of the Nasdaq-100 Index<SUP>&reg;</SUP>, the Russell 2000<SUP>&reg;</SUP> Index and the S&amp;P 500<SUP>&reg;</SUP> Index due April 22, 2030</B></P></DIV>
    <!-- Field: /Page -->

<P STYLE="color: white; font: bold 12pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: center; background-color: #4F81BD">The
Russell 2000<SUP>&reg;</SUP> Index</P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The RTY Index measures the capitalization-weighted
price performance of 2,000 U.S. small-capitalization stocks listed on eligible U.S. exchanges and is designed to track the performance
of the small-capitalization segment of the U.S. equity market. For more information about the RTY Index, see &ldquo;Indices&mdash;The
Russell Indices&rdquo; in the accompanying underlying supplement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0">Historical Information</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">We obtained the closing levels of the RTY Index
displayed in the graph below from Bloomberg without independent verification. The historical performance of the RTY Index should not be
taken as an indication of the future performance of the RTY Index. Future performance of the RTY Index may differ significantly from historical
performance, and no assurance can be given as to the closing levels of the RTY Index during the term of the securities, including on any
eligible trading day during an observation period or on the final calculation day. We cannot give you assurance that the performance of
the RTY Index will not result in a loss on your initial investment.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The following graph sets forth daily closing levels
of the RTY Index for the period from January 1, 2020 to October 17, 2025. The closing level on October 17, 2025 was 2,452.173.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 100%; font-family: Georgia, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><IMG SRC="image_004.jpg" ALT="" STYLE="height: 322px; width: 614px"></B></FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="font-family: Georgia, Times, Serif; text-align: center">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="font-family: Georgia, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">* The dotted lines indicate the coupon threshold level and the downside threshold level of 70% and 60%, respectively, of the starting level of the RTY Index.</FONT></TD></TR>
  </TABLE>
<P STYLE="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 9.35pt; text-align: center">&nbsp;</P>

<P STYLE="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 9.35pt; text-align: center">PAST PERFORMANCE IS NOT
INDICATIVE OF FUTURE RESULTS.</P>

<P STYLE="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 9.35pt; text-align: center">&nbsp;</P>


<!-- Field: Page; Sequence: 25; Value: 2 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">PS-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->25<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="font: 18pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; color: #BB0826"><B>Market Linked Securities&mdash;Callable with Contingent Coupon with Daily Observation and Contingent Downside</B></P><P STYLE="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; color: #BB0826"><B>Principal at Risk Securities Linked to the Lowest Performing of the Nasdaq-100 Index<SUP>&reg;</SUP>, the Russell 2000<SUP>&reg;</SUP> Index and the S&amp;P 500<SUP>&reg;</SUP> Index due April 22, 2030</B></P></DIV>
    <!-- Field: /Page -->

<P STYLE="color: white; font: bold 12pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: center; background-color: #4F81BD">The
S&amp;P 500<SUP>&reg;</SUP> Index</P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The SPX Index consists of stocks of 500 companies
selected to provide a performance benchmark for the U.S. equity markets. For more information about the SPX Index, see &ldquo;Indices&mdash;The
S&amp;P U.S. Indices&rdquo; in the accompanying underlying supplement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0">Historical Information</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">We obtained the closing levels of the SPX Index
displayed in the graph below from Bloomberg without independent verification. The historical performance of the SPX Index should not be
taken as an indication of the future performance of the SPX Index. Future performance of the SPX Index may differ significantly from historical
performance, and no assurance can be given as to the closing levels of the SPX Index during the term of the securities, including on any
eligible trading day during an observation period or on the final calculation day. We cannot give you assurance that the performance of
the SPX Index will not result in a loss on your initial investment.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The following graph sets forth daily closing levels
of the SPX Index for the period from January 1, 2020 to October 17, 2025. The closing level on October 17, 2025 was 6,664.01.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 100%; font-family: Georgia, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><IMG SRC="image_005.jpg" ALT="" STYLE="height: 322px; width: 614px"></B></FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="font-family: Georgia, Times, Serif; text-align: center">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="font-family: Georgia, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">* The dotted lines indicate the coupon threshold level and the downside threshold level of 70% and 60%, respectively, of the starting level of the SPX Index.</FONT></TD></TR>
  </TABLE>
<P STYLE="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 9.35pt; text-align: center">&nbsp;</P>

<P STYLE="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 9.35pt; text-align: center">PAST PERFORMANCE IS NOT
INDICATIVE OF FUTURE RESULTS.</P>

<P STYLE="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 9.35pt; text-align: center">&nbsp;</P>


<!-- Field: Page; Sequence: 26; Value: 2 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">PS-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->26<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="font: 18pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; color: #BB0826"><B>Market Linked Securities&mdash;Callable with Contingent Coupon with Daily Observation and Contingent Downside</B></P><P STYLE="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; color: #BB0826"><B>Principal at Risk Securities Linked to the Lowest Performing of the Nasdaq-100 Index<SUP>&reg;</SUP>, the Russell 2000<SUP>&reg;</SUP> Index and the S&amp;P 500<SUP>&reg;</SUP> Index due April 22, 2030</B></P></DIV>
    <!-- Field: /Page -->

<P STYLE="color: white; font: bold 12pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: center; background-color: #4F81BD">Tax
Considerations</P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">You should review carefully the sections in the
accompanying prospectus supplement entitled &ldquo;Material U.S. Federal Income Tax Consequences&mdash;Tax Consequences to U.S. Holders&mdash;Notes
Treated as Prepaid Forward or Derivative Contracts with Associated Coupons&rdquo; and, if you are a non-U.S. holder, &ldquo;&mdash;Tax
Consequences to Non-U.S. Holders.&rdquo;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">In determining our reporting responsibilities,
if any, we intend to treat (i) the securities for U.S. federal income tax purposes as prepaid forward contracts with associated contingent
coupons and (ii) any contingent coupon payments as ordinary income, as described in the section entitled &ldquo;Material U.S. Federal
Income Tax Consequences&mdash;Tax Consequences to U.S. Holders&mdash;Notes Treated as Prepaid Forward or Derivative Contracts with Associated
Coupons&rdquo; in the accompanying prospectus supplement. Our special tax counsel, Davis Polk &amp; Wardwell LLP, has advised that it
believes this treatment to be reasonable, but that there are other reasonable treatments that the Internal Revenue Service (the &ldquo;IRS&rdquo;)
or a court may adopt.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><I>Sale, exchange or redemption of a security.</I>
Assuming the treatment described above is respected, if you are a U.S. holder, upon a sale or exchange of the securities (including upon
early redemption or redemption at maturity), you should recognize capital gain or loss equal to the difference between the amount realized
on the sale or exchange and your tax basis in the securities, which should equal the amount you paid to acquire the securities (assuming
contingent coupon payments are properly treated as ordinary income, consistent with the position referred to above). This gain or loss
should be short-term capital gain or loss unless you hold the securities for more than one year, in which case the gain or loss should
be long-term capital gain or loss, whether or not you are an initial purchaser of the securities at the issue price. The deductibility
of capital losses is subject to limitations. If you sell your securities between the time your right to a contingent coupon payment is
fixed and the time it is paid, it is likely that you will be treated as receiving ordinary income equal to the contingent coupon payment.
Although uncertain, it is possible that proceeds received from the sale or exchange of your securities prior to an observation period
end-date but that can be attributed to an expected contingent coupon payment could be treated as ordinary income. You should consult your
tax advisor regarding this issue.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">As noted above, there are other reasonable treatments
that the IRS or a court may adopt, in which case the timing and character of any income or loss on the securities could be materially
affected. In addition, in 2007 the U.S. Treasury Department and the IRS released a notice requesting comments on the U.S. federal income
tax treatment of &ldquo;prepaid forward contracts&rdquo; and similar instruments. The notice focuses in particular on whether to require
investors in these instruments to accrue income over the term of their investment. It also asks for comments on a number of related topics,
including the character of income or loss with respect to these instruments and the relevance of factors such as the nature of the underlying
property to which the instruments are linked. While the notice requests comments on appropriate transition rules and effective dates,
any Treasury regulations or other guidance promulgated after consideration of these issues could materially affect the tax consequences
of an investment in the securities, possibly with retroactive effect. You should consult your tax advisor regarding the U.S. federal income
tax consequences of an investment in the securities, including possible alternative treatments and the issues presented by this notice.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><I>Non-U.S. holders.</I> Insofar as we have responsibility
as a withholding agent, we do not currently intend to treat contingent coupon payments to non-U.S. holders (as defined in the accompanying
prospectus supplement) as subject to U.S. withholding tax. However, non-U.S. holders should in any event expect to be required to provide
appropriate Forms W-8 or other documentation in order to establish an exemption from backup withholding, as described under the heading
&ldquo;&mdash;Information Reporting and Backup Withholding&rdquo; in the accompanying prospectus supplement. If any withholding is required,
we will not be required to pay any additional amounts with respect to amounts withheld.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Treasury regulations under Section 871(m) generally
impose a withholding tax on certain &ldquo;dividend equivalents&rdquo; under certain &ldquo;equity linked instruments.&rdquo; A recent
IRS notice excludes from the scope of Section 871(m) instruments issued prior to January 1, 2027 that do not have a &ldquo;delta of one&rdquo;
with respect to underlying securities that could pay U.S.-source dividends for U.S. federal income tax purposes (each an &ldquo;Underlying
Security&rdquo;). Based on our representation that the securities do not have a &ldquo;delta of one&rdquo; within the meaning of the regulations,
our special tax counsel believes that these regulations should not apply to the securities with regard to non-U.S. holders, and we have
determined to treat the securities as not being subject to Section 871(m). Our determination is not binding on the IRS, and the IRS may
disagree with this determination. Section 871(m) is complex and its application may depend on your particular circumstances, including
whether you enter into other transactions with respect to an Underlying Security. You should consult your tax advisor regarding the potential
application of Section 871(m) to the securities.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Non-U.S. holders should also discuss with their
tax advisors the estate tax consequences of investing in the securities.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>


<!-- Field: Page; Sequence: 27; Value: 2 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">PS-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->27<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="font: 18pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; color: #BB0826"><B>Market Linked Securities&mdash;Callable with Contingent Coupon with Daily Observation and Contingent Downside</B></P><P STYLE="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; color: #BB0826"><B>Principal at Risk Securities Linked to the Lowest Performing of the Nasdaq-100 Index<SUP>&reg;</SUP>, the Russell 2000<SUP>&reg;</SUP> Index and the S&amp;P 500<SUP>&reg;</SUP> Index due April 22, 2030</B></P></DIV>
    <!-- Field: /Page -->

<P STYLE="color: white; font: bold 12pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: center; background-color: #4F81BD">Validity
of the Securities</P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">In the opinion of Davis Polk &amp; Wardwell LLP,
as special United States products counsel to Barclays Bank PLC, when the securities offered by this pricing supplement have been issued
by Barclays Bank PLC pursuant to the indenture, the trustee has made, in accordance with instructions from Barclays Bank PLC, appropriate
entries or notations in its records relating to the master global note that represents such securities (the &ldquo;master note&rdquo;),
and such securities have been delivered against payment as contemplated herein, such securities will be valid and binding obligations
of Barclays Bank PLC, enforceable in accordance with their terms, subject to applicable bankruptcy, insolvency and similar laws affecting
creditors&rsquo; rights generally, concepts of reasonableness and equitable principles of general applicability (including, without limitation,
concepts of good faith, fair dealing and the lack of bad faith) and possible judicial or regulatory actions or application giving effect
to governmental actions or foreign laws affecting creditors&rsquo; rights, <I>provided </I>that such counsel expresses no opinion as to
(i) the effect of fraudulent conveyance, fraudulent transfer or similar provision of applicable law on the conclusions expressed above
or (ii) the validity, legally binding effect or enforceability of any provision that permits holders to collect any portion of the stated
principal amount upon acceleration of the securities to the extent determined to constitute unearned interest. This opinion is given as
of the date hereof and is limited to the laws of the State of New York. Insofar as this opinion involves matters governed by English law,
Davis Polk &amp; Wardwell LLP has relied, with Barclays Bank PLC&rsquo;s permission, on the opinion of Davis Polk &amp; Wardwell London
LLP, dated as of May 15, 2025, filed as an exhibit to the Registration Statement on Form F-3ASR by Barclays Bank PLC on May 15, 2025,
and this opinion is subject to the same assumptions, qualifications and limitations as set forth in such opinion of Davis Polk &amp; Wardwell
London LLP. In addition, this opinion is subject to customary assumptions about the trustee&rsquo;s authorization, execution and delivery
of the indenture and its authentication of the master note and the validity, binding nature and enforceability of the indenture with respect
to the trustee, all as stated in the opinion of Davis Polk &amp; Wardwell LLP, dated May 15, 2025, which has been filed as an exhibit
to the Registration Statement referred to above.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>


<!-- Field: Page; Sequence: 28; Options: Last -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">PS-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->28<!-- Field: /Sequence --></P></DIV>
    <!-- Field: /Page -->

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-FILING FEES
<SEQUENCE>2
<FILENAME>dp236095_exfilingfees.htm
<DESCRIPTION>EX-FILING FEES
<TEXT>
<XBRL>
<?xml version='1.0' encoding='ASCII'?>
<!-- Template (c) 2024-2025 Novaworks, LLC -->
<!-- Field: Set; Name: AliasFileType; Value: Forms View; Template: Fee Exhibit\Fee Exhibit FC.xds -->
<!-- Field: Set; Name: Platform; Value: Novaworks Fee Exhibit Editor; Version: 1.2b -->
<!-- Field: Set; Name: Control; Value: VGVtcGxhdGU6IChkZWZhdWx0KQ0KQmFzZSBGb250OiBUaW1lcyBOZXcgUm9tYW4sIFRpbWVzLCBTZXJpZg0KQ2FwdGlvbiBTaXplOiAxMnB0DQpUYWJsZSBUaXRsZSBTaXplOiAxMXB0DQpUYWJsZSBIZWFkIFNpemU6IDhwdA0KVGFibGUgQm9keSBTaXplOiAxMHB0 -->
<!-- Field: Set; Name: MD5; Value: 4c50ac9aec6e5e24c3293f98d0e477d1 -->
<html xmlns="http://www.w3.org/1999/xhtml" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xs="http://www.w3.org/2001/XMLSchema-instance" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:iso4217="http://www.xbrl.org/2003/iso4217" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2015-02-26" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:dei="http://xbrl.sec.gov/dei/2025" xmlns:ffd="http://xbrl.sec.gov/ffd/2025">
<head>
  <title>Filing Fee Exhibit</title>
  <meta http-equiv="Content-Type" content="text/html"/>
  </head>
<body style="font: 10pt Times New Roman, Times, Serif">

<div style="display: none">
  <ix:header>
    <ix:hidden>
      <ix:nonNumeric name="ffd:SubmissnTp" contextRef="c_report" id="fee_001">424B2</ix:nonNumeric>
      <ix:nonNumeric name="ffd:FeeExhibitTp" contextRef="c_report" id="fee_002">EX-FILING FEES</ix:nonNumeric>
      <ix:nonNumeric name="dei:EntityCentralIndexKey" contextRef="c_report" id="fee_003">0000312070</ix:nonNumeric>
      <ix:nonNumeric name="ffd:RegnFileNb" contextRef="c_report" id="fee_004">333-287303</ix:nonNumeric>
      <ix:nonNumeric name="ffd:OfferingTableNa" contextRef="c_report" xs:nil="true" id="fee_005"></ix:nonNumeric>
      <ix:nonNumeric name="ffd:OffsetTableNa" contextRef="c_report" id="fee_006">N/A</ix:nonNumeric>
      <ix:nonNumeric name="ffd:CombinedProspectusTableNa" contextRef="c_report" id="fee_007">N/A</ix:nonNumeric>
      </ix:hidden>
    <ix:references>
      <link:schemaRef xlink:href="https://xbrl.sec.gov/ffd/2025/ffd-2025.xsd" xlink:type="simple"/>
      </ix:references>
    <ix:resources>
      <xbrli:context id="c_offering_1">
        <xbrli:entity>
          <xbrli:identifier scheme="http://www.sec.gov/CIK">0000312070</xbrli:identifier>
          <xbrli:segment>
            <xbrldi:typedMember dimension="ffd:OfferingAxis"><dei:lineNo>1</dei:lineNo></xbrldi:typedMember>
            </xbrli:segment>
          </xbrli:entity>
        <xbrli:period>
          <xbrli:startDate>2025-10-21</xbrli:startDate>
          <xbrli:endDate>2025-10-21</xbrli:endDate>
          </xbrli:period>
        </xbrli:context>
      <xbrli:context id="c_report">
        <xbrli:entity>
          <xbrli:identifier scheme="http://www.sec.gov/CIK">0000312070</xbrli:identifier>
          </xbrli:entity>
        <xbrli:period>
          <xbrli:startDate>2025-10-21</xbrli:startDate>
          <xbrli:endDate>2025-10-21</xbrli:endDate>
          </xbrli:period>
        </xbrli:context>
      <xbrli:unit id="USD">
        <xbrli:measure>iso4217:USD</xbrli:measure>
        </xbrli:unit>
      <xbrli:unit id="pure">
        <xbrli:measure>xbrli:pure</xbrli:measure>
        </xbrli:unit>
      <xbrli:unit id="shares">
        <xbrli:measure>xbrli:shares</xbrli:measure>
        </xbrli:unit>
      </ix:resources>
    </ix:header>
  </div>

<p style="font: bold 12pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 12pt; text-align: right">Ex-Filing Fees</p>

<p style="font: bold 12pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 6pt; text-align: center">CALCULATION OF FILING FEE TABLES</p>

<p style="font: bold 12pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 6pt; text-align: center"><ix:nonNumeric name="ffd:FormTp" contextRef="c_report" id="fee_008">F-3</ix:nonNumeric></p>

<p style="font: bold 12pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 12pt; text-align: center"><ix:nonNumeric name="dei:EntityRegistrantName" contextRef="c_report" id="fee_009">BARCLAYS BANK PLC</ix:nonNumeric></p>

<p style="font: bold 11pt Times New Roman, Times, Serif; border-top: Gray 3pt double; padding-top: 6pt; text-align: center; margin-top: 0pt; margin-bottom: 4pt">Table 1: Newly Registered and Carry Forward Securities</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
<tr style="font-size: 2pt; vertical-align: bottom; text-align: center; font-weight: bold">
  <td style="width: 12%">&#160;</td>
  <td style="width: 0.5%">&#160;</td>
  <td style="width: 15%">&#160;</td>
  <td style="width: 0.5%">&#160;</td>
  <td style="width: 15%">&#160;</td>
  <td style="width: 0.5%">&#160;</td>
  <td style="width: 6.5%">&#160;</td>
  <td style="width: 0.5%">&#160;</td>
  <td style="width: 8%">&#160;</td>
  <td style="width: 0.5%">&#160;</td>
  <td style="width: 9%">&#160;</td>
  <td style="width: 0.5%">&#160;</td>
  <td style="width: 1%">&#160;</td>
  <td style="width: 5%">&#160;</td>
  <td style="width: 0.5%">&#160;</td>
  <td style="width: 1%">&#160;</td>
  <td style="width: 9%">&#160;</td>
  <td style="width: 0.5%">&#160;</td>
  <td style="width: 5%">&#160;</td>
  <td style="width: 0.5%">&#160;</td>
  <td style="width: 1%">&#160;</td>
  <td style="width: 8%">&#160;</td></tr>
<tr style="font-size: 8pt; vertical-align: bottom; text-align: center; font-weight: bold">
  <td style="border-bottom: Black 1pt solid">Line Item Type</td>
  <td style="padding-bottom: 1pt">&#160;</td>
  <td style="border-bottom: Black 1pt solid">Security Type</td>
  <td style="padding-bottom: 1pt">&#160;</td>
  <td style="border-bottom: Black 1pt solid">Security Class Title</td>
  <td style="padding-bottom: 1pt">&#160;</td>
  <td style="border-bottom: Black 1pt solid">Notes</td>
  <td style="padding-bottom: 1pt">&#160;</td>
  <td style="border-bottom: Black 1pt solid">Fee Calculation<br/> Rule</td>
  <td style="padding-bottom: 1pt">&#160;</td>
  <td style="border-bottom: Black 1pt solid">Amount Registered</td>
  <td>&#160;</td>
  <td colspan="2" style="border-bottom: Black 1pt solid">Proposed Maximum Offering<br/> Price Per Unit</td>
  <td>&#160;</td>
  <td colspan="2" style="border-bottom: Black 1pt solid">Maximum Aggregate Offering Price</td>
  <td style="padding-bottom: 1pt">&#160;</td>
  <td style="border-bottom: Black 1pt solid">Fee Rate</td>
  <td>&#160;</td>
  <td colspan="2" style="border-bottom: Black 1pt solid">Amount of Registration Fee</td></tr>
<tr style="font-size: 2pt; vertical-align: top; text-align: left">
  <td>&#160;</td>
  <td>&#160;</td>
  <td>&#160;</td>
  <td>&#160;</td>
  <td>&#160;</td>
  <td>&#160;</td>
  <td>&#160;</td>
  <td>&#160;</td>
  <td>&#160;</td>
  <td>&#160;</td>
  <td>&#160;</td>
  <td>&#160;</td>
  <td>&#160;</td>
  <td>&#160;</td>
  <td>&#160;</td>
  <td>&#160;</td>
  <td>&#160;</td>
  <td>&#160;</td>
  <td>&#160;</td>
  <td>&#160;</td>
  <td>&#160;</td>
  <td>&#160;</td></tr>
<tr style="vertical-align: top; text-align: left">
  <td colspan="22" style="padding-top: 2pt; font-style: italic; text-align: center; padding-bottom: 2pt">Newly Registered Securities</td></tr>
<tr style="vertical-align: top; text-align: left">
  <td style="white-space: nowrap"><ix:nonNumeric name="ffd:PrevslyPdFlg" contextRef="c_offering_1" format="ixt:booleanfalse" id="fee_010">Fees to be Paid</ix:nonNumeric></td>
  <td>&#160;</td>
  <td style="white-space: nowrap"><ix:nonNumeric name="ffd:OfferingSctyTp" contextRef="c_offering_1" id="fee_011">Debt</ix:nonNumeric></td>
  <td>&#160;</td>
  <td><ix:nonNumeric name="ffd:OfferingSctyTitl" contextRef="c_offering_1" id="fee_012">Global Medium-Term Notes, Series A</ix:nonNumeric></td>
  <td>&#160;</td>
  <td style="text-align: center">(1)</td>
  <td>&#160;</td>
  <td style="text-align: center"><ix:nonNumeric name="ffd:Rule457rFlg" contextRef="c_offering_1" format="ixt:booleantrue" id="fee_013">457(r)</ix:nonNumeric></td>
  <td>&#160;</td>
  <td style="text-align: right"><ix:nonFraction name="ffd:AmtSctiesRegd" unitRef="shares" decimals="0" format="ixt:numdotdecimal" contextRef="c_offering_1" id="fee_014">6,962</ix:nonFraction></td>
  <td>&#160;</td>
  <td>$</td>
  <td style="text-align: right"><ix:nonFraction name="ffd:MaxOfferingPricPerScty" unitRef="USD" decimals="INF" format="ixt:numdotdecimal" contextRef="c_offering_1" id="fee_015">1,000</ix:nonFraction></td>
  <td>&#160;</td>
  <td>$</td>
  <td style="text-align: right"><ix:nonFraction name="ffd:MaxAggtOfferingPric" unitRef="USD" decimals="INF" format="ixt:numdotdecimal" contextRef="c_offering_1" id="fee_016">6,962,000</ix:nonFraction></td>
  <td>&#160;</td>
  <td style="text-align: center"><ix:nonFraction name="ffd:FeeRate" unitRef="pure" decimals="INF" format="ixt:numdotdecimal" contextRef="c_offering_1" id="fee_017">0.0001381</ix:nonFraction></td>
  <td>&#160;</td>
  <td>$</td>
  <td style="text-align: right"><ix:nonFraction name="ffd:FeeAmt" unitRef="USD" decimals="INF" format="ixt:numdotdecimal" contextRef="c_offering_1" id="ixv-223">961.45</ix:nonFraction></td></tr>
<tr style="font-size: 4pt; vertical-align: top; text-align: left">
  <td style="width: 11%">&#160;</td>
  <td style="width: 1%">&#160;</td>
  <td style="width: 15%">&#160;</td>
  <td style="width: 1%">&#160;</td>
  <td style="width: 15%">&#160;</td>
  <td style="width: 1%">&#160;</td>
  <td style="width: 5%">&#160;</td>
  <td style="width: 1%">&#160;</td>
  <td style="width: 8%">&#160;</td>
  <td style="width: 1%">&#160;</td>
  <td style="width: 8%">&#160;</td>
  <td style="width: 1%">&#160;</td>
  <td style="width: 1%">&#160;</td>
  <td style="width: 5%">&#160;</td>
  <td style="width: 1%">&#160;</td>
  <td style="border-bottom: Black 1pt solid; width: 1%">&#160;</td>
  <td style="border-bottom: Black 1pt solid; width: 8%">&#160;</td>
  <td style="width: 1%">&#160;</td>
  <td style="width: 5%">&#160;</td>
  <td style="width: 1%">&#160;</td>
  <td style="border-bottom: Black 1pt solid; width: 1%">&#160;</td>
  <td style="border-bottom: Black 1pt solid; width: 8%">&#160;</td></tr>
<tr style="vertical-align: top; text-align: left">
  <td colspan="14" style="text-align: right">Total Offering Amounts:</td>
  <td>&#160;</td>
  <td>$</td>
  <td style="text-align: right"><ix:nonFraction name="ffd:TtlOfferingAmt" contextRef="c_report" decimals="INF" format="ixt:numdotdecimal" unitRef="USD" id="ixv-224">6,962,000</ix:nonFraction></td>
  <td>&#160;</td>
  <td>&#160;</td>
  <td>&#160;</td>
  <td>&#160;</td>
  <td style="text-align: right"><ix:nonFraction name="ffd:TtlFeeAmt" contextRef="c_report" decimals="INF" format="ixt:numdotdecimal" unitRef="USD" id="ixv-225">961.45</ix:nonFraction></td></tr>
<tr style="vertical-align: top; text-align: left">
  <td colspan="14" style="text-align: right">Total Fees Previously Paid:</td>
  <td>&#160;</td>
  <td>&#160;</td>
  <td>&#160;</td>
  <td>&#160;</td>
  <td>&#160;</td>
  <td>&#160;</td>
  <td>&#160;</td>
  <td style="text-align: right"><ix:nonFraction name="ffd:TtlPrevslyPdAmt" contextRef="c_report" decimals="INF" format="ixt:numdotdecimal" unitRef="USD" id="ixv-226">0.00</ix:nonFraction></td></tr>
<tr style="vertical-align: top; text-align: left">
  <td colspan="14" style="text-align: right">Total Fee Offsets:</td>
  <td>&#160;</td>
  <td>&#160;</td>
  <td>&#160;</td>
  <td>&#160;</td>
  <td>&#160;</td>
  <td>&#160;</td>
  <td style="border-bottom: Black 1pt solid">&#160;</td>
  <td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="ffd:TtlOffsetAmt" contextRef="c_report" decimals="INF" format="ixt:numdotdecimal" unitRef="USD" id="ixv-227">0.00</ix:nonFraction></td></tr>
<tr style="vertical-align: top; text-align: left">
  <td colspan="14" style="text-align: right">Net Fee Due:</td>
  <td>&#160;</td>
  <td>&#160;</td>
  <td>&#160;</td>
  <td>&#160;</td>
  <td>&#160;</td>
  <td>&#160;</td>
  <td style="border-bottom: Black 3pt double">$</td>
  <td style="border-bottom: Black 3pt double; text-align: right"><ix:nonFraction name="ffd:NetFeeAmt" contextRef="c_report" decimals="INF" format="ixt:numdotdecimal" unitRef="USD" id="ixv-228">961.45</ix:nonFraction></td></tr>
</table>

<p style="font: bold 8pt Arial, Helvetica, Sans-Serif; color: rgb(50,101,255); margin-top: 0pt; margin-bottom: 0pt">&#160;</p>

<p style="font: bold 8pt Times New Roman, Times, Serif; margin-top: 6pt; margin-bottom: 6pt">__________________________________________<br/>
Offering Note(s)</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 6pt; width: 100%">
<tr style="vertical-align: top; text-align: justify">
  <td style="width: 15pt; text-align: right">(1)</td><td style="width: 5pt"/>
  <td style="text-align: justify"><ix:nonNumeric name="ffd:OfferingNote" escape="1" contextRef="c_offering_1" id="ixv-229">The filing fee paid with this filing pursuant to Rule 457(r) under the Securities Act of 1933, as amended (the &#8220;Securities Act&#8221;), was originally deferred in accordance with Rule 456(b) under the Securities Act.</ix:nonNumeric></td></tr>
  </table>

<p style="font: bold 11pt Times New Roman, Times, Serif; border-top: Gray 3pt double; padding-top: 6pt; text-align: center; margin-top: 0pt; margin-bottom: 4pt">Narrative Disclosure</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 6pt; margin-bottom: 6pt">
The maximum aggregate offering price of the securities to which the prospectus relates is $<ix:nonFraction name="ffd:NrrtvMaxAggtOfferingPric" decimals="INF" format="ixt:numdotdecimal" unitRef="USD" contextRef="c_report" id="ixv-230">6,962,000</ix:nonFraction>.
<ix:nonNumeric name="ffd:FnlPrspctsFlg" contextRef="c_report" format="ixt:booleantrue" id="ixv-231">The prospectus is a final prospectus for the related offering.</ix:nonNumeric></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 6pt; margin-bottom: 6pt">&#160;</p>


</body>
</html>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>3
<FILENAME>image_001.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 image_001.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  H'!PD'!@H)" D+"PH,#QD0#PX.
M#QX6%Q(9)" F)2,@(R(H+3DP*"HV*R(C,D0R-CL]0$! )C!&2T4^2CD_0#W_
MVP!# 0L+"P\-#QT0$!T]*2,I/3T]/3T]/3T]/3T]/3T]/3T]/3T]/3T]/3T]
M/3T]/3T]/3T]/3T]/3T]/3T]/3T]/3W_P  1"  = 'D# 2(  A$! Q$!_\0
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!V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>4
<FILENAME>image_006.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 image_006.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0@)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" "H KD# 2(  A$! Q$!_\0
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MA<TW_P &S_\ R/6#11[.(>UD;W_"PM=_Z%S3?_!L_P#\CT?\+"UW_H7--_\
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MA<TW_P &S_\ R/6#11[.(>UD;W_"PM=_Z%S3?_!L_P#\CT?\+"UW_H7--_\
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MC_H :/\ ^#B7_P"1J/\ A(O%'_0 T?\ \'$O_P C5/11[606(/\ A(O%'_0
MT?\ \'$O_P C4?\ "1>*/^@!H_\ X.)?_D:IZ*/:R"Q!_P )%XH_Z &C_P#@
MXE_^1J/^$B\4?] #1_\ P<2__(U3T4>UD%B#_A(O%'_0 T?_ ,'$O_R-1_PD
M7BC_ * &C_\ @XE_^1JGHH]K(+$'_"1>*/\ H :/_P"#B7_Y&H_X2+Q1_P!
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M#%/!?(]M)/((E:-8S\WWUSC@^OY9_#3DTVTU&[PTDD+QI;!W+ JP9 , 8X/
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M'"D[CST!Z=#FL=K.ZCMQ.]M,L)Z2%"%.??I4]KI5U=V$]W FZ.$@%0"6.?3
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M+IMF]Z@PMRT"F0#IPV,T:("MX?U6\U?0[?4[FQBMEN84GABBN#*2C*&&254
M\].1[US_ /PGETENBRZ-LOY)1&MJ#<LR_*6)<?9]_8@%48'!YX)KLDMH(K5;
M6."-+94$:Q*@"! ,!0.F,<8J@OAS0TL7L5T;3EM'<2/ +5!&S#H2N,$^]":
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M2:KJ2B(VL2P!E<HGEG@<J"O '?!S[BH)/#5FLZ)ON(P;A8@78?O5(SN7Y?\
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M$_*,8QUQ1>(6E<>_BK>TF;/:K;",.I967OEE(_3BJ%GK!M-9DU Q&0ON^4L
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M)%CAA0R2.QP%4#))]@!68/%&E?9C-YER,2B#R39S";>5W8$6S>?E!;[O0$]
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MX?"CCG\3"BBBJ("BBB@ HHHH **** '*Q1U=3AE.0:DNKJ:\N7N+A]\K_>;
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M^HKJ7_?_ /\ K4?\([_U%=2_[_\ _P!:MJBHYF:<J,7_ (1W_J*ZE_W_ /\
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M **** "BBB@ HHHH **** "BBB@#)\0_\>5E_P!A73O_ $LAKO:X'7SNBTR
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M_0:TW_P*3_&O=:*/:OL'LEW/"O\ A)-"_P"@UIO_ (%)_C1_PDFA?]!K3?\
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M>%_^ADT?_P #HO\ XJO0J*/9+N%SSW_A,O"__0R:/_X'1?\ Q5'_  F7A?\
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M^AOU?_OQ9_\ R/1]FUS_ *&_5_\ OQ9__(]*=8TY3,K7<:-"[QNKG:0RJ'8
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M8-[9C*8^M:.F>+)OM\6G:Y9+93S-L@N8GWV\[?W0Q *,>RL.>@+4RL3Q@/\
MBC-9D'#PV<LT9!Y5T4NI_!E!_"FI,+'H]%%%:DA1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110!PEM_R,_B
MG_L)1_\ I';5?JA;?\C/XI_["4?_ *1VU7ZQEN4@JI?Z?%J"0)*SJ(9XYUV$
M#+(<@'(Z<5;KD?%6I7EKK5E9V]_J%K')97$H%A9BX=Y%:()D&-\+\[<\#IS0
MAFJWANV?43<M<W1A,_VDV>5\KS<8W_=WY[XW8SSBDT7PY%HDBNE_>7(2W2UB
M6X,>(XD^ZHVHI/U.3[US\6I^)9?%5I:R1WT$$A$=ROD[HH_W!)=&\C;CS,8)
MF;TV\X$POO$-[I;/%<2Q2Q7-M82-;P(Q+B8+<3+E6&W:3C(PNUL^P(V=0\+:
M?J,E^\QF4WJHLFQ@-N, [>.-RJJMZA0.*>?#EF=0-[YD_F&\:]QN&-Y@\@CI
MTV\^N>^.*QK9_$EM>0%KJ^O%-Y<6QCN((E0QK'(T<A*1J1EE1<Y"G/3-9MAJ
M/BZXLYDFDNHKAYK5&(M6+0[IE67;NMD0J%)[R8QG<1S3 ZX:!:KH>GZ3YDWV
M>Q-N8FW#<?)967<<8Y*#. ._2LV_T#2[><E]8GT^6_EDC.)HE,_F$$Q#>I[C
MC;\W)YK,MX=57Q;IUQ?76J&.$7=HLRVBGS1YL3)YFV+"JR@_,-H_=CD<YUM4
MM=0D\8V%S:R7"Q0Z?<D*J)Y;2;XMJ,Q4D;N>A!^3C'.4!I:?HL.EWMU/:SS)
M#<;6:U^7RU941 P^7=G:BC[V/:JM]X5T[4+74+>X\QEO;I;M]P1MDBHB#"LI
M4C$8X8,.37/QWWB26UV6]QJC,[VBS33V"QO [3*LJQJ8P&0(2=Q# 8SN/;2\
M265TDGAV87NI,MI>-YT]O;K++@PR*'*K&1U(4X7 #GIP0 2:?X7LK>W@?2=6
MGMVA\R(SV<=LH<;_ )D95B\O(92,A0P((SUJ'_A7VCJU_P"67B2]BEB=4@@#
M*),[B)/+\S/)^\Q'X8K+M4\2:382M8"ZF::7462TFA41Q-Y[-&P.W=E@21N)
M!W<#I6]X0N]4NK*Y.IO*Y67]TTT3H^W R#N@A!YSR%[]:8%^30K*75Y-1D$C
M220&%HMW[LYX+8_O8^7/IQ5'P]X:TKP[>7,5A,AE\M-T7DP(T:$G;DQQJY!P
M>7)SM/?-8=Y<^*X--%VEQ?,9;ZXCDC$"@P1+)((R@6"1SN 3DJV00>,YJ-IO
M$<2WVH06\C7DMA8)),L+KT>?S"H:(G< P)'EDC=]WH* -3_A7NE&XU"8W-T6
MOH)[>0A(58+*06.\1AF(P,%RU7]7\.+?I=&"0I+=S0O([/@Q*F 2F!G<5R.3
MW_"LBWO_ !-_9-K,#---<>;:@&V8&)V;]U,X:*([5&X-\H!^7'N2ZGKR>-([
M2%;]K#S#')YL!,>T0D[PRP!1EPO_ "U/)(VC.%-0.JO=.M[[3)=/D4I!)'Y>
M(CM*#MMQTQQCZ5F3>&&N%S-K>IM,4:&2;$"M)$V,QD", #C(( ;D\UREU#XC
MN="L?MUUJDK-%I]].5LX]\$@F4R*JK%R5'S;2&.4';(/4ZU<WD-EIQ@N-1CM
MG/\ I%S;6?FW &PE?W?EMC)QGY./0=D ^'0-*CN)8(9F#I=17S0!U)0B,1(,
M8R$(C[]2#S5<>"K(Z:MC+>WTL26$NG1EFC!2"39P,(,D"-<$YZG.:Y[S=>35
MVO&_M*#4)["S5(X;'?#<.LDV5E8HPCX92?F7&X\\#$LNJ>*%.JBV^W3[)!L=
MK9HTCC,G.Q6MMQ8+TQYW0GGC+ W=:\/W$ERVH:3(Z:B\JL7-RL010A0XS%(#
MD8X*^^1CFE:_#W3TCTZ6YE#WMK#''))]F@D$A3D']Y&Q7J?NE?Y5'IDGB/4Y
M=.@GU"^M(3!<O-/%; ,S+)&(PQF@7!VL_1%SC(ITVH^(AHMW-+'>1SP"*U @
M@&9)0W[R=1Y<A\M@0  C8&>.X-0-2;PAIT]B;.22X,1%V#\PR?M#,S]NVXX]
M.,YK7BM"MC]EN9Y;O*E'DF"AG!]=@4>W %<)IQUFZU/1-2U)]2B?R+RV.RS)
MW?OT\L2 P@J'1<EBJ?<'W<D&:TO/$$%AI,02]MYULK/RK6&P @D<@>:LI"?N
MMOIE,=@>E*P&\GA@QPP(NMZGNML"VE/DEH5VE2HS'A@1C.\,> <YYJ)O!EG\
MBP7U];Q>5%'+%&R$3"-V=2Q9"0=S,3M(SFH=&EU[^T[>6]GNY(+B:\1X)+=$
M2!4E(B8$(&Y4#!8D$'/O4?BK4KRUUJRL[>_U"UCDLKB4"PLQ<.\BM$$R#&^%
M^=N>!TYH ?9># ;:6/4[ZXF4SW4D,$;*(X/-E=@RD(&W;6_B) )..,5H6_AF
MWBO8+V:\N[J\BN//\^8H"Y\IH@I"JHVA7., <\G-8%MJ7BS_ (2.**]B:&+@
M-$D3O$5\O).Y8& ;?GK,!QC;ZMMSXEAM=/O)&NKJ^ET6661IK.,-!,3 ?+7:
MBD'[YV$\E><X&&!V6FV$6EZ?#90,[11 A2Y!/))[8]:FAFBN(5F@E26)QE7C
M8,I'L17%G4-9$8'VO6/[-^T[?MW]F?Z7M\O./*\K[N_C=Y?_ ,56KX0DEM]"
MTW3I[2\CECLUD:26$HN22-ISC#]R,=#2L,Z.BBBD 5B^,?\ D2-?_P"P;<?^
MBVK:K%\8_P#(D:__ -@VX_\ 1;4T!Z-1116Q 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 <);?\ (S^*
M?^PE'_Z1VU7ZST/V?QCXBMI1MDGGBO(@?XXS!%%D>N&B8'\/6M"L9;E(*C,$
M)N%N#$AF12BR%1N"D@D ]<$J./8>E244AA4<,,5O$(H(DBC&<(BA0,G)X'O4
ME% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 5&8
M(3<+<&)#,BE%D*C<%)!(!ZX)4<>P]*DHH **** "BBB@ HHHH *Q?&/_ ")&
MO_\ 8-N/_1;5M5B>+SO\*:E:(-T][ UG!&.KR2@HH'KR?R!IH#T>BBBMB HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH R]:T"PUV*);M'6:!B\%Q"VR6%CP2K#U[CD'N#6 _ASQ+:MBVU
M:PO8AT^V6[12?BZ':?P0444K)@,_L_Q>O']FZ&WO_:DRY_#[.?YT?8/&'_0*
MT/\ \&TW_P C444N5#N'V#QA_P! K0__  ;3?_(U'V#QA_T"M#_\&TW_ ,C4
M44<J"X?8/&'_ $"M#_\ !M-_\C4?8/&'_0*T/_P;3?\ R-111RH+A]@\8?\
M0*T/_P &TW_R-1]@\8?] K0__!M-_P#(U%%'*@N'V#QA_P! K0__  ;3?_(U
M'V#QA_T"M#_\&TW_ ,C444<J"X?8/&'_ $"M#_\ !M-_\C4?8/&'_0*T/_P;
M3?\ R-111RH+A]@\8?\ 0*T/_P &TW_R-1]@\8?] K0__!M-_P#(U%%'*@N'
MV#QA_P! K0__  ;3?_(U'V#QA_T"M#_\&TW_ ,C444<J"X?8/&'_ $"M#_\
M!M-_\C4?8/&'_0*T/_P;3?\ R-111RH+A]@\8?\ 0*T/_P &TW_R-1]@\8?]
M K0__!M-_P#(U%%'*@N'V#QA_P! K0__  ;3?_(U'V#QA_T"M#_\&TW_ ,C4
M44<J"X?8/&'_ $"M#_\ !M-_\C4?8/&'_0*T/_P;3?\ R-111RH+A]@\8?\
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8% !1110 4444 %%%% !1110 4444 ?_9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>5
<FILENAME>image_007.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 image_007.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0@)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" "N KD# 2(  A$! Q$!_\0
M'P   04! 0$! 0$           $" P0%!@<("0H+_\0 M1   @$# P($ P4%
M! 0   %] 0(#  01!1(A,4$&$U%A!R)Q%#*!D:$((T*QP152T? D,V)R@@D*
M%A<8&1HE)B<H*2HT-38W.#DZ0T1%1D=(24I35%565UA96F-D969G:&EJ<W1U
M=G=X>7J#A(6&AXB)BI*3E)66EYB9FJ*CI*6FIZBIJK*SM+6VM[BYNL+#Q,7&
MQ\C)RM+3U-76U]C9VN'BX^3EYN?HZ>KQ\O/T]?;W^/GZ_\0 'P$  P$! 0$!
M 0$! 0        $" P0%!@<("0H+_\0 M1$  @$"! 0#! <%! 0  0)W  $"
M Q$$!2$Q!A)!40=A<1,B,H$(%$*1H;'!"2,S4O 58G+1"A8D-.$E\1<8&1HF
M)R@I*C4V-S@Y.D-$149'2$E*4U155E=865IC9&5F9VAI:G-T=79W>'EZ@H.$
MA8:'B(F*DI.4E9:7F)F:HJ.DI::GJ*FJLK.TM;:WN+FZPL/$Q<;'R,G*TM/4
MU=;7V-G:XN/DY>;GZ.GJ\O/T]?;W^/GZ_]H # ,!  (1 Q$ /P#VCQ!XALO#
MMDL]R))99#M@MH0#),W7"@_J3@#N:X2Z\6^*+]B8[BUTJ(_=C@B$T@^KO\I_
M!/Q-0^(9VO?'6KO*<_8?*LX1V53$DK8]R9!G_='I56MH05KLPG4:=D2_VKXF
M_P"AKU$?2VM/_C-']J^)O^ALU+_P&M/_ (S45%:<D>QGSR[DO]J^)O\ H;-2
M_P# :T_^,T?VKXF_Z&S4O_ :T_\ C-144<D>P<\NY+_:OB;_ *&S4O\ P&M/
M_C-']J^)O^ALU+_P&M/_ (S45%')'L'/+N2_VKXF_P"ALU+_ ,!K3_XS1_:O
MB;_H;-2_\!K3_P",U%11R1[!SR[DO]J^)O\ H;-2_P# :T_^,T?VKXF_Z&S4
MO_ :T_\ C-144<D>P<\NY+_:OB;_ *&S4O\ P&M/_C-']J^)O^ALU+_P&M/_
M (S45%')'L'/+N2_VKXF_P"ALU+_ ,!K3_XS1_:OB;_H;-2_\!K3_P",U%11
MR1[!SR[DO]J^)O\ H;-2_P# :T_^,T?VKXF_Z&S4O_ :T_\ C-144<D>P<\N
MY+_:OB;_ *&S4O\ P&M/_C-']J^)O^ALU+_P&M/_ (S45%')'L'/+N2_VKXF
M_P"ALU+_ ,!K3_XS1_:OB;_H;-2_\!K3_P",U%11R1[!SR[DO]J^)O\ H;-2
M_P# :T_^,T?VKXF_Z&S4O_ :T_\ C-144<D>P<\NY+_:OB;_ *&S4O\ P&M/
M_C-']J^)O^ALU+_P&M/_ (S45%')'L'/+N2_VKXF_P"ALU+_ ,!K3_XS1_:O
MB;_H;-2_\!K3_P",U%11R1[!SR[DO]J^)O\ H;-2_P# :T_^,T?VKXF_Z&S4
MO_ :T_\ C-144<D>P<\NY+_:OB;_ *&S4O\ P&M/_C-']J^)O^ALU+_P&M/_
M (S45%')'L'/+N2_VKXF_P"ALU+_ ,!K3_XS1_:OB;_H;-2_\!K3_P",U%11
MR1[!SR[DO]J^)O\ H;-2_P# :T_^,T?VKXF_Z&S4O_ :T_\ C-144<D>P<\N
MY+_:OB;_ *&S4O\ P&M/_C-']J^)O^ALU+_P&M/_ (S45%')'L'/+N2_VKXF
M_P"ALU'_ ,![3_XS5BW\3>*K)@PU*WU!0>8[RW5"1Z!XPNWZ[3]*I44<D>P>
MTEW/0O#7BNU\1))%Y,EG?PC,UI*02!TW*1PRD]Q^(!XKH*\:BG:PUW1K^$XE
MCOX;<GU29UB93ZCYP?JH/:O9:YY1Y78Z(2YE<****DL**** *.JZK::-8M=W
MCD("%5$7<\CGHJJ.68]@*YA]4\3:IAXVM]%MV'RQF,3W&/\ :).Q3[ /]:=J
MY^V>/%AEYCT[3TGB7L))GD4M]0L.!Z!F]:N5A4FT[(:1G?9-</)\7ZL#Z+!9
M@?K :/L>M_\ 0X:Q_P!^++_Y'K1HK/GEW'8SOL>M_P#0X:Q_WXLO_D>C['K?
M_0X:Q_WXLO\ Y'K1HHYY=P,[['K?_0X:Q_WXLO\ Y'H^QZW_ -#AK'_?BR_^
M1ZT:*.>7<#.^QZW_ -#AK'_?BR_^1Z/L>M_]#AK'_?BR_P#D>M&BCGEW SOL
M>M_]#AK'_?BR_P#D>C['K?\ T.&L?]^++_Y'K1HHYY=P,[['K?\ T.&L?]^+
M+_Y'H^QZW_T.&L?]^++_ .1ZT:*.>7<#.^QZW_T.&L?]^++_ .1Z/L>M_P#0
MX:Q_WXLO_D>M&BCGEW SOL>M_P#0X:Q_WXLO_D>C['K?_0X:Q_WXLO\ Y'K1
MHHYY=P,[['K?_0X:Q_WXLO\ Y'H^QZW_ -#AK'_?BR_^1ZT:*.>7<#.^QZW_
M -#AK'_?BR_^1Z/L>M_]#AK'_?BR_P#D>M&BCGEW SOL>M_]#AK'_?BR_P#D
M>C['K?\ T.&L?]^++_Y'K1HHYY=P,[['K?\ T.&L?]^++_Y'H^QZW_T.&L?]
M^++_ .1ZT:*.>7<#.^QZW_T.&L?]^++_ .1Z/L>M_P#0X:Q_WXLO_D>M&BCG
MEW SOL>M_P#0X:Q_WXLO_D>C['K?_0X:Q_WXLO\ Y'K1HHYY=P,[['K?_0X:
MQ_WXLO\ Y'H^QZW_ -#AK'_?BR_^1ZT:*.>7<#.^QZW_ -#AK'_?BR_^1Z/L
M>M_]#AK'_?BR_P#D>M&BCGEW SOL>M_]#AK'_?BR_P#D>C['K?\ T.&L?]^+
M+_Y'K1HHYY=P,[['K?\ T.&L?]^++_Y'H^QZW_T.&L?]^++_ .1ZT:*.>7<#
M.^QZW_T.&L?]^++_ .1Z5?\ A);7YK?Q#]J(_@O[.,@^V8A&1]>?I6A11SR[
MA8GT7Q*;V\.FZE:&PU$ LB;]\5PHZM$^!G'=2 P],<UT%>>^*S]G\.W6HIQ<
M::IOH&'57B&[]0"I]0Q'>O0JZ(2YD2>1:K_R.GB;_K]B_P#22WJ*I=5_Y'3Q
M-_U^Q?\ I);U%7;#X4<D_B844451 5N/I]I</;(ICM2ULLI"G)D8G&!O<#]?
MS[94-L9;>:<RQQI%@?-G+$YP!@'G@]:D&J:@N,7UR,# Q,W ].M)^12TW)K&
MTMVO[B"Z\P+'%*1\OS!E4GIGJ,9QGMCWJXVEP7D%JMM+LF^S%\-$%#CS&&6(
M/!Q['IUK&CFEBF$L<KI*#D.K$$9]ZD,]RZM*UPYX\LYEY(.21C.2,YSVR?>D
MTP31:U+3(]/ V722L'*,F5R".^ QXZ]<'VJ3^QE6QCG>[C65XQ(L9*C()QC[
MV[/_  ''O5":\NKA%2>YFE5?NAW+ ?G3[>>]<+9P7,JHYP(_-VJ2?J<4[.P:
M7-%]!C!F9+MFBMWD29C#@@H,_*-W/XD58N-*@N/LBP%8UD^SQA_+PQW*QR0&
MQVYZ_7UQY9KVSN71KB19DD+-MESASU.0>OO4BR7]Q!-=F[E/D,A):1MV3D*1
M].?SI6?<=UV+!TB 6GVT7<GV39G/DC?G=MQMW8QWSFDM[%+;Q/#9.5F19U4[
MEX8<=1S52SU&>R<,K,P52JJ9'4+DY.-K ]J9->3SWKW;.5F9M^Y#C!]J+,5T
M73H\<=BEQ+>(CO&)0F5Y7/098$G&3TQVS4BZ ?.,;W*K]]U.!AHU PXRP'.>
M,D=#S6:MY=);FW6YF6$]8PY"G\.E.MWNY[N!8)9#/Q'$0^".P .>*+,+KL7;
MNRAM-,FV21S'SXMLB[20"CDKP2!R.@/84D6CH\2;KAEE, N"HCRH3..N>OMC
MVS5:X:[DM([B>YDD29V4!W+'* <G/^]Q^-0B[N!;_9Q<2^3G/E[SMSG/3IUH
MLPNC6EAM)_%:6C ?9Q/Y)58A'T8C'RGG_>ZT1Z=:W=A;1PRNLKR3"-FA +X5
M3AOFX'Y]:SXX)I(Q>?:461I<(7D(=G&"3GH,9!R2*B:]NFD$C7,Q<$D,9#D$
MC!Y^@'Y46[#NNQ=OM(6QMRYNXVF7;NBW+W&>,,3QQU I]A90WFGQ)Y:)-)=K
M#YWS$@$9Z9Q52&2]O(S:BZD,4<;2>6\AV@*">!^%11WMW%$(H[F9(P=P19"
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M+M9UF\V4D3SB9\&1BOS  8QC [# [5HU(!1110 4444 %%%% !1110 4444
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M* .,O/\ DH6I_P#8*LO_ $;=5<JEK -EX^260 1:CIZ0Q-ZR0O(Q7ZE9B?\
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M%/4?_ FT_P#C]']E>)O^A3U'_P ";3_X_7KM%'M)![*)Y%_97B;_ *%/4?\
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M]"?K'_?^S_\ DBC[7K?_ $)^L?\ ?^S_ /DBNXHH]E$+G#_:];_Z$_6/^_\
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M<X?[7K?_ $)^L?\ ?^S_ /DBC[7K?_0GZQ_W_L__ )(KN**/91"YP_VO6_\
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M\2_V&7^T7WG+=?+MLIC*Z;.5)-E@#=@Y\KGIN%=MIUX]PK12VUW%)"D>Y[A
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MY+14?_"-^)_^A@TC_P $\O\ \DT?\(WXG_Z&#2/_  3R_P#R31RL+DE%1_\
M"-^)_P#H8-(_\$\O_P DT?\ "-^)_P#H8-(_\$\O_P DT<K"Y)14?_"-^)_^
MA@TC_P $\O\ \DT?\(WXG_Z&#2/_  3R_P#R31RL+DE%1_\ "-^)_P#H8-(_
M\$\O_P DT?\ "-^)_P#H8-(_\$\O_P DT<K"Y)14?_"-^)_^A@TC_P $\O\
M\DT?\(WXG_Z&#2/_  3R_P#R31RL+DE%1_\ "-^)_P#H8-(_\$\O_P DT?\
M"-^)_P#H8-(_\$\O_P DT<K"Y)14?_"-^)_^A@TC_P $\O\ \DT?\(WXG_Z&
M#2/_  3R_P#R31RL+DE%1_\ "-^)_P#H8-(_\$\O_P DT?\ "-^)_P#H8-(_
M\$\O_P DT<K"Y)14?_"-^)_^A@TC_P $\O\ \DT?\(WXG_Z&#2/_  3R_P#R
M31RL+DE%1_\ "-^)_P#H8-(_\$\O_P DT?\ "-^)_P#H8-(_\$\O_P DT<K"
MY)14?_"-^)_^A@TC_P $\O\ \DT?\(WXG_Z&#2/_  3R_P#R31RL+DE%1_\
M"-^)_P#H8-(_\$\O_P DT?\ "-^)_P#H8-(_\$\O_P DT<K"Y)14?_"-^)_^
MA@TC_P $\O\ \DT?\(WXG_Z&#2/_  3R_P#R31RL+DE%1_\ "-^)_P#H8-(_
M\$\O_P DT?\ "-^)_P#H8-(_\$\O_P DT<K"Y)14?_"-^)_^A@TC_P $\O\
M\DT?\(WXG_Z&#2/_  3R_P#R31RL+DE%1_\ "-^)_P#H8-(_\$\O_P DT?\
M"-^)_P#H8-(_\$\O_P DT<K"Y)14?_"-^)_^A@TC_P $\O\ \DT?\(WXG_Z&
M#2/_  3R_P#R31RL+DE%1_\ "-^)_P#H8-(_\$\O_P DT?\ "-^)_P#H8-(_
M\$\O_P DT<K"Y)14?_"-^)_^A@TC_P $\O\ \DT?\(WXG_Z&#2/_  3R_P#R
M31RL+DE%1_\ "-^)_P#H8-(_\$\O_P DT?\ "-^)_P#H8-(_\$\O_P DT<K"
MY)14?_"-^)_^A@TC_P $\O\ \DT?\(WXG_Z&#2/_  3R_P#R31RL+DE%1_\
M"-^)_P#H8-(_\$\O_P DT?\ "-^)_P#H8-(_\$\O_P DT<K"Y)14?_"-^)_^
MA@TC_P $\O\ \DT?\(WXG_Z&#2/_  3R_P#R31RL+DE%1_\ "-^)_P#H8-(_
M\$\O_P DT?\ "-^)_P#H8-(_\$\O_P DT<K"Y)14?_"-^)_^A@TC_P $\O\
M\DT?\(WXG_Z&#2/_  3R_P#R31RL+DE%1_\ "-^)_P#H8-(_\$\O_P DT?\
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$B@#_V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>6
<FILENAME>image_002.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 image_002.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0@)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" %T B@# 2(  A$! Q$!_\0
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M;./0*.@ 'I5N@!D<:0QJB+A5  'TI]%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%4+G6],M+R6TN+V*.XAMC=R(QY2('&\^@S0!?HK'/B
MC2%LVN7N'1$D$3(\#B16*[@"A&[[OS=.G/2M&"\M[IY%@D$GE[=Q7I\PR.>A
MX(/XB@#DOBW_ ,DK\0?]>X_]#6NKT[_D&6G_ %Q3_P!!%<I\6_\ DE?B#_KW
M'_H:UU>G?\@RT_ZXI_Z"* +-%%% !1110 4444 %%%% !1110 4444 %%%%
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH ***@NKN*UC9FW.X4L(HQN=A[+WZT 3U1?4"\\4-I"UP'SNF0@
MQQXXY.>3GL.:8(+J_9)+EC#:O$0UGM&XDY!W,#Z=A5V""*VA6&"-8XT&%1!@
M"@"K;:=M$<M[(+NZ1BRRN@&S/91V''UJ]110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110!Y]XIBN#XG\K OC+#&$B
MDMH-L.YW"@,X).2"/;C/6NQT&19O#^G2*\CJUM&0TK!G/RCJ0 "?I7+>)8IH
MM3E,^IQWL<R[4TY+:%KA4)&0N8V+C(!YQ]>*[&P 73[<!74"-1MD0(PX[@<
M^PXH L5@0^$;*)+Z)[F[F@OF=[B*5E(=F[Y"AN.,<\8'I6_10!EV>A06EO=H
M+BZEEN_]=<22?O&PNT<@ # '8?K3;?P[86NK_P!HPK(LFW"Q;OW:':J%@.Q*
MJH^@K6HH X/XP6%G/\-=;NI;2"2XAMQY<KQ@NGSKT)&1^%=GIW_(,M/^N*?^
M@BN4^+?_ "2OQ!_U[C_T-:ZO3O\ D&6G_7%/_010!9HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ I&944LS!5')). *K7=^EJT:".6:61MJI$NX_CV ^M0'3Y+WS!JC13Q>8&C
MA12%4#.,_P![\>* "6ZN;QI[>Q5H6C('VF:/*9[[1_%QWZ5/;V$$$YN2@>Z=
M LD[#YFP/T^@XJT  , 8%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 <=<Q>$8]>OUDTZ9;]@)+B6
M*VF_>$Y'+*.3\O\ *NHT]TDTZV>*"6"-HE*Q3+AT&. P/0BL'Q%X9FUC4H[L
M>3/'%$JI!/(RKN#DMT!QN4X)QD;5K;TJTDL-(L[.5Q))!"D;,.A( % %RBBJ
M&MM<IH&HM9;OM0M9##MZ[]IVX]\XH OT5Y>MC%?I.FDW,1TV&QM[BY#RMY;3
M;9 22,G> 4<CJ2JY]:W/#FKWR>('TR]B#S.@,CLQ\U=L:%69>@4AL9_O!J #
MXM_\DK\0?]>X_P#0UKJ]._Y!EI_UQ3_T$5Y]\:+G7(_!&I0V6GVLVEO;?Z5<
M23[9(SO&-JXY[5Z#IW_(,M/^N*?^@B@"S1110 4444 %%%% !1110 4444 %
M%%% !1110 445F>(9+R+0+R2P#?:53*[1R.>2/?&:<5=I";LKFG17D_A34_$
M27LQLX9K]-O[R.23Y0?7)/!KKO[9\5?]"XG_ '_7_&NF>&E%VNOOL8PKJ2O9
M_<=517*_VSXJ_P"A<3_O^O\ C1_;/BK_ *%Q/^_Z_P"-1["7=?>BO:KL_N9U
M5%<K_;/BK_H7$_[_ *_XT?VSXJ_Z%Q/^_P"O^-'L)=U]Z#VJ[/[F=517*_VS
MXJ_Z%Q/^_P"O^-']L^*O^A<3_O\ K_C1["7=?>@]JNS^YG545RO]L^*O^A<3
M_O\ K_C1_;/BK_H7$_[_ *_XT>PEW7WH/:KL_N9U5%<K_;/BK_H7$_[_ *_X
MU!_PDOB/[4UM_8""50&8>:,#/3G./PS2=&2ZK[T"JI]']S.O>18T+NP"@9)J
MA'<76H>1+:?N+7<2YFC(=P.FT=@?4\^U<V+GQ,]S%=7/AU9;B($(WG@*O7D+
MNQG!QFK?]L^*O^A<3_O^O^-'L9=U]Z#VJ[/[F=%9V-O81&.W3:&;<Q))9CZD
MGDFK%<K_ &SXJ_Z%Q/\ O^O^-']L^*O^A<3_ +_K_C3]A+NOO0>U79_<SJJ*
MY7^V?%7_ $+B?]_U_P :/[9\5?\ 0N)_W_7_ !H]A+NOO0>U79_<SJJ*Y7^V
M?%7_ $+B?]_U_P :/[9\5?\ 0N)_W_7_ !H]A+NOO0>U79_<SJJ*Y7^V?%7_
M $+B?]_U_P :/[9\5?\ 0N)_W_7_ !H]A+NOO0>U79_<SJJ*Y7^V?%7_ $+B
M?]_U_P :/[9\5?\ 0N)_W_7_ !H]A+NOO0>U79_<SJJ*Y7^V?%7_ $+B?]_U
M_P :/[9\5?\ 0N)_W_7_ !H]A+NOO0>U79_<SJJ*Y7^V?%7_ $+B?]_U_P :
M/[9\5?\ 0N)_W_7_ !H]A+NOO0>U79_<SJJ*Y7^V?%7_ $+B?]_U_P :/[9\
M5?\ 0N)_W_7_ !H]A+NOO0>U79_<SJJ*Y7^V?%7_ $+B?]_U_P :/[9\5?\
M0N)_W_7_ !H]A+NOO0>U79_<SJJ*Y7^V?%7_ $+B?]_U_P :/[9\5?\ 0N)_
MW_7_ !H]A+NOO0>U79_<SJJ*Y4:SXJSSX=3_ +_K_C730-(]O&\J;)&0%TSG
M:<<BHG3<=[?>5&:EL24445F6%%%% !1110 4444 %%%% ',:WJUW;Z^ED+N2
MRM?LHE$T=DTY=RQ!4D A<  ^^3Z5T-HY>SA<R&4L@.\IL+<=<=OI6!K]EJ,>
MI'4]-G$3BU\N0&X2/>%)8<-$_J><CJ:U]&O/[0T2PO<L?/MTDRV,G*@\X 'Z
M"@"]1110 U4100JJ 3D@#J:7:N[=@;L8SCG%+10!Q?Q;_P"25^(/^O<?^AK7
M5Z=_R#+3_KBG_H(KE/BW_P DK\0?]>X_]#6NKT[_ )!EI_UQ3_T$4 6:***
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ML<'M0!U%%9VAZS:^(-&M]3LRWE3+RC##1L#AD8=F4@@CU%:- !1110 4444
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M RN"!SZ4K?POK.HZ5M\NVL'@:\$.\$M*9)]V7!7"C"YS\W)![8H [NWU.PO
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ME3:%C&$/RCN>IKT2@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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ME?B#_KW'_H:UU>G?\@RT_P"N*?\ H(H LT444 %%%% !1110 444$@#). *
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MP_N\_P!/7BIZKW@+0  $_.G12?XAZ<T 6**** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH @N[=[F QI=36S9!\R';N^GS C]*XF_\&:C?W]V'>+_2)G?^T#)\
MPA:(Q^7Y8&,\_>]/RKO:* ..C\-7=^T]UJEM"LZ6<5K;QQ7# %DWY<L " V\
MC'IG/6I='\-W^E>(O.6?-BJ'D2GY\HHV>7T&'#MD?WL5UE% 'FGQH\/P7_@C
M4M6>\OXY;.VPL,-P5ADRX^^G1NM>A:=_R#+3_KBG_H(KE/BW_P DK\0?]>X_
M]#6NKT[_ )!EI_UQ3_T$4 6:**BN;J"S@:>YE2*)>K.<"A*X$M8^L^)+'1AY
M;DS73?<MXN6)[9]*R)=<U3Q%*UMH$1@M0</?2C'_ 'R/\GZ5JZ-X9LM'/G &
MXO&^_<2\L3WQZ5O[.,-:F_;_ #[?F8\[G\'WF3'HNK>))%GUV1K:SSE+&(X)
M_P!X_P"3]*ZJUM+>QMU@M84BB7HJ# J:BHG4<M.G8N,%'7J%%%%9EA1110 4
M444 %%%% !1110!7M%VK+\NW,K'[NW//7J<_6K%5[086;"XS*Y^Z!W]C^O6K
M% !1110 4444 %%%% !1110 57O%W0 ;=WSH<;=W\0[9%6*KWH#0 $9^=.-H
M/\0]2* +%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 444A(4$D@ <DF@!:*P-;\
M02VMA;76DK:WL3W<,$TOG K$K2*I(Q]YOFX'XFLG4O&-YIPN]1:*%]/M[Z2Q
M\@*?,)5"=^[./O#&,=.<T =K17"W?BG6K$BVE6T>=X(;KSD@<I&KA_D*ALD[
MT"@Y'W^G'.WHGB:#5;M[=W2*<J"D&TY&%!;+="<GH.<8/>@#*^+?_)*_$'_7
MN/\ T-:ZO3O^09:?]<4_]!%<)\7]<TR#P??>'I;Q$U34H0MI;E6S(=ZCKC _
M$UAWWQ.TJ9TTF?7(-'MXHU25R&>5N,$?(#CZ9%:0IN6NR[D2FHZ;L]!U?Q5;
M6$WV.SC:]U!CM6"+G!_VB/Y52MO#5YJ\ZWOB2?S"#E+.,X1/KC_/N:Y_2/B+
M\,=%AV6NO0^81\\K02EV^IV?I6G_ ,+C\ ?]#'#_ -^)?_B:MU%#2G]_7_@$
M<CEK/[OZW.VCBCAC6.)%1%&%51@ 4^N&_P"%Q^ /^ACA_P"_$O\ \31_PN/P
M!_T,</\ WXE_^)K V.YHKAO^%Q> /^ACA_[\2_\ Q-'_  N/P!_T,</_ 'XE
M_P#B: .YHKAO^%Q^ /\ H8X?^_$O_P 31_PN/P!_T,</_?B7_P")H [FBN&_
MX7'X _Z&.'_OQ+_\31_PN/P!_P!#'#_WXE_^)H [FBN&_P"%Q> /^ACA_P"_
M$O\ \31_PN/P!_T,</\ WXE_^)H [FBN&_X7'X _Z&.'_OQ+_P#$T?\ "X_
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M_P#?B7_XFC_A<?@#_H8X?^_$O_Q- '<U7O<?9QG'^L3KM_O#^]Q_7TYKCO\
MA<?@#_H8X?\ OQ+_ /$TR7XM^!;A/+@U^-WR&PL$F< Y)Y0] ": .\HKAO\
MA<?@#_H8X?\ OQ+_ /$T?\+C\ ?]#'#_ -^)?_B: .YHKAO^%Q^ /^ACA_[\
M2_\ Q-'_  N/P!_T,</_ 'XE_P#B: .YHKAO^%Q^ /\ H8X?^_$O_P 31_PN
M+P!_T,</_?B7_P")H [FBN&_X7'X _Z&.'_OQ+_\31_PN/P!_P!#'#_WXE_^
M)H [FBN&_P"%Q^ /^ACA_P"_$O\ \31_PN/P!_T,</\ WXE_^)H [FBN&_X7
M'X _Z&.'_OQ+_P#$T?\ "XO '_0QP_\ ?B7_ .)H [FBN&_X7'X _P"ACA_[
M\2__ !-'_"X_ '_0QP_]^)?_ (F@#N:*X;_A<?@#_H8X?^_$O_Q-'_"X_ '_
M $,</_?B7_XF@#N:*X;_ (7'X _Z&.'_ +\2_P#Q-'_"XO '_0QP_P#?B7_X
MF@#N:*X;_A<?@#_H8X?^_$O_ ,31_P +C\ ?]#'#_P!^)?\ XF@#N:*X;_A<
M?@#_ *&.'_OQ+_\ $T?\+C\ ?]#'#_WXE_\ B: .YHKAO^%Q^ /^ACA_[\2_
M_$UV=I=6]]:17=K,DUO,@>.1#D,IZ$4 34444 %%%% !1110 4444 %%%% !
M01D8/2BB@"E>Z5:7UF+5T\N(2QS8BPOS(P8?JHJC-X5TZXO9)Y?.>&61IGM2
MP\HR,FPOC&<[2>^.^,\UMT4 8]CX=MK&*X5;F[DDFA6 S22 ND:@A54@#&,G
MGKD\DTL'AW3[35CJ40=&"X6+=^[0[50L!V)5%'7'%:YZ<5R7BZVO-0\+RM=V
M[12PW$+QQ6MPSA\2+RV%7(')QR.,T ;.NZ/IOB'3;C2-1 :.X3#*K[7VY!R#
MU'(JS'%810846_EQ?(2<?*1Q@GUK@=9M[E]3U"*WC<:\^J1RV<NP[A;B(#(;
MLG#@\XR?>H+328]22,6*1P6]KIMNUXLUNQC>X0ME9%X+, 6)ZG.V@#TK[/;Y
MQY,6>N-HI?LT'_/"/_O@5Q?ARYU.QU^+3+B'<KPIO:2-O-\M8OE<OG& ?D(_
MO$G-=S0!%]F@_P">$?\ WP*1X+6-"[Q0JH&22H %35R7B]KV6RACGM(H[-;Z
M$FX$C2JJ D[I(]HRO !&<<CD8S0!IZCH.C:EJ&E7UTD?G64K2VI5@H9F7!X_
MBXK2\JT.["0?(<-P.#[UY4ML4TV^CGMI9'DLWCT=_*;#R^?(0T0Q^[R3&0.R
M@<D#-:U[I=]HMU<S)+'+%YD;W,A@9EPTQ8/( ?G*[B>,?*B^M 'H7V:#_GA'
M_P!\"C[-!_SPC_[X%5]'NKB^T>TNKJ'R9Y8E=X_[I(]ZNT 1?9H/^>$?_? I
MLD5I$H:1($!. 6 '-3G...M<#XJCO[K4+9M4CAM;'[)<(%5?M2/*=FT'*@ D
M;@.,]0",T =+!X?T>V\1W6JI$@U"[A2.12P(*)G!"]NO6M)8K1U#*D#*3@$
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MRM%&!MCYVX"NN><L3SDXJXNA:M#::3>EV.HM8QJZ%#YRE(65EW=@0W(Z[]M
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M3G!JS0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !6+K'AN
MSUS4;*XODCF@MHIHS;R1A@_F!1G/8C;^O:MJB@#B3\/MPB6344F"VZ6C&2 Y
M,*,Q08#A=P5MI)!!P#@<YDN/ \\D%Q##JJ1I/%/ Q-MN(CEE,O'S?>!)&>A'
M8&NRHH P8_#0CEBD^UD^7J;ZACR^NY679U_VNOMTJ6V\/1Q>%'T"6=I(WADA
M:55VG#YR0.?6MFB@#F$\*3R7L5[>:DLMQ'+;MF.#8I2'?@8W'DER2<_05?ET
MJ^37YM3L[NW19X8X9(IH&<X1F.00XZ[_ $[5L44 <<_@5Y; 63ZGB&WMIH+)
ME@&Z$R,&#L<X<J57& .G-1+\.H(TDV7Q+_:(IX0\9VQ[$*LIPP)#%G;@C!;V
MY[:B@#D8_!30M9-!>0P/ VYYX(&CE/[PR,H8/RK9QA@W!/<YK=T73&TG1+?3
M6G$WD(8UD";<KGC(R><5HT4 <O;>!M,@\)MHGEQ"22U-M)>10*DCY[G\0#C/
M:C3O"'V*_@O7NHC-'<><PBA(##RFC RS,W\1.23Z "NHHH Y.3P;,L<HM=3$
M;SQ7-O,SP;OW<TK2?*-PPR[B 3D'N*M6WA1+7R1'=MLAU 7J@IV$7EA,Y_'/
MZ5T5% ')P>"1 +$?V@6^RQ01_P"I^]Y<WFYZ\9Z>W6JUSX.EM;.QDMIY+FXL
M(HXXE2-1EEE$@8AG (XP5R,CH<UVM% '-:3HMZ_AC4[+47$5SJ,ER[%5'[L2
MDXX#$< CC)^O>HV\&1R0M%)>LT;SP2L!'C(CB$17KWQG/;WKJ:* .,E\#3W4
M4*W>J1R&UB@BMMMN4 $3$@OA\DD-@X*^HQ5BU\&?9;O3[M;Y5FL9))8UC@PA
M:1CYN06).5PHR<C&<DFNKHH YCQ3X1;Q+)G[:D49MGMS'+"954M_RT5=P&X>
MX(^E:&EZ(VG6E_;&Y$B74SRJ?+P4W  @\G/(]OZUKT4 <?8^!$LA;@:B[BW2
MV"#R@ K1;=[#G@OL3Z8[U7M?A_+;7"7']J1--&D2AS;$M(T<J2!Y"7)8G8 0
M" .P'2NXHH XX^!I6B,+ZH#"D4D,(%OR TZRY8[N3\NWC'7-7[KPT6UM]66?
MS,S&5K8Q [U,'E% 2P&3C.3Q_.NBHH P/"&B2Z)HWEW+,US*Y9MY!9$'RQH2
M.#M0*..X-;]%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 4M5EOX+!WTRVCN+H$;8Y&V@C///TK _
MM/QK_P! &R_\"1_C7645I&:BK.*9$HMO=HY/^T_&O_0!LO\ P)'^-']I^-?^
M@#9?^!(_QKK**KVJ_E7X_P"9/LW_ #/^OD<Q:ZAXN>[A2YT2TC@9P)'6<$JN
M>2!GTJ+4UU!O'L/V&6",_P!DR;C/&SJ?WJ],,.:ZRBHG)2V5BXQMUN>;Z7J>
MKZ?X>\.6<$C?\32QCMK=C'GR+@'+,<CIY99L'_GG[TW3_%&L2:*]S:ZB=3F.
MG-/,WV=3]FE$BJ!M4#^$N=IR3LST->A/8V\E]%>O&6GB4I&Q8X4'KA<XSVSC
M..*6SL[?3[.*TM(A%!$-J(.PJ"CSR6_N+SQ!;@:I/=6$#7,4%R-@6X)MU8J2
MJ@,0=P!&.XZ@U'!K&MZ3I&GVD=U++"UI8/)-($0VZNKAL,5P!E$&6!QGK7IV
M** /+1JFIO\ VA?SW1DN#ID?DQE5>.51<NN\ J 3MVY(X^;(X(K33Q)?)H4]
MU)J<CW;",3P+;JOV)VEV$;SPH X^?)&-W(XKOZ* .!\(:G>:IXE,MY*)FAM[
MF 2(<JRK-'@Y"J&ZXW #.,U')XDUFV76TBG^W7D,,DL0@V/%&!(%Y4*'1PI^
MZVX':2#7H5% 'G<?B'4VVQSZL+?3S-(HU%?+F((B5E0L$"'YBW09.-O6K]EX
MCOI=9MK&6YS*^HR(T1AV-Y M]ZDJ1E06[GZ9KM<"B@#RMKS5+N/29K[5;@&5
M+&YEE6*./86G((SM^Z..#GFNJ\-ZGJNHZI<6EY(<:6K6UT?+"B>8ME6''3R]
MK<=Y/:NJJO9V-O81-';1E0[F1RS%F9CU))))/U]!0!P,^NZY!8V-Q+J$BQW<
M]V)9F$42P>6["- 60@9 SSDG;QC--T[6-1M+BYO;N\:.2>_LC=HX'EQ1/ NX
MC<H*J6XR?3US7I%% 'G*>(-;N["[O(]0E06^F3W4:K;KB2032JA.5S@*J\#&
M>M=1X>NKV2^U2TN[E[A;=HC')(BJWSQAB/E !&2<5O44 %%%% !45R\Z6[M;
M1++,/NH[[0?QP<?E4M% %$3ZD7MP;& *P_?'[0<QG/;Y?F_2F_:-5\F5O[/M
M_,# 1K]I.&'<D[>/IS6A10!2$VH?:(U-G"(2F7?S^5;'0#;R,]\U%]IU?[+N
M_LZW\_?CR_M1QMQUSLZ^V*TJ* .6\0B^?Q1X;^QO%%-_I.3*C.@_=CJ 1_.L
M&SU75=#T"WN5_?":^O;1HEC.#</._DL,Y(7<-O7&&'I7H]5[BQMKJ>WFGC+O
M;MOCRQVAO7;G!/H2..U '!Z=K^M)*T*:F=6OHGO8I[;R%41^4&\ML* 1E@HY
M/.[CI4!U6\OM0T=#J\]Q:)<VDTUPJ(@29UD#1'"XQPORGD;L$Y(KT2UL[>R1
MTMHA&KR-*P'=F)9C^))-3XH \MM=5UO1M#B^R32S++!/*4>-<6^+I5+*<9X1
MV/S9'&>@Q4J:GJ-Q?_:I[YG6*RU!+;#)(DQ58R-V$"N1\WW>"%_WJ]-HH \]
ML/$E^FC7=W/?R?;8K:9CIT=F&\D(!L<8QC(Y^8X;=QC%1Z'JU[J7BVSBN;@7
M"6L\JQR)() 5: -@NJJK8/<# .1DXKT:B@#A=6U?6K:75)X;J3R(M2BLPFU$
M6"%D1FDW%3SDXW'(&>G%9"ZQJZS7NI&]D-PFE/\ 9PNUTD5+AAO V@,=N,E>
M#U'!%>HT4 <3#K=_JOB)+6UU)UL&OYD$D$:'=&D$;@!BI&-S-SWZ9J7PEJNJ
MW=Y:K?W;W"W6FBZ8-$J".3S-N%P!QCL<]*[&B@#S?4M:U2XMM0M_M\PGD2_2
M>TCB4&TCC5O+<'&1G"\G(;?QC%7[JU^PMX0BBN)HH$BE0HNU5D8P$@, ,9)S
MTQWKN:* /+[75]:TC0]-MH;F6:*2QL9))9%1#;ARROABN ,*HRV<9R:V;N\O
M-0^'4\]TXDD,ZJDD9SO03J%;( !.!U P>HXKMZ* //;GQ!K7FS"VO6:\$EWY
MUGY"D6T<1)C;IGY@JC))#>9QTJO!XL\17.G:K=1(Q-O +J)3"/\ 5SLIB[<E
M(PY/X9KTJB@#S:;Q)J\5DT[:FAM8990ICFB,TX"(0%8IY<A#%AM7!.1SD&MW
M1II4OO%4WVF=I!*DL<4V,Q@P(1@8X&<C_@/UKK,#TILD:2QM&ZY5P58>H- '
MF<7BK6#IEK):ZC_:$,T%J]W>;8T%J[D[U!V[5Z#[P.W.3UJU%J6M:I;SQRZE
M-%$FF7$RO;*A,I61E1BQ3^Z/X0 3R.*[^VMH;.UBM;>,)#$@C1!T50, ?E4M
M 'FVDZE>Z9#8V,%TRM$;*.WL?(4?:8Y$4RR' !)!+\C &SG.34<6L>(VL1='
M69]YM+:?:;:/;NDN&C88VYP% XSUYSVKTVB@#SJ_UW6+:TE*3F2>V;4HXYY(
M%+'RP/+)XQGZ8S5BZUG5+/4KBPN-5E@LHIFS?O$FX'R$=4/R[<%BW;)V[<YK
MO:IZAI5IJBHMVCL$SMV2O&>1@C*D9!]* .8O;NXU'P%H5W.YDGN)]/DD=5V[
MB98R3@=/I6=-K^O6UHMR+N24W"W>X&!<6ZQW"H'4 9.U"Q.<YQFO08HHX(4A
MA14BC4*B*,!0. !3Z /+#K5]87%ZMCJ;2V4U[.[:BS1KN=8HMJ;BI0CEN@^;
M;@=ZZ&RUO59?$VG6MS-LM9K6.2XVPX5+DIGR=Q&0&&7YY&T#OBNRQ10 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
0% !1110 4444 %%%% '_V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>7
<FILENAME>image_003.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 image_003.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0@)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" %" F8# 2(  A$! Q$!_\0
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M^$6\/?\ 0!TO_P  X_\ "M:B@#)_X1;P]_T =+_\ X_\*/\ A%O#W_0!TO\
M\ X_\*UJ* ,G_A%O#W_0!TO_ , X_P#"C_A%O#W_ $ =+_\  ./_  K6HH R
M?^$6\/?] '2__ ./_"C_ (1;P]_T =+_ / ./_"M:B@#)_X1;P]_T =+_P#
M./\ PH_X1;P]_P! '2__  #C_P *UJ* ,G_A%O#W_0!TO_P#C_PH_P"$6\/?
M] '2_P#P#C_PK6HH R?^$6\/?] '2_\ P#C_ ,*/^$6\/?\ 0!TO_P  X_\
M"M:B@#)_X1;P]_T =+_\ X_\*/\ A%O#W_0!TO\ \ X_\*UJ* ,G_A%O#W_0
M!TO_ , X_P#"C_A%O#W_ $ =+_\  ./_  K6HH R?^$6\/?] '2__ ./_"C_
M (1;P]_T =+_ / ./_"M:B@#)_X1;P]_T =+_P# ./\ PH_X1;P]_P! '2__
M  #C_P *UJ* ,G_A%O#W_0!TO_P#C_PH_P"$6\/?] '2_P#P#C_PK6HH R?^
M$6\/?] '2_\ P#C_ ,*/^$6\/?\ 0!TO_P  X_\ "M:B@#)_X1;P]_T =+_\
M X_\*/\ A%O#W_0!TO\ \ X_\*UJ* ,G_A%O#W_0!TO_ , X_P#"C_A%O#W_
M $ =+_\  ./_  K6HH R?^$6\/?] '2__ ./_"C_ (1;P]_T =+_ / ./_"M
M:B@#)_X1;P]_T =+_P# ./\ PH_X1;P]_P! '2__  #C_P *UJ* ,G_A%O#W
M_0!TO_P#C_PH_P"$6\/?] '2_P#P#C_PK6HH R?^$6\/?] '2_\ P#C_ ,*/
M^$6\/?\ 0!TO_P  X_\ "M:B@#)_X1;P]_T =+_\ X_\*/\ A%O#W_0!TO\
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M4 =;X5_Y%#1/^O"#_P!%K6O61X5_Y%#1/^O"#_T6M:] !1110 4444 %%%%
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M96!8$DG!JZO@G08I]*FM[-K=M*0QVOD2N@"$Y*, ?F4GJ#G- ',:5X^UN=]
MO]1L+"/2?$$C16BP.[3P':63S,\,"%.<8Q[UD6_C/6]9TOPEJ^IV6G"WU'6H
MK>".WDG1XR#(I=L, WW>%.1ZY[=SIO@'P[I.HI?6=DZR1;S!&T[O';E_O&-"
M2J9[X I\'@?0;?3-)TZ.VD%MI-T+NT7SF)24%CDG.3RQX- &)X>\8:_KC6VK
MBPTU/#US<30+F<I<0JA90[;OE;)4_*!D ]ZP;?XD:QJFH"PFL[8:?J5G>-:W
M=NDJ8,2,<J[X\P<#E5 Y[UVUOX!\.6NL?VG'8MYHD>9(FF<PQR.,,ZQ$[58^
MH'>JUG\-/#%A<PSV]K<*\"RI"&NY66))%*LBJ6P%PQX'?F@!_P .)Y;CX:Z#
M-/*\LKV:EG=BS,?4DUX]X/T[Q-JT6E7NDV^OK=_;BTFJ3ZEFT:)9&##RR<GY
M1MQZBO?])TJTT32+;2[&,QVEM&(XD+%B%'N>34>AZ'8>'-)BTS38FCM8V9E5
MG+$%F+'D\]2: . L_B?J=[XF6&#1VDTEM3.G%EMIMZX.WS3+CR\;OX.H'>L;
MQ-XM\7:Q\./$FI0R:=86EK=R60:#S1<,%F5,ALX7(./SZ5Z-'X%\/1ZY_:Z6
M3"X\\W0C\Y_)$Y&#*(\[=^/XL9IS^"-"D\.WNA-;2?V?>SM<3Q^<V6=G#D[L
MY'('2@#DHO$/B#2DOM%T>TTR3_A';".XOGN9ICYS.K2;(BQ+#Y0?F<GGC%6+
M3Q[K.MZYY6E6MA'IRZ1#JCM=!S+M<$[ %(&>.OMWS72:QX&T#7;S[7>VLOG&
M(0RF&XDB$\8Z)(%(WK['-6HO#&DP:C<WT5MY<UQ:+9/M8A?)7.U0O08SVH X
M#2/B!XPU63PY$MCH:/K]K--;DM+B Q\DO_>!'11T]:E/Q,U>[\,Z+=6%E9_V
MM?"X,EMY<LY_=,5)14Q\I(^\S #WKL['P9HFG2Z-);6SJVCQ20V1,K'8KC#
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MX"F@#6HK)_MY?^@7JG_@*:GL=6AOKF2W$%S!,B!RD\10E22 1^(- %^BBB@
MHHHH \[^,O\ R*%I_P!?Z?\ HN2BCXR_\BA:?]?Z?^BY** .M\*_\BAHG_7A
M!_Z+6M>LCPK_ ,BAHG_7A!_Z+6M>@ HZT44 9L?A[2(H;B%-.MQ'<#$J[.&&
M<@>P!Y '2G#1+%([>&*%8[>#?B%1\C[@0VX=\Y/7J:T** ,O_A&]&%C]B_LZ
M#[/O\S9M_BQC.>N<<?3CI4LVB:7<26TDMA;LUL L/R#Y "" !Z @$#MBK]%
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M/I6C10!G?V7+G/\ :U__ -])ZY_N?A]*!I4HQ_Q-M0.,=63G!)_N?A^%:-%
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MM:]9'A7_ )%#1/\ KP@_]%K6O0 4444 %%%% !1110 5S_@W_D"W'_81O/\
MTHDKH*Y_P;_R!;C_ +"-Y_Z424 =!1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4454;4K6.6XCDDV>0N
MYV;A0/K32;V$VD61(AE,08>8%#%>X!Z']#3JYAK'4DG.JM+(7<+-)''P=BXV
MQ 9]"Q/J12I)JNIM!+ Z131Q^5/NZ(S#<Q ]1A0/J:U]FNYGS^1T$-W!<2S1
M1/N>%ML@P>#Z5-67;0C3K^"W#R2":$@R/R6=3G)/J=Q_*M2LY))Z%Q=]PH)
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M444 >=_&7_D4+3_K_3_T7)11\9?^10M/^O\ 3_T7)10!UOA7_D4-$_Z\(/\
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M8[?+_NQZ95P#^5:VG>!-?M/!UWI5QXVU.?4Y2?)O\G]R.,#!))[Y.<\\8P*
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M-%RT^[)/_+1@"WX@>E<M\1[1+_7= M[6R:YU8"6:(/>"WB,2%&8.2IW?,(R
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M"-XB RVX4@*<Y^;D[B./3O6D    , = *6BH;;*2L%%%%(84444 %-$:"1I
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M4 %%%% !1110 4444 %%%% !1110 4444 %9*?\ (VS_ /7C'_Z,>M:LE/\
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MV2"&-411C"C J4*H8L% 8C!..<5G'5I!G_B5:@<9Z(G.,?[7?/Z&@ZM("?\
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M'5I!G_B5:@<9Z(G.#C^]^/X4 :5%9O\ :LF<?V5J'_?">N/[WX_2@:M(2/\
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M4 %%%% !1110 4444 %%%% !62G_ "-L_P#UXQ_^C'K6K)3_ )&V?_KQC_\
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MKDNI1R,/-3#P]B_]_P"N.*TZ*:DUL)I/<****0PHHHH **** "BBB@ HHHH
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M^DW_ !CK>2]L_P"U[T#1H  /M-_QC_E]E],?WO\ )YK1HH SO[&@QC[3?_\
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MQE_Y%"T_Z_T_]%R44 =;X5_Y%#1/^O"#_P!%K6O61X5_Y%#1/^O"#_T6M:]
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M]^U6K=8! IMQ'Y3?.ICQM.><C'KG/XT 8?\ PDUU_P!"OKO_ 'Q#_P#':/\
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M/];70W%U!:JC7$T<2NZQJ78 %B< #/<FG1Q1Q;O+C5-[%FVC&2>I/O0!A?\
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MWG0$AI%Y ;J0JDY-=U10 4444 %5M0M7O=/GMH[J:U>1"%GA(#QGL1GBK-%
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M,8OR6)!!Q7HMW9VNH6LEK>6\5Q;R##Q2H&5A[@\5)%%'!$D44:QQH JH@P%
MZ #L* '(BQHJ( JJ, #L*6BB@ HHHH XGQ3H*ZCXBLA:Z;<[[ED%[<1X6%HE
M)Y9L[EE3@HP&>V<$UT^DZ1;:/;-% 9)'D8O+/,VZ25O5F[GM]!5^B@ HHHH
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9[81QW6KW\\8E#!9;EV .#S@GW-%%% '_V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>8
<FILENAME>image_004.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 image_004.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0@)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" %" F8# 2(  A$! Q$!_\0
M'P   04! 0$! 0$           $" P0%!@<("0H+_\0 M1   @$# P($ P4%
M! 0   %] 0(#  01!1(A,4$&$U%A!R)Q%#*!D:$((T*QP152T? D,V)R@@D*
M%A<8&1HE)B<H*2HT-38W.#DZ0T1%1D=(24I35%565UA96F-D969G:&EJ<W1U
M=G=X>7J#A(6&AXB)BI*3E)66EYB9FJ*CI*6FIZBIJK*SM+6VM[BYNL+#Q,7&
MQ\C)RM+3U-76U]C9VN'BX^3EYN?HZ>KQ\O/T]?;W^/GZ_\0 'P$  P$! 0$!
M 0$! 0        $" P0%!@<("0H+_\0 M1$  @$"! 0#! <%! 0  0)W  $"
M Q$$!2$Q!A)!40=A<1,B,H$(%$*1H;'!"2,S4O 58G+1"A8D-.$E\1<8&1HF
M)R@I*C4V-S@Y.D-$149'2$E*4U155E=865IC9&5F9VAI:G-T=79W>'EZ@H.$
MA8:'B(F*DI.4E9:7F)F:HJ.DI::GJ*FJLK.TM;:WN+FZPL/$Q<;'R,G*TM/4
MU=;7V-G:XN/DY>;GZ.GJ\O/T]?;W^/GZ_]H # ,!  (1 Q$ /P#U3PUX:T&;
MPKH\LNB::\CV4+,[6B$L2@R2<<FM7_A%O#W_ $ =+_\  ./_  I/"O\ R*&B
M?]>$'_HM:UZ ,G_A%O#W_0!TO_P#C_PH_P"$6\/?] '2_P#P#C_PK6HH R?^
M$6\/?] '2_\ P#C_ ,*/^$6\/?\ 0!TO_P  X_\ "M:B@#)_X1;P]_T =+_\
M X_\*/\ A%O#W_0!TO\ \ X_\*UJ* ,G_A%O#W_0!TO_ , X_P#"C_A%O#W_
M $ =+_\  ./_  K6HH R?^$6\/?] '2__ ./_"C_ (1;P]_T =+_ / ./_"M
M:B@#)_X1;P]_T =+_P# ./\ PH_X1;P]_P! '2__  #C_P *UJ* ,G_A%O#W
M_0!TO_P#C_PH_P"$6\/?] '2_P#P#C_PK6HH R?^$6\/?] '2_\ P#C_ ,*/
M^$6\/?\ 0!TO_P  X_\ "M:B@#)_X1;P]_T =+_\ X_\*/\ A%O#W_0!TO\
M\ X_\*UJ* ,G_A%O#W_0!TO_ , X_P#"C_A%O#W_ $ =+_\  ./_  K6HH R
M?^$6\/?] '2__ ./_"C_ (1;P]_T =+_ / ./_"M:B@#)_X1;P]_T =+_P#
M./\ PH_X1;P]_P! '2__  #C_P *UJ* ,G_A%O#W_0!TO_P#C_PH_P"$6\/?
M] '2_P#P#C_PK6HH R?^$6\/?] '2_\ P#C_ ,*/^$6\/?\ 0!TO_P  X_\
M"M:B@#)_X1;P]_T =+_\ X_\*/\ A%O#W_0!TO\ \ X_\*UJ* ,G_A%O#W_0
M!TO_ , X_P#"C_A%O#W_ $ =+_\  ./_  K6HH R?^$6\/?] '2__ ./_"C_
M (1;P]_T =+_ / ./_"M:B@#)_X1;P]_T =+_P# ./\ PH_X1;P]_P! '2__
M  #C_P *UJ* ,G_A%O#W_0!TO_P#C_PH_P"$6\/?] '2_P#P#C_PK6HH R?^
M$6\/?] '2_\ P#C_ ,*/^$6\/?\ 0!TO_P  X_\ "M:B@#)_X1;P]_T =+_\
M X_\*/\ A%O#W_0!TO\ \ X_\*UJ* ,G_A%O#W_0!TO_ , X_P#"C_A%O#W_
M $ =+_\  ./_  K6HH R?^$6\/?] '2__ ./_"C_ (1;P]_T =+_ / ./_"M
M:B@#)_X1;P]_T =+_P# ./\ PH_X1;P]_P! '2__  #C_P *UJ* ,G_A%O#W
M_0!TO_P#C_PH_P"$6\/?] '2_P#P#C_PK6HH R?^$6\/?] '2_\ P#C_ ,*/
M^$6\/?\ 0!TO_P  X_\ "M:B@#)_X1;P]_T =+_\ X_\*/\ A%O#W_0!TO\
M\ X_\*U695QN8#)P,GJ:6@#)_P"$6\/?] '2_P#P#C_PH_X1;P]_T =+_P#
M./\ PK6HH R?^$6\/?\ 0!TO_P  X_\ "C_A%O#W_0!TO_P#C_PK6HH R?\
MA%O#W_0!TO\ \ X_\*/^$6\/?] '2_\ P#C_ ,*UJ* ,G_A%O#W_ $ =+_\
M ./_  H_X1;P]_T =+_\ X_\*UJ* ,G_ (1;P]_T =+_ / ./_"C_A%O#W_0
M!TO_ , X_P#"M:B@#)_X1;P]_P! '2__  #C_P */^$6\/?] '2__ ./_"M:
MB@#)_P"$6\/?] '2_P#P#C_PH_X1;P]_T =+_P# ./\ PK6HH R?^$6\/?\
M0!TO_P  X_\ "C_A%O#W_0!TO_P#C_PK6HH R?\ A%O#W_0!TO\ \ X_\*/^
M$6\/?] '2_\ P#C_ ,*UJ* ,G_A%O#W_ $ =+_\  ./_  H_X1;P]_T =+_\
M X_\*UJ* /+/BUH>D6'A6UEL]*L;>0WJ*7BMT0D;'XR!TX%%7_C+_P BA:?]
M?Z?^BY** .M\*_\ (H:)_P!>$'_HM:UZR/"O_(H:)_UX0?\ HM:UZ "BBB@
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M&\U@1(@PCH0<H1ZC% &'JGB[Q#HVD+%?6NEKK,E]]E@$)DF2==N[>D29?/\
MLDC'7.*YRR\7ZGXEUWP1<7<364ZZK?6EU!"[*CF.+NI/KV).#7;GX=^'#IZ6
M@MKA62Y-V+I;J07!F(P7,N[>3CCK4FG^ /#NES64MG:21FRN9;JW!G=@DDBA
M7/)Y! Z&@#G/C))<#2-!AMA>N9]6BB:&RG,4LRE7^16[$^]<_I.I^(? .B:W
MJUUI^I1V$\UO!IMAJ=W]IE69CM9R5R0O3Y1R<<5ZQJNA6&M/8/?1,[6-RMW!
MARNV1<X)QUZG@T_5]'L->TR73M3MUN+67&Y"2.0<@@CD$'D$4 ><R_$K7X=
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MR/7UKIO&1O[#3O T$MU*LYUVTBG,<A&X$-E6(/S#IG/7%=WIVG6FDZ=!I]A
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M_P# 4T?V\O\ T"]4_P# 4T :U%9/]O+_ - O5/\ P%-']O+_ - O5/\ P%-
M&M163_;R_P#0+U3_ ,!31_;R_P#0+U3_ ,!30!K45D_V\O\ T"]4_P# 4T?V
M\O\ T"]4_P# 4T :U%9/]O+_ - O5/\ P%-']O+_ - O5/\ P%- &M163_;R
M_P#0+U3_ ,!31_;R_P#0+U3_ ,!30!K45D_V\O\ T"]4_P# 4T?V\O\ T"]4
M_P# 4T :U%9/]O+_ - O5/\ P%-']O+_ - O5/\ P%- &M163_;R_P#0+U3_
M ,!31_;R_P#0+U3_ ,!30!K45D_V\O\ T"]4_P# 4T?V\O\ T"]4_P# 4T :
MU%9/]O+_ - O5/\ P%-']O+_ - O5/\ P%- &M163_;R_P#0+U3_ ,!31_;R
M_P#0+U3_ ,!30!K45D_V\O\ T"]4_P# 4T?V\O\ T"]4_P# 4T :U%9/]O+_
M - O5/\ P%-']O+_ - O5/\ P%- &M163_;R_P#0+U3_ ,!31_;R_P#0+U3_
M ,!30!K45D_V\O\ T"]4_P# 4T?V\O\ T"]4_P# 4T :U%9/]O+_ - O5/\
MP%-']O+_ - O5/\ P%- &M163_;R_P#0+U3_ ,!31_;R_P#0+U3_ ,!30!K4
M5D_V\O\ T"]4_P# 4T?V\O\ T"]4_P# 4T :U%9/]O+_ - O5/\ P%-']O+_
M - O5/\ P%- &M163_;R_P#0+U3_ ,!31_;R_P#0+U3_ ,!30!K45D_V\O\
MT"]4_P# 4T?V\O\ T"]4_P# 4T :U%9/]O+_ - O5/\ P%-']O+_ - O5/\
MP%- &M163_;R_P#0+U3_ ,!31_;R_P#0+U3_ ,!30!K45D_V\O\ T"]4_P#
M4T?V\O\ T"]4_P# 4T :U%9/]O+_ - O5/\ P%-']O+_ - O5/\ P%- &M16
M3_;R_P#0+U3_ ,!31_;R_P#0+U3_ ,!30!K45D_V\O\ T"]4_P# 4T?V\O\
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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MA)MW9LT445D:!1110!YW\9?^10M/^O\ 3_T7)11\9?\ D4+3_K_3_P!%R44
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MB&5G:";3K\".)=I$!)8@E6/YC^=;=K8VUFTIMXA'YI#.%Z$]*R/$D\M@(;R
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M7 QQSQGK]<UH^%OAZ/#/AW5-(77]2NA?@@3.^&@RI7*=<'G.?84 =K17C:_
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MDVH7.$C;)R",?3N<5V?@V;[1X0TR;[0+G?#N\T7+3[LD_P#+1@"WX@>E<O\
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M4 %%%% !1110 4444 %%%% !1110 4444 %9*?\ (VS_ /7C'_Z,>M:LE/\
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M)5J SCJB<9S_ +7;'ZT#5I#C_B5:@,XZHG&1G^]^'XT :59*?\C;/_UXQ_\
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MC0 C_2;_ (Q_R^2^N?[W^1Q6C10!G#1H!C_2;_C'6\E[9_VO>@:- ,?Z3?\
M&.MY+V&/[WO6C10!G?V-!C'VF_\ _ V7TQ_>_P GFJ=E:I:>*KE4DF<-91DF
M65I"/G8<%B<=*W:R4_Y&V?\ Z\8__1CT :U%%% !1110!YW\9?\ D4+3_K_3
M_P!%R44?&7_D4+3_ *_T_P#1<E% '6^%?^10T3_KP@_]%K6O61X5_P"10T3_
M *\(/_1:UKT %%%% !1110 4444 <_I__(]:[_UYV?\ .:N@KG]/_P"1ZUW_
M *\[/^<U=!0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M_H4KW_P+M_\ XY6^JA%"J % P .U+0!S_P#;FM_]"E>_^!=O_P#'*/[<UO\
MZ%*]_P# NW_^.5T%% '/_P!N:W_T*5[_ .!=O_\ '*@A\3ZK/<7$$?A2^,EN
MP60?:K<8)4,/X^>"*Z"]O;;3;*6\O)T@MH5W22N<*H]2:?$L/S30A/WV&+IC
MY^, Y[\8H P_[<UO_H4KW_P+M_\ XY1_;FM_]"E>_P#@7;__ !RN@HH Y_\
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MC4/M$@?[K0W7?>@/!'# [B<CD FT*P@FEM=8T2XBM-0N4CNM4M&<NLJS?/\
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M#0!YUX2\-_VG=6VL>4(--\@Q(/-#/<0XVF"5,;6 ?S&+9.XL""!7I2JJ*%4
M*HP .PI(XXX8DBB14C0!511@*!T %.H **** "N.\;:,=1FLVM-*EN+V0B%I
ME"^282PWQSY()7&2" 2& (P:[&B@#-T?0[718Y! \\TLI!DGN93)*^!@ L><
M < ?_7K2HHH **** .9\8Q7<5@U]:WI14B>*>S>81I<QL/F"L?N2@ E6_ \'
M(QO"GA<SW3:O<Q1)9740*0H<I=1\-"9(RN$,:!0 .<[CFNWO+&TU&#R+VU@N
M8MP;RYHPZY'0X/>K   P!@4 %%%% !1110!Q/B+P_P#VCXHM/LNG7*"<J;ZZ
M1E2)D4':V0=PF0[=K 9P2"2*ZG2]+M](L_L]OO;+%Y)96W22N>K,W<FKM% !
M1110 5Q?C=9;&-[V2\,NFS!$N["1P#A7!$D0[D' 9.C*<=<9[2J]S86=Y)#)
M=6D$[P-OA:6,,8V]5)Z'Z4 <MX1\)SZ:T]UJB1":6193;QOYD7GC.ZX&5&UV
M)/"X &!78T44 %%%% !7"77A@7WC*3[/97MC9X:::ZCD$8$Q Q) 5.X,PW*X
M( ( )&<&N[HH KV-C;Z;916EI&(X8EVJH_F3W)ZD]ZL444 %%%% 'G_B^&^M
M=0CA2]6YBO;@-:PS."UI=%66,X_BB)[8.U@&Y&<;7A+PPNAV0\Z)4?S&>"V\
MSS5LU8 %(W(!P<9/8GH!6])86<M[%>R6D#W<2E8YVC!= >H#=15B@ HHHH *
M" 001D'M110!Y_8>$([O7;Y#97^G:5$-D(\T1L2S'S(T*$DP,-K;3T).W'-=
M[%%'!$D42*D: *J*,!0.@ I]% !1110 5YIK]C?-K,>BM-'JOG>:;03S .L;
M%6F@DX.,ID))C(#%3U!/I=5UL+-+Y[Y+2!;N10CSB,!V4= 6ZD4 9OAK0%T/
M3((I6\ZZ6/896.XHF21$K$;BBYP,\XK:HHH **** &311S0R12QK)&ZE61@"
M&!Z@@UP?A_PC'=7-U)>6=_9V$<B);6\\P#R1+SY<H4D/&K?<W'...F!7?T4
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@#SOXR_P#(H6G_ %_I_P"BY**/C+_R*%I_U_I_Z+DHH \:
ML?$^OQ6%M''KFII&D2JJK=R * !@ 9J?_A*_$?\ T']5_P# R3_&BB@ _P"$
MK\1_]!_5?_ R3_&C_A*_$?\ T']5_P# R3_&BB@ _P"$K\1_]!_5?_ R3_&C
M_A*_$?\ T']5_P# R3_&BB@ _P"$K\1_]!_5?_ R3_&C_A*_$?\ T']5_P#
MR3_&BB@ _P"$K\1_]!_5?_ R3_&C_A*_$?\ T']5_P# R3_&BB@ _P"$K\1_
M]!_5?_ R3_&C_A*_$?\ T']5_P# R3_&BB@ _P"$K\1_]!_5?_ R3_&C_A*_
M$?\ T']5_P# R3_&BB@ _P"$K\1_]!_5?_ R3_&C_A*_$?\ T']5_P# R3_&
MBB@ _P"$K\1_]!_5?_ R3_&C_A*_$?\ T']5_P# R3_&BB@ _P"$K\1_]!_5
M?_ R3_&C_A*_$?\ T']5_P# R3_&BB@ _P"$K\1_]!_5?_ R3_&C_A*_$?\
MT']5_P# R3_&BB@ _P"$K\1_]!_5?_ R3_&C_A*_$?\ T']5_P# R3_&BB@
M_P"$K\1_]!_5?_ R3_&C_A*_$?\ T']5_P# R3_&BB@ _P"$K\1_]!_5?_ R
M3_&C_A*_$?\ T']5_P# R3_&BB@ _P"$K\1_]!_5?_ R3_&C_A*_$?\ T']5
M_P# R3_&BB@ _P"$K\1_]!_5?_ R3_&C_A*_$?\ T']5_P# R3_&BB@ _P"$
MK\1_]!_5?_ R3_&C_A*_$?\ T']5_P# R3_&BB@ _P"$K\1_]!_5?_ R3_&C
M_A*_$?\ T']5_P# R3_&BB@ _P"$K\1_]!_5?_ R3_&C_A*_$?\ T']5_P#
MR3_&BB@ _P"$K\1_]!_5?_ R3_&C_A*_$?\ T']5_P# R3_&BB@ _P"$K\1_
M]!_5?_ R3_&C_A*_$?\ T']5_P# R3_&BB@ _P"$K\1_]!_5?_ R3_&C_A*_
M$?\ T']5_P# R3_&BB@ _P"$K\1_]!_5?_ R3_&C_A*_$?\ T']5_P# R3_&
MBB@ _P"$K\1_]!_5?_ R3_&C_A*_$?\ T']5_P# R3_&BB@ _P"$K\1_]!_5
M?_ R3_&C_A*_$?\ T']5_P# R3_&BB@ _P"$K\1_]!_5?_ R3_&C_A*_$?\
MT']5_P# R3_&BB@ _P"$K\1_]!_5?_ R3_&C_A*_$?\ T']5_P# R3_&BB@
M_P"$K\1_]!_5?_ R3_&C_A*_$?\ T']5_P# R3_&BB@ _P"$K\1_]!_5?_ R
M3_&C_A*_$?\ T']5_P# R3_&BB@ _P"$K\1_]!_5?_ R3_&C_A*_$?\ T']5
M_P# R3_&BB@ _P"$K\1_]!_5?_ R3_&C_A*_$?\ T']5_P# R3_&BB@ _P"$
MK\1_]!_5?_ R3_&C_A*_$?\ T']5_P# R3_&BB@ _P"$K\1_]!_5?_ R3_&C
M_A*_$?\ T']5_P# R3_&BB@ _P"$K\1_]!_5?_ R3_&C_A*_$?\ T']5_P#
MR3_&BB@ _P"$K\1_]!_5?_ R3_&C_A*_$?\ T']5_P# R3_&BB@ _P"$K\1_
M]!_5?_ R3_&C_A*_$?\ T']5_P# R3_&BB@ _P"$K\1_]!_5?_ R3_&C_A*_
M$?\ T']5_P# R3_&BB@ _P"$K\1_]!_5?_ R3_&C_A*_$?\ T']5_P# R3_&
BBB@#)\0Z_K-[81QW6KW\\8E#!9;EV .#S@GW-%%% '__V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>9
<FILENAME>image_005.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 image_005.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0@)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" %" F8# 2(  A$! Q$!_\0
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M^$6\/?\ 0!TO_P  X_\ "M:B@#)_X1;P]_T =+_\ X_\*/\ A%O#W_0!TO\
M\ X_\*UJ* ,G_A%O#W_0!TO_ , X_P#"C_A%O#W_ $ =+_\  ./_  K6HH R
M?^$6\/?] '2__ ./_"C_ (1;P]_T =+_ / ./_"M:B@#)_X1;P]_T =+_P#
M./\ PH_X1;P]_P! '2__  #C_P *UJ* ,G_A%O#W_0!TO_P#C_PH_P"$6\/?
M] '2_P#P#C_PK6HH R?^$6\/?] '2_\ P#C_ ,*/^$6\/?\ 0!TO_P  X_\
M"M:B@#)_X1;P]_T =+_\ X_\*/\ A%O#W_0!TO\ \ X_\*UJ* ,G_A%O#W_0
M!TO_ , X_P#"C_A%O#W_ $ =+_\  ./_  K6HH R?^$6\/?] '2__ ./_"C_
M (1;P]_T =+_ / ./_"M:B@#)_X1;P]_T =+_P# ./\ PH_X1;P]_P! '2__
M  #C_P *UJ* ,G_A%O#W_0!TO_P#C_PH_P"$6\/?] '2_P#P#C_PK6HH R?^
M$6\/?] '2_\ P#C_ ,*/^$6\/?\ 0!TO_P  X_\ "M:B@#)_X1;P]_T =+_\
M X_\*/\ A%O#W_0!TO\ \ X_\*UJ* ,G_A%O#W_0!TO_ , X_P#"C_A%O#W_
M $ =+_\  ./_  K6HH R?^$6\/?] '2__ ./_"C_ (1;P]_T =+_ / ./_"M
M:B@#)_X1;P]_T =+_P# ./\ PH_X1;P]_P! '2__  #C_P *UJ* ,G_A%O#W
M_0!TO_P#C_PH_P"$6\/?] '2_P#P#C_PK6HH R?^$6\/?] '2_\ P#C_ ,*/
M^$6\/?\ 0!TO_P  X_\ "M5F5!EF"CU)Q2T 9/\ PBWA[_H Z7_X!Q_X4?\
M"+>'O^@#I?\ X!Q_X5K44 9/_"+>'O\ H Z7_P" <?\ A1_PBWA[_H Z7_X!
MQ_X5K44 9/\ PBWA[_H Z7_X!Q_X4?\ "+>'O^@#I?\ X!Q_X5K44 9/_"+>
M'O\ H Z7_P" <?\ A1_PBWA[_H Z7_X!Q_X5K44 9/\ PBWA[_H Z7_X!Q_X
M4?\ "+>'O^@#I?\ X!Q_X5K44 9/_"+>'O\ H Z7_P" <?\ A1_PBWA[_H Z
M7_X!Q_X5K44 9/\ PBWA[_H Z7_X!Q_X4?\ "+>'O^@#I?\ X!Q_X5K44 9/
M_"+>'O\ H Z7_P" <?\ A1_PBWA[_H Z7_X!Q_X5K44 9/\ PBWA[_H Z7_X
M!Q_X4?\ "+>'O^@#I?\ X!Q_X5K44 9/_"+>'O\ H Z7_P" <?\ A1_PBWA[
M_H Z7_X!Q_X5K44 9/\ PBWA[_H Z7_X!Q_X4?\ "+>'O^@#I?\ X!Q_X5K4
M4 >6?%K0](L/"MK+9Z58V\AO44O%;HA(V/QD#IP**O\ QE_Y%"T_Z_T_]%R4
M4 =;X5_Y%#1/^O"#_P!%K6O61X5_Y%#1/^O"#_T6M:] !1110 4444 %%%%
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M(\+?,'#9W;B>6)R<D]<UFZ9X"\/:29S;6LI:6W:U#37$DIBA/6.,L3L7V&*
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M7JG_ ("FC^WE_P"@7JG_ ("F@#6HK)_MY?\ H%ZI_P" IH_MY?\ H%ZI_P"
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M_P" IH_MY?\ H%ZI_P" IH UJ*R?[>7_ *!>J?\ @*:/[>7_ *!>J?\ @*:
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M:?\ 7^G_ *+DHH ZWPK_ ,BAHG_7A!_Z+6M>LCPK_P BAHG_ %X0?^BUK7H
M**** ,H>'-+B29;:U2U:8J7> ;6(#;L ]AGL/6IAHFF"\GN_L$'GSJ5E<H#N
M!P&S]<#/KCFK]% &7_PC>C?8?L7]G0?9]_F;-O\ %C&<]<XX^G'2M***.&)(
MHD5(T4*J*,!0.@ IU% '/Z?_ ,CUKO\ UYV?\YJZ"N?T_P#Y'K7?^O.S_G-7
M04 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %9*?\C;/_ ->,?_HQ
MZUJR4_Y&V?\ Z\8__1CT :U%%% !1110!YW\9?\ D4+3_K_3_P!%R44?&7_D
M4+3_ *_T_P#1<E% '6^%?^10T3_KP@_]%K6O61X5_P"10T3_ *\(/_1:UKT
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M8_=#L,#]#B@#1HK._L#2,8_LVUQT_P!4/3;_ "XH.@Z0<YTVU.<Y_=#N,']
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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MCM[&@>(-*.,7:\XQ\K=P2.WH#4%FG169_P )#I6,_:UQU^ZWIN]/3F@^(-*
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MR;P=X>N/#T6@2Z3;MI41#1VV#M4Y)R.^<D\^YJCI_P -?!NE:A!?V.@6L-U
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M9<ZCIVK6T]G;9\^57P(\#)W9Z<<UA^)? /ASQ5K#R76D6[W31*TM[DAN.$7
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M,/A-X#!S_P (U:?F_P#C6OK7@[P[XBBMH]6TFWNDM5*P!P1Y8..!@CC@<>U
M#-#\;^&O$EV]IH^LVUW<(F\QH2&V],X(YZBJ5W\3O!5C=S6MQXBLTGA<I(N2
M=K#@C(&*MZ'X%\,>&[UKW1]&M[2Y9#&9$R3M."1R3Z"J5U\+O!-Y=2W,_AVT
M>:9R[M\PRQ.2< XH U9/%F@1>'UUY]6M1I3_ ';K?\A.<8'OGC'6L_3_ (D>
M#M5OX;&R\06DUS.VR.,$@LQZ 9'6KLG@[P[+X=3P^^DVQTE#N6UP=H.2<^N<
MD\^]4+#X9^#-,OX+ZS\/VL5S XDBD&XE6'0C)ZT 6=9\>>%O#U^;'5M;M;6Z
M"AC$Y)8 ],X'%6=*\6:!K>GW-_INK6UQ:VN3/*KX$0 SEL]!CFJFL^ /"OB#
M46U#5=$MKJ[90K2MN!(' S@BK&E>#O#VB:==V&G:3;V]I> BXB )$HQC!SG(
MP3^= &4/BMX%+!1XELLDXY+8_/%:^M>+O#_AV&WEU?5K:T2Y&82[9\P<<C'4
M<CGWK&'PF\!@Y_X1JT_-_P#&M?6O!WAWQ%%:Q:MI-O=):J5@# CRP<<#&..!
MQ[4 ,T3QOX9\27;VFCZS;7=PB;S$A(;;ZX(YZBJ5W\3O!5C=S6MSXBLTGA<I
M(N2=K#@C(&*MZ'X%\,>&[UKW1]&M[2Y9#&9$R3M/4<D^@JE=?"[P3>W<UU<>
M';1YIG+R-\PRQ.2< XH U9/%F@1>'UUY]6M1I3?=NM_R$YQ@>^>,=:R_#_BC
M1/$WBF[DT;4H;Q(K*-7,>?E.]_45HOX.\.R>'4\/OI-L=)0[EM<':#G.?7.2
M3GWK.\/>%M#\,>*;N/1=.BLUELHV<1D_,=[^I- '6T444 %%%% 'G?QE_P"1
M0M/^O]/_ $7)11\9?^10M/\ K_3_ -%R44 =;X5_Y%#1/^O"#_T6M:]9'A7_
M )%#1/\ KP@_]%K6O0!R7B6S\!6EZMWXE@T.*ZN>1+?+&&DV@#JW7 Q6SH%W
MHEUI4:^'Y[*73XB8T%FRF-#UQ\O Z]/>N/\ B1*\&K:++8^9/J8CG$=H-,-Z
MCQG8'<J&7:5^7!SW([U>^'/AAM"T2XG>YNVDO]C;;BU6WDB"KM *#(!Z_ACT
MH Z6RUNRU#5M1TVV9VGT\QB<[?E!<$@ ]R,<^E9\OC+3+=I6G6XCMD,RI<E!
MY<K1??5<'.1@@9 S@XS5?2] N_#5W?7<-Q+J$4L4$44+[5<D,VYF*H,GY\Y[
M\YK/O?!%Y?VG]FR7%NEE!-<W%O*-QD+REBH9<8 4NW0G/'2@#9_X2RW\W[+]
M@O?[1\S9]AVIYOW-^[.[;C;WW=>.M:^GW]OJ>GP7UJQ:"= Z$C!P?4=C7,?\
M(YJW]O\ _"1?Z#_:.[9]G\U_*\OR]OW]N<[N?N]./>M_0=+_ +%T*STXR"1H
M(PK.!@,W4D>V2: *&G_\CUKO_7G9_P YJZ"O(_$/PS3Q=XXOPWB#5+3[+9V_
M*OO+[VE/4XP!C]370:!\,QH7A[4-)7Q-K4HNPP$OG;3%D8RHYYH [RBO&T^
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MQ3R#D]<]*R=2^!<>HZG<WC>+]9!GD:3#MN(R<XSGF@#URLE/^1MF_P"O&/\
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MTSZ^G/TJE:75O=^*[AK:>*95LHP3&X8 [V.#CV(H VZ*** "BBB@#SOXR_\
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ME% $?V>'_GC'_P!\BC[/#_SQC_[Y%244 1_9X?\ GC'_ -\BC[/#_P \8_\
MOD5)10!']GA_YXQ_]\BC[/#_ ,\8_P#OD5)10!']GA_YXQ_]\BLR%$3Q;.$5
M5!L8^@Q_&]:]9*?\C;/_ ->,?_HQZ -:BBB@ HHHH \[^,O_ "*%I_U_I_Z+
MDHH^,O\ R*%I_P!?Z?\ HN2B@#K?"O\ R*&B?]>$'_HM:UZR/"O_ "*&B?\
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MO7/]STXH T**S_L%YG_D,77_ '[B]<_W/3C_ .OS0+"\&,ZQ=G&/^6<7//\
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M <=1Q5^@#G_[<US_ *%*]_\  NW_ /BZ/[<US_H4KW_P+M__ (NN@HH Y_\
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M0T6?4YM:32TFO(+2"Z\RZM!(&GM'P65"YY>W?J&'/\)XR!U^D>'M-T-[M[&
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M+Y,98E8]YY;:"!GVIECX7TVSU<ZL!/->-"D0>XD+[=J[=PS_ !D  MU.*VZ
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MWI\D@!PK B2('J0<!DZ.IQUQGM:KW%C:7DD,ES:P3/ V^)I(PQC;U7/0^XH
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M@ 9J?_A*_$?_ $']5_\  R3_ !HHH /^$K\1_P#0?U7_ ,#)/\:/^$K\1_\
M0?U7_P #)/\ &BB@ _X2OQ'_ -!_5?\ P,D_QH_X2OQ'_P!!_5?_  ,D_P :
M** #_A*_$?\ T']5_P# R3_&C_A*_$?_ $']5_\  R3_ !HHH /^$K\1_P#0
M?U7_ ,#)/\:/^$K\1_\ 0?U7_P #)/\ &BB@ _X2OQ'_ -!_5?\ P,D_QH_X
M2OQ'_P!!_5?_  ,D_P :** #_A*_$?\ T']5_P# R3_&C_A*_$?_ $']5_\
M R3_ !HHH /^$K\1_P#0?U7_ ,#)/\:/^$K\1_\ 0?U7_P #)/\ &BB@ _X2
MOQ'_ -!_5?\ P,D_QH_X2OQ'_P!!_5?_  ,D_P :** #_A*_$?\ T']5_P#
MR3_&C_A*_$?_ $']5_\  R3_ !HHH /^$K\1_P#0?U7_ ,#)/\:/^$K\1_\
M0?U7_P #)/\ &BB@ _X2OQ'_ -!_5?\ P,D_QH_X2OQ'_P!!_5?_  ,D_P :
M** #_A*_$?\ T']5_P# R3_&C_A*_$?_ $']5_\  R3_ !HHH /^$K\1_P#0
M?U7_ ,#)/\:/^$K\1_\ 0?U7_P #)/\ &BB@ _X2OQ'_ -!_5?\ P,D_QH_X
M2OQ'_P!!_5?_  ,D_P :** #_A*_$?\ T']5_P# R3_&C_A*_$?_ $']5_\
M R3_ !HHH /^$K\1_P#0?U7_ ,#)/\:/^$K\1_\ 0?U7_P #)/\ &BB@ _X2
MOQ'_ -!_5?\ P,D_QH_X2OQ'_P!!_5?_  ,D_P :** #_A*_$?\ T']5_P#
MR3_&C_A*_$?_ $']5_\  R3_ !HHH /^$K\1_P#0?U7_ ,#)/\:/^$K\1_\
M0?U7_P #)/\ &BB@ _X2OQ'_ -!_5?\ P,D_QH_X2OQ'_P!!_5?_  ,D_P :
M** #_A*_$?\ T']5_P# R3_&C_A*_$?_ $']5_\  R3_ !HHH /^$K\1_P#0
M?U7_ ,#)/\:/^$K\1_\ 0?U7_P #)/\ &BB@ _X2OQ'_ -!_5?\ P,D_QH_X
M2OQ'_P!!_5?_  ,D_P :** #_A*_$?\ T']5_P# R3_&C_A*_$?_ $']5_\
M R3_ !HHH /^$K\1_P#0?U7_ ,#)/\:/^$K\1_\ 0?U7_P #)/\ &BB@ _X2
MOQ'_ -!_5?\ P,D_QH_X2OQ'_P!!_5?_  ,D_P :** #_A*_$?\ T']5_P#
MR3_&C_A*_$?_ $']5_\  R3_ !HHH /^$K\1_P#0?U7_ ,#)/\:/^$K\1_\
M0?U7_P #)/\ &BB@ _X2OQ'_ -!_5?\ P,D_QH_X2OQ'_P!!_5?_  ,D_P :
M** #_A*_$?\ T']5_P# R3_&C_A*_$?_ $']5_\  R3_ !HHH /^$K\1_P#0
M?U7_ ,#)/\:/^$K\1_\ 0?U7_P #)/\ &BB@ _X2OQ'_ -!_5?\ P,D_QH_X
M2OQ'_P!!_5?_  ,D_P :** #_A*_$?\ T']5_P# R3_&C_A*_$?_ $']5_\
M R3_ !HHH /^$K\1_P#0?U7_ ,#)/\:/^$K\1_\ 0?U7_P #)/\ &BB@ _X2
MOQ'_ -!_5?\ P,D_QH_X2OQ'_P!!_5?_  ,D_P :** #_A*_$?\ T']5_P#
MR3_&C_A*_$?_ $']5_\  R3_ !HHH /^$K\1_P#0?U7_ ,#)/\:/^$K\1_\
K0?U7_P #)/\ &BB@#)\0Z_K-[81QW6KW\\8E#!9;EV .#S@GW-%%% '_V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>11
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.3</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Submission<br></strong></div></th>
<th class="th"><div>Oct. 21, 2025</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_SubmissionLineItems', window );"><strong>Submission [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Central Index Key</a></td>
<td class="text">0000312070<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Registrant Name</a></td>
<td class="text">BARCLAYS BANK PLC<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_RegnFileNb', window );">Registration File Number</a></td>
<td class="text">333-287303<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_FormTp', window );">Form Type</a></td>
<td class="text">F-3<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_SubmissnTp', window );">Submission Type</a></td>
<td class="text">424B2<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_FeeExhibitTp', window );">Fee Exhibit Type</a></td>
<td class="text">EX-FILING FEES<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_OfferingTableNa', window );">Offering Table N/A</a></td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_OffsetTableNa', window );">Offset Table N/A</a></td>
<td class="text">N/A<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_CombinedProspectusTableNa', window );">Combined Prospectus Table N/A</a></td>
<td class="text">N/A<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_CombinedProspectusTableNa">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_CombinedProspectusTableNa</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>ffd:naItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_FeeExhibitTp">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_FeeExhibitTp</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>ffd:feeExhibitTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_FormTp">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_FormTp</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>ffd:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_OfferingTableNa">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_OfferingTableNa</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>ffd:naItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_OffsetTableNa">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_OffsetTableNa</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>ffd:naItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_RegnFileNb">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_RegnFileNb</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>ffd:fileNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_SubmissionLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_SubmissionLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_SubmissnTp">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_SubmissnTp</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>ffd:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>12
<FILENAME>R2.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.3</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Offerings - Offering: 1<br></strong></div></th>
<th class="th">
<div>Oct. 21, 2025 </div>
<div>USD ($) </div>
<div>shares</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_OfferingTable', window );"><strong>Offering:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_PrevslyPdFlg', window );">Fee Previously Paid</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_Rule457rFlg', window );">Rule 457(r)</a></td>
<td class="text">true<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_OfferingSctyTp', window );">Security Type</a></td>
<td class="text">Debt<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_OfferingSctyTitl', window );">Security Class Title</a></td>
<td class="text">Global Medium-Term Notes, Series A<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_AmtSctiesRegd', window );">Amount Registered | shares</a></td>
<td class="nump">6,962<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_MaxOfferingPricPerScty', window );">Proposed Maximum Offering Price per Unit</a></td>
<td class="nump">1,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_MaxAggtOfferingPric', window );">Maximum Aggregate Offering Price</a></td>
<td class="nump">$ 6,962,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_FeeRate', window );">Fee Rate</a></td>
<td class="nump">0.01381%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_FeeAmt', window );">Amount of Registration Fee</a></td>
<td class="nump">$ 961.45<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_OfferingNote', window );">Offering Note</a></td>
<td class="text">The filing fee paid with this filing pursuant to Rule 457(r) under the Securities Act of 1933, as amended (the &#8220;Securities Act&#8221;), was originally deferred in accordance with Rule 456(b) under the Securities Act.<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_AmtSctiesRegd">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of securities being registered.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_AmtSctiesRegd</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>ffd:nonNegativeDecimal2ItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_FeeAmt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total amount of registration fee (amount due after offsets).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_FeeAmt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>ffd:nonNegative1TMonetary2ItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_FeeRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The rate per dollar of fees that public companies and other issuers pay to register their securities with the Commission.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_FeeRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_MaxAggtOfferingPric">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The maximum aggregate offering price for the offering that is being registered.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_MaxAggtOfferingPric</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>ffd:nonNegative100TMonetary2ItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_MaxOfferingPricPerScty">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The maximum offering price per share/unit being registered.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_MaxOfferingPricPerScty</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>ffd:nonNegativeDecimal4lItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_OfferingNote">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_OfferingNote</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_OfferingSctyTitl">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The title of the class of securities being registered (for each class being registered).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_OfferingSctyTitl</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>ffd:securityTitleItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_OfferingSctyTp">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Type of securities: "Asset-backed Securities", "ADRs/ADSs", "Debt", "Debt Convertible into Equity", "Equity", "Face Amount Certificates", "Limited Partnership Interests", "Mortgage Backed Securities", "Non-Convertible Debt", "Unallocated (Universal) Shelf", "Exchange Traded Vehicle Securities", "Other"</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_OfferingSctyTp</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>ffd:securityTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_OfferingTable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_OfferingTable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_PrevslyPdFlg">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_PrevslyPdFlg</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_Rule457rFlg">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br> -Section 457<br> -Subsection r<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_Rule457rFlg</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_OfferingAxis=1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_OfferingAxis=1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>13
<FILENAME>R3.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.3</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Fees Summary<br></strong></div></th>
<th class="th">
<div>Oct. 21, 2025 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_FeesSummaryLineItems', window );"><strong>Fees Summary [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_TtlOfferingAmt', window );">Total Offering</a></td>
<td class="nump">$ 6,962,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_TtlPrevslyPdAmt', window );">Previously Paid Amount</a></td>
<td class="nump">0.00<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_TtlFeeAmt', window );">Total Fee Amount</a></td>
<td class="nump">961.45<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_TtlOffsetAmt', window );">Total Offset Amount</a></td>
<td class="nump">0.00<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_NetFeeAmt', window );">Net Fee</a></td>
<td class="nump">961.45<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_NrrtvMaxAggtOfferingPric', window );">Narrative - Max Aggregate Offering Price</a></td>
<td class="nump">$ 6,962,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_FnlPrspctsFlg', window );">Final Prospectus</a></td>
<td class="text">true<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_FeesSummaryLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_FeesSummaryLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_FnlPrspctsFlg">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_FnlPrspctsFlg</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_NetFeeAmt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_NetFeeAmt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_NrrtvMaxAggtOfferingPric">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_NrrtvMaxAggtOfferingPric</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>ffd:nonNegative100TMonetary2ItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_TtlFeeAmt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_TtlFeeAmt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>ffd:nonNegative1TMonetary2ItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_TtlOfferingAmt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_TtlOfferingAmt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>ffd:nonNegative1TMonetary2ItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_TtlOffsetAmt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_TtlOffsetAmt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>ffd:nonNegative1TMonetary2ItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_TtlPrevslyPdAmt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_TtlPrevslyPdAmt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>ffd:nonNegative1TMonetary2ItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>14
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>15
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
.report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

.report table.authRefData a {
	display: block;
	font-weight: bold;
}

.report table.authRefData p {
	margin-top: 0px;
}

.report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

.report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

.report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

.report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
.pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
.report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

.report hr {
	border: 1px solid #acf;
}

/* Top labels */
.report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

.report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

.report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

.report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

.report td.pl div.a {
	width: 200px;
}

.report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
.report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
.report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
.report .re, .report .reu {
	background-color: #def;
}

.report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
.report .ro, .report .rou {
	background-color: white;
}

.report .rou td {
	border-bottom: 1px solid black;
}

.report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
.report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
.report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

.report .nump {
	padding-left: 2em;
}

.report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
.report .text {
	text-align: left;
	white-space: normal;
}

.report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

.report .text .more {
	display: none;
}

.report .text .note {
	font-style: italic;
	font-weight: bold;
}

.report .text .small {
	width: 10em;
}

.report sup {
	font-style: italic;
}

.report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>17
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.25.3</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>2</ContextCount>
  <ElementCount>26</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>false</FootnotesReported>
  <SegmentCount>1</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>3</UnitCount>
  <MyReports>
    <Report instance="dp236095_exfilingfees.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>995210 - Document - Submission</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://xbrl.sec.gov/ffd/role/document/submissionTable</Role>
      <ShortName>Submission</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report instance="dp236095_exfilingfees.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R2.htm</HtmlFileName>
      <LongName>995211 - Document - Offerings</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://xbrl.sec.gov/ffd/role/document/feesOfferingTable</Role>
      <ShortName>Offerings</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>2</Position>
    </Report>
    <Report instance="dp236095_exfilingfees.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R3.htm</HtmlFileName>
      <LongName>995215 - Document - Fees Summary</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://xbrl.sec.gov/ffd/role/document/feesSummaryTable</Role>
      <ShortName>Fees Summary</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>3</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <InputFiles>
    <File doctype="EX-FILING FEES" original="dp236095_exfilingfees.htm">dp236095_exfilingfees.htm</File>
  </InputFiles>
  <SupplementalFiles/>
  <BaseTaxonomies>
    <BaseTaxonomy items="2">http://xbrl.sec.gov/dei/2025</BaseTaxonomy>
    <BaseTaxonomy items="24">http://xbrl.sec.gov/ffd/2025</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>false</HasPresentationLinkbase>
  <HasCalculationLinkbase>false</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>JSON
<SEQUENCE>20
<FILENAME>MetaLinks.json
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
{
 "version": "2.2",
 "instance": {
  "dp236095_exfilingfees.htm": {
   "dts": {
    "inline": {
     "local": [
      "dp236095_exfilingfees.htm"
     ]
    },
    "schema": {
     "remote": [
      "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
      "http://www.xbrl.org/2005/xbrldt-2005.xsd",
      "http://www.xbrl.org/lrr/arcrole/deprecated-2009-12-16.xsd",
      "https://www.xbrl.org/dtr/type/2024-01-31/types.xsd",
      "https://xbrl.sec.gov/dei/2025/dei-2025.xsd",
      "https://xbrl.sec.gov/ffd/2025/ffd-2025.xsd"
     ]
    }
   },
   "keyStandard": 26,
   "keyCustom": 0,
   "axisStandard": 1,
   "axisCustom": 0,
   "memberStandard": 1,
   "memberCustom": 0,
   "hidden": {
    "total": 7,
    "http://xbrl.sec.gov/ffd/2025": 6,
    "http://xbrl.sec.gov/dei/2025": 1
   },
   "contextCount": 2,
   "entityCount": 1,
   "segmentCount": 1,
   "elementCount": 107,
   "unitCount": 3,
   "baseTaxonomies": {
    "http://xbrl.sec.gov/ffd/2025": 24,
    "http://xbrl.sec.gov/dei/2025": 2
   },
   "report": {
    "R1": {
     "role": "http://xbrl.sec.gov/ffd/role/document/submissionTable",
     "longName": "995210 - Document - Submission",
     "shortName": "Submission",
     "isDefault": "true",
     "groupType": "Fee_Exhibit",
     "subGroupType": "",
     "menuCat": "Cover",
     "order": "1",
     "firstAnchor": {
      "contextRef": "c_report",
      "name": "dei:EntityRegistrantName",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "p",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "dp236095_exfilingfees.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c_report",
      "name": "dei:EntityRegistrantName",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "p",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "dp236095_exfilingfees.htm",
      "first": true,
      "unique": true
     }
    },
    "R2": {
     "role": "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable",
     "longName": "995211 - Document - Offerings",
     "shortName": "Offerings",
     "isDefault": "false",
     "groupType": "Fee_Exhibit",
     "subGroupType": "",
     "menuCat": "Cover",
     "order": "2",
     "firstAnchor": {
      "contextRef": "c_offering_1",
      "name": "ffd:PrevslyPdFlg",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "dp236095_exfilingfees.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c_offering_1",
      "name": "ffd:PrevslyPdFlg",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "dp236095_exfilingfees.htm",
      "first": true,
      "unique": true
     }
    },
    "R3": {
     "role": "http://xbrl.sec.gov/ffd/role/document/feesSummaryTable",
     "longName": "995215 - Document - Fees Summary",
     "shortName": "Fees Summary",
     "isDefault": "false",
     "groupType": "Fee_Exhibit",
     "subGroupType": "",
     "menuCat": "Cover",
     "order": "3",
     "firstAnchor": {
      "contextRef": "c_report",
      "name": "ffd:TtlOfferingAmt",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "INF",
      "ancestors": [
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "dp236095_exfilingfees.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c_report",
      "name": "ffd:TtlOfferingAmt",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "INF",
      "ancestors": [
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "dp236095_exfilingfees.htm",
      "first": true,
      "unique": true
     }
    }
   },
   "tag": {
    "ffd_AggtRedRpPricFsclYr": {
     "xbrltype": "nonNegative1TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "AggtRedRpPricFsclYr",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/securities424iTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Aggregate Redeemed or Repurchased Price, Fiscal Year",
        "terseLabel": "Aggregate Redeemed or Repurchased, FY"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_AggtRedRpPricPrrFsclYr": {
     "xbrltype": "nonNegative1TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "AggtRedRpPricPrrFsclYr",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/securities424iTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Aggregate Redeemed or Repurchased Price, Prior Fiscal Year",
        "terseLabel": "Aggregate Redeemed or Repurchased, Prior FY"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_AggtSalesPricFsclYr": {
     "xbrltype": "nonNegative1TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "AggtSalesPricFsclYr",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/securities424iTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Aggregate Sales Price, Fiscal Year",
        "terseLabel": "Aggregate Sales Price"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_AmtRedCdts": {
     "xbrltype": "nonNegative1TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "AmtRedCdts",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/securities424iTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Amount of Redemption Credits",
        "terseLabel": "Redemption Credits"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_AmtSctiesRcvd": {
     "xbrltype": "nonNegativeDecimal2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "AmtSctiesRcvd",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Amount of Securities Received",
        "terseLabel": "Amount of Securities Received",
        "documentation": "Amount of securities to be received by the registrant (or cancelled upon issuance of securities to be registered on the form)"
       }
      }
     },
     "auth_ref": [
      "r6"
     ]
    },
    "ffd_AmtSctiesRegd": {
     "xbrltype": "nonNegativeDecimal2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "AmtSctiesRegd",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Amount of Securities Registered",
        "terseLabel": "Amount Registered",
        "documentation": "The amount of securities being registered."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_CeasedOprsDt": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "CeasedOprsDt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Ceased Operations Date",
        "terseLabel": "Ceased Operations Date"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_CfwdFormTp": {
     "xbrltype": "formTypeItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "CfwdFormTp",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Carry Forward Form Type",
        "terseLabel": "Carry Forward Form Type",
        "documentation": "The Form Type of the prior shelf registration statement from which unsold securities are carried forward under 415(a)(6). This should be an EDGAR submission type (S-3, S-3/A, S-3ASR, etc.), which means there is a fixed set of possible responses. Note that while the XBRL response should be an EDGAR submission type, the human-readable Ex. 107 could include a simpler label (e.g., \"Form S-3\" in the human-readable and \"S-3ASR\" in the XBRL)."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "ffd_CfwdPrevslyPdFee": {
     "xbrltype": "nonNegative1TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "CfwdPrevslyPdFee",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Carry Forward Previously Paid Fee",
        "terseLabel": "Filing Fee Previously Paid in Connection with Unsold Securities to be Carried Forward",
        "documentation": "The fee previously paid in connection with the securities being brought forward from the prior shelf registration statement on which unsold securities are carried forward under 415(a)(6)."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "ffd_CfwdPrrFctvDt": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "CfwdPrrFctvDt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Carry Forward Prior Effective Date",
        "terseLabel": "Carry Forward Initial Effective Date",
        "documentation": "The initial effective date of the prior shelf registration statement from which unsold securities are carried forward under 415(a)(6)."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "ffd_CfwdPrrFileNb": {
     "xbrltype": "fileNumberItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "CfwdPrrFileNb",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Carry Forward File Number",
        "terseLabel": "Carry Forward File Number",
        "documentation": "The EDGAR File Number of the prior shelf registration statement from which unsold securities are carried forward under 415(a)(6). If the prior registration statement has a Securities Act File Number and an Investment Company Act File Number, the Securities Act File Number should be used."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "ffd_CmbndPrspctsItemAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "CmbndPrspctsItemAxis",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesByCmbndPrspctsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Combined Prospectus Item [Axis]",
        "terseLabel": "Combined Prospectus",
        "documentation": "A sequence number (1, 2, 3...) used to distinguish different references to earlier prospectuses on a single fee bearing submission."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_CmbndPrspctsLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "CmbndPrspctsLineItems",
     "lang": {
      "en-us": {
       "role": {
        "label": "Combined Prospectus [Line Items]",
        "terseLabel": "Combined Prospectus:"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_CmbndPrspctsTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "CmbndPrspctsTable",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesByCmbndPrspctsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Combined Prospectus [Table]",
        "terseLabel": "Combined Prospectus Table"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_CombinedProspectusTableNa": {
     "xbrltype": "naItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "CombinedProspectusTableNa",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Combined Prospectus Table [N/A]",
        "terseLabel": "Combined Prospectus Table N/A"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_CshPdByRegistrantInTx": {
     "xbrltype": "nonNegative100TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "CshPdByRegistrantInTx",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cash Paid by Registrant in Transaction",
        "terseLabel": "Cash Consideration Paid",
        "documentation": "Amount of cash consideration paid by registrant in connection with the exchange or other transaction being registered (in a 457(f) calculation)."
       }
      }
     },
     "auth_ref": [
      "r12"
     ]
    },
    "ffd_CshRcvdByRegistrantInTx": {
     "xbrltype": "nonNegative100TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "CshRcvdByRegistrantInTx",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cash Received by Registrant in Transaction",
        "terseLabel": "Cash Consideration Received",
        "documentation": "Amount of cash consideration received by registrant in connection with the exchange or other transaction being registered (in a 457(f) calculation)."
       }
      }
     },
     "auth_ref": [
      "r12"
     ]
    },
    "dei_EntityCentralIndexKey": {
     "xbrltype": "centralIndexKeyItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityCentralIndexKey",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Central Index Key",
        "terseLabel": "Central Index Key",
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK."
       }
      }
     },
     "auth_ref": [
      "r0"
     ]
    },
    "dei_EntityRegistrantName": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityRegistrantName",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Registrant Name",
        "terseLabel": "Registrant Name",
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC."
       }
      }
     },
     "auth_ref": [
      "r0"
     ]
    },
    "ffd_FeeAmt": {
     "xbrltype": "nonNegative1TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "FeeAmt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable",
      "http://xbrl.sec.gov/ffd/role/document/securities424iTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fee Amount",
        "terseLabel": "Amount of Registration Fee",
        "documentation": "Total amount of registration fee (amount due after offsets)."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_FeeExhibitTp": {
     "xbrltype": "feeExhibitTypeItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "FeeExhibitTp",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fee Exhibit Type",
        "terseLabel": "Fee Exhibit Type"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_FeeIntrstAmt": {
     "xbrltype": "nonNegative1TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "FeeIntrstAmt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesSummaryTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fee Interest Amount",
        "terseLabel": "Interest Amount"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_FeeNote": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "FeeNote",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/securities424iTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fee Note",
        "terseLabel": "Fee Note"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_FeeNoteMaxAggtOfferingPric": {
     "xbrltype": "nonNegative100TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "FeeNoteMaxAggtOfferingPric",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fee Note Maximum Aggregate Offering Price",
        "terseLabel": "Fee Note MAOP"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_FeeRate": {
     "xbrltype": "percentItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "FeeRate",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable",
      "http://xbrl.sec.gov/ffd/role/document/securities424iTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fee Rate",
        "terseLabel": "Fee Rate",
        "documentation": "The rate per dollar of fees that public companies and other issuers pay to register their securities with the Commission."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_FeesOthrRuleFlg": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "FeesOthrRuleFlg",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fees, Other Rule [Flag]",
        "terseLabel": "Other Rule",
        "documentation": "Checkbox indicating whether filer is using a rule other than 457(a), 457(o), or 457(f) to calculate the registration fee due."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_FeesSummaryLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "FeesSummaryLineItems",
     "lang": {
      "en-us": {
       "role": {
        "label": "Fees Summary [Line Items]",
        "terseLabel": "Fees Summary:"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_FnlPrspctsFlg": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "FnlPrspctsFlg",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesSummaryTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Final Prospectus [Flag]",
        "terseLabel": "Final Prospectus"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_FormTp": {
     "xbrltype": "submissionTypeItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "FormTp",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Form Type",
        "terseLabel": "Form Type"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_GnlInstrIIhiFlg": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "GnlInstrIIhiFlg",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "General Instruction II.H,I [Flag]",
        "terseLabel": "General Instruction II.H,I"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_IssrBizAdrCity": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "IssrBizAdrCity",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Issuer Business Address, City",
        "terseLabel": "City"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_IssrBizAdrStatOrCtryCd": {
     "xbrltype": "stateOrCountryCodeItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "IssrBizAdrStatOrCtryCd",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Issuer Business Address, State or Country Code",
        "terseLabel": "State or Country Code"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_IssrBizAdrStrt1": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "IssrBizAdrStrt1",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Issuer Business Address, Street 1",
        "terseLabel": "Street 1"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_IssrBizAdrStrt2": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "IssrBizAdrStrt2",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Issuer Business Address, Street 2",
        "terseLabel": "Street 2"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_IssrBizAdrZipCd": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "IssrBizAdrZipCd",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Issuer Business Address, Zip Code",
        "terseLabel": "Zip Code"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_IssrNm": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "IssrNm",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Issuer Name",
        "terseLabel": "Issuer Name"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_MaxAggtOfferingPric": {
     "xbrltype": "nonNegative100TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "MaxAggtOfferingPric",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Maximum Aggregate Offering Price",
        "terseLabel": "Maximum Aggregate Offering Price",
        "documentation": "The maximum aggregate offering price for the offering that is being registered."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_MaxOfferingPricPerScty": {
     "xbrltype": "nonNegativeDecimal4lItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "MaxOfferingPricPerScty",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Maximum Offering Price per Security",
        "terseLabel": "Proposed Maximum Offering Price per Unit",
        "documentation": "The maximum offering price per share/unit being registered."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_NetFeeAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "NetFeeAmt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesSummaryTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Net Fee Amount",
        "terseLabel": "Net Fee"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_NetSalesAmt": {
     "xbrltype": "nonNegative1TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "NetSalesAmt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/securities424iTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Net Sales Amount",
        "terseLabel": "Net Sales"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_NrrtvDsclsr": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "NrrtvDsclsr",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesSummaryTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Narrative Disclosure",
        "terseLabel": "Narrative Disclosure"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_NrrtvMaxAggtAmt": {
     "xbrltype": "nonNegativeDecimal2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "NrrtvMaxAggtAmt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesSummaryTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Narrative Disclosure, Maximum Aggregate Offering Amount",
        "terseLabel": "Narrative - Max Aggregate Offering Amount"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_NrrtvMaxAggtOfferingPric": {
     "xbrltype": "nonNegative100TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "NrrtvMaxAggtOfferingPric",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesSummaryTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Narrative Disclosure, Maximum Aggregate Offering Price",
        "terseLabel": "Narrative - Max Aggregate Offering Price"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_OfferingAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "OfferingAxis",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offering [Axis]",
        "terseLabel": "Offering",
        "documentation": "A sequence number (1, 2, 3...) used to distinguish different security offerings on a single fee bearing submission."
       }
      }
     },
     "auth_ref": []
    },
    "ffd_OfferingLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "OfferingLineItems",
     "lang": {
      "en-us": {
       "role": {
        "label": "Offering [Line Items]",
        "terseLabel": "Offering:"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_OfferingNote": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "OfferingNote",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offering Note",
        "terseLabel": "Offering Note"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_OfferingSctyTitl": {
     "xbrltype": "securityTitleItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "OfferingSctyTitl",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable",
      "http://xbrl.sec.gov/ffd/role/document/securities424iTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offering Security Title",
        "terseLabel": "Security Class Title",
        "documentation": "The title of the class of securities being registered (for each class being registered)."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_OfferingSctyTp": {
     "xbrltype": "securityTypeItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "OfferingSctyTp",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offering Security Type",
        "terseLabel": "Security Type",
        "documentation": "Type of securities: \"Asset-backed Securities\", \"ADRs/ADSs\", \"Debt\", \"Debt Convertible into Equity\", \"Equity\", \"Face Amount Certificates\", \"Limited Partnership Interests\", \"Mortgage Backed Securities\", \"Non-Convertible Debt\", \"Unallocated (Universal) Shelf\", \"Exchange Traded Vehicle Securities\", \"Other\""
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_OfferingTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "OfferingTable",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offering [Table]",
        "terseLabel": "Offering:"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_OfferingTableNa": {
     "xbrltype": "naItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "OfferingTableNa",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offering Table [N/A]",
        "terseLabel": "Offering Table N/A"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_OffsetAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "OffsetAxis",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offset [Axis]",
        "terseLabel": "Offset",
        "documentation": "A sequence number (1, 2, 3...) used to distinguish different offsets as applied to a fee bearing submission."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_OffsetClmInitlFilgDt": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "OffsetClmInitlFilgDt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offset Claim Initial Filing Date",
        "terseLabel": "Initial Filing Date",
        "documentation": "The initial filing date of the earlier registration statement with which the earlier (offsetting) fee was paid for a claimed offset. If the offset fee was paid with an amendment, do not provide the amendment date under this element; instead, provide the date of the initial filing (i.e. the \"parent\" filing) ."
       }
      }
     },
     "auth_ref": [
      "r5",
      "r8"
     ]
    },
    "ffd_OffsetClmdAmt": {
     "xbrltype": "nonNegative1TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "OffsetClmdAmt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offset Claimed Amount",
        "terseLabel": "Fee Offset Claimed",
        "documentation": "The amount of offsetting fees being claimed."
       }
      }
     },
     "auth_ref": [
      "r5",
      "r8"
     ]
    },
    "ffd_OffsetClmdInd": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "OffsetClmdInd",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offset Claimed Indicator",
        "terseLabel": "Offset Claimed"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_OffsetExpltnForClmdAmt": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "OffsetExpltnForClmdAmt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offset Explanation for Claimed Amount",
        "terseLabel": "Explanation for Claimed Amount"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_OffsetLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "OffsetLineItems",
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Offset:",
        "label": "Offset [Line Items]"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_OffsetNote": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "OffsetNote",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offset Note",
        "terseLabel": "Offset Note"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_OffsetPrrFeeAmt": {
     "xbrltype": "nonNegative1TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "OffsetPrrFeeAmt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offset Prior Fee Amount",
        "terseLabel": "Fee Paid with Fee Offset Source",
        "documentation": "The fee previously paid from which an offset is being derived."
       }
      }
     },
     "auth_ref": [
      "r5",
      "r8"
     ]
    },
    "ffd_OffsetPrrFileNb": {
     "xbrltype": "fileNumberItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "OffsetPrrFileNb",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offset Prior File Number",
        "terseLabel": "File Number",
        "documentation": "The EDGAR File Number of the earlier registration statement with which the earlier (offsetting) fee was paid. If the offset filing for the offset has a Securities Act File Number and an Investment Company Act File Number, the Securities Act File Number should be used."
       }
      }
     },
     "auth_ref": [
      "r5",
      "r8"
     ]
    },
    "ffd_OffsetPrrFilerNm": {
     "xbrltype": "filerNameItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "OffsetPrrFilerNm",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offset Prior Filer Name",
        "terseLabel": "Registrant or Filer Name",
        "documentation": "The name of the registrant that filed the earlier registration statement with which the earlier (offsetting) fee was paid."
       }
      }
     },
     "auth_ref": [
      "r5",
      "r8"
     ]
    },
    "ffd_OffsetPrrFormTp": {
     "xbrltype": "formTypeItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "OffsetPrrFormTp",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offset Prior Form Type",
        "terseLabel": "Form or Filing Type",
        "documentation": "The Form Type of the offset filing."
       }
      }
     },
     "auth_ref": [
      "r5",
      "r8"
     ]
    },
    "ffd_OffsetPrrNbOfUnsoldScties": {
     "xbrltype": "nonNegativeIntegerItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "OffsetPrrNbOfUnsoldScties",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offset Prior Unsold Number of Securities",
        "terseLabel": "Unsold Securities Associated with Fee Offset Claimed",
        "documentation": "The number of unsold securities registered on the prior registration statement that are associated with the claimed offset."
       }
      }
     },
     "auth_ref": [
      "r5",
      "r8"
     ]
    },
    "ffd_OffsetPrrSctyTitl": {
     "xbrltype": "securityTitleItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "OffsetPrrSctyTitl",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offset Prior Security Title",
        "terseLabel": "Security Title Associated with Fee Offset Claimed",
        "documentation": "The title of the class of securities from which offset fees were derived."
       }
      }
     },
     "auth_ref": [
      "r5",
      "r8"
     ]
    },
    "ffd_OffsetPrrSctyTp": {
     "xbrltype": "securityTypeItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "OffsetPrrSctyTp",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offset Prior Security Type",
        "terseLabel": "Security Type Associated with Fee Offset Claimed",
        "documentation": "Type of securities: \"Asset-backed Securities\", \"ADRs/ADSs\", \"Debt\", \"Debt Convertible into Equity\", \"Equity\", \"Face Amount Certificates\", \"Limited Partnership Interests\", \"Mortgage Backed Securities\", \"Non-Convertible Debt\", \"Unallocated (Universal) Shelf\", \"Exchange Traded Vehicle Securities\", \"Other\""
       }
      }
     },
     "auth_ref": [
      "r5",
      "r8"
     ]
    },
    "ffd_OffsetPrrUnsoldOfferingAmt": {
     "xbrltype": "nonNegative1TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "OffsetPrrUnsoldOfferingAmt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offset Prior Unsold Offering Amount",
        "terseLabel": "Unsold Aggregate Offering Amount Associated with Fee Offset Claimed",
        "documentation": "The aggregate offering amount of unsold securities registered on the prior registration statement that are associated with the claimed offset."
       }
      }
     },
     "auth_ref": [
      "r5",
      "r8"
     ]
    },
    "ffd_OffsetSrcFilgDt": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "OffsetSrcFilgDt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offset Source Filing Date",
        "terseLabel": "Filing Date",
        "documentation": "The filing date of the earlier registration statement with which the earlier (offsetting) fee was paid in an offset."
       }
      }
     },
     "auth_ref": [
      "r5",
      "r8"
     ]
    },
    "ffd_OffsetTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "OffsetTable",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Offset Payment:",
        "label": "Offset [Table]"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_OffsetTableNa": {
     "xbrltype": "naItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "OffsetTableNa",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offset Table [N/A]",
        "terseLabel": "Offset Table N/A"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_PrevslyPdFlg": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "PrevslyPdFlg",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable",
      "http://xbrl.sec.gov/ffd/role/document/securities424iTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fee Previously Paid [Flag]",
        "terseLabel": "Fee Previously Paid"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_RegnFileNb": {
     "xbrltype": "fileNumberItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "RegnFileNb",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Registration File Number",
        "terseLabel": "Registration File Number"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_RptgFsclYrEndDt": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "RptgFsclYrEndDt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Reporting Fiscal Year End Date",
        "terseLabel": "Reporting FY End Date"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_Rule011Flg": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "Rule011Flg",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 0-11 [Flag]",
        "terseLabel": "Rule 0-11"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_Rule011a2OffsetFlg": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "Rule011a2OffsetFlg",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Rule 0-11(a)(2) Offset",
        "label": "Rule 0-11(a)(2) Offset [Flag]"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_Rule415a6Flg": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "Rule415a6Flg",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 415(a)(6) [Flag]",
        "terseLabel": "Rule 415(a)(6)",
        "documentation": "Checkbox indicating whether filer is claiming a 415(a)(6) carryforward."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "ffd_Rule429AggtOfferingAmt": {
     "xbrltype": "nonNegative100TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "Rule429AggtOfferingAmt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesByCmbndPrspctsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 429 Aggregate Offering Amount",
        "terseLabel": "Maximum Aggregate Offering Price of Securities Previously Registered",
        "documentation": "The maximum aggregate offering amount of unsold securities registered on the prior registration statement that are carried forward under Rule 429. Only applicable if 457(o) was used in the fee calculation for the prior registration statement."
       }
      }
     },
     "auth_ref": [
      "r3"
     ]
    },
    "ffd_Rule429CmbndPrspctsFlg": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "Rule429CmbndPrspctsFlg",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesByCmbndPrspctsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 429 Combined Prospectus [Flag]",
        "terseLabel": "Rule 429",
        "documentation": "Checkbox indicating whether filer is using a combined prospectus under Rule 429."
       }
      }
     },
     "auth_ref": [
      "r3"
     ]
    },
    "ffd_Rule429EarlierFileNb": {
     "xbrltype": "fileNumberItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "Rule429EarlierFileNb",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesByCmbndPrspctsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 429 Earlier File Number",
        "terseLabel": "File Number",
        "documentation": "The Securities Act File Number of the earlier effective registration statement(s) from which securities may be offered and sold using the combined prospectus pursuant to Rule 429."
       }
      }
     },
     "auth_ref": [
      "r3"
     ]
    },
    "ffd_Rule429EarlierFormTp": {
     "xbrltype": "formTypeItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "Rule429EarlierFormTp",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesByCmbndPrspctsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 429 Earlier Form Type",
        "terseLabel": "Form Type",
        "documentation": "The Form Type of the earlier registration statement from which unsold securities are carried forward under Rule 429. This should be an EDGAR submission type (S-3, S-3/A, S-3ASR, etc.), which means there is a fixed set of possible responses. Note that while the XBRL response should be an EDGAR submission type, the human-readable Ex. 107 could include a simpler label (e.g., \"Form S-3\" in the human-readable and \"S-3ASR\" in the XBRL)."
       }
      }
     },
     "auth_ref": [
      "r3"
     ]
    },
    "ffd_Rule429InitlFctvDt": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "Rule429InitlFctvDt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesByCmbndPrspctsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 429 Initial Effective Date",
        "terseLabel": "Initial Effective Date",
        "documentation": "The filing date of the earlier registration statement from which unsold securities are carried forward under Rule 429."
       }
      }
     },
     "auth_ref": [
      "r3"
     ]
    },
    "ffd_Rule429NbOfUnsoldScties": {
     "xbrltype": "nonNegativeDecimal2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "Rule429NbOfUnsoldScties",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesByCmbndPrspctsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 429 Number Of Unsold Securities",
        "terseLabel": "Amount of Securities Previously Registered",
        "documentation": "The number of securities registered on the prior registration statement that are carried forward under Rule 429."
       }
      }
     },
     "auth_ref": [
      "r3"
     ]
    },
    "ffd_Rule429PrspctsNote": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "Rule429PrspctsNote",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesByCmbndPrspctsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 429 Prospectus Note",
        "terseLabel": "Combined Prospectus Note"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_Rule429SctyTitl": {
     "xbrltype": "securityTitleItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "Rule429SctyTitl",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesByCmbndPrspctsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 429 Security Title",
        "terseLabel": "Security Class Title"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_Rule429SctyTp": {
     "xbrltype": "securityTypeItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "Rule429SctyTp",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesByCmbndPrspctsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 429 Security Type",
        "terseLabel": "Security Type"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_Rule457aFlg": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "Rule457aFlg",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 457(a) [Flag]",
        "terseLabel": "Rule 457(a)",
        "documentation": "Checkbox indicating whether filer is using Rule 457(a) to calculate the registration fee due."
       }
      }
     },
     "auth_ref": [
      "r4"
     ]
    },
    "ffd_Rule457bOffsetFlg": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "Rule457bOffsetFlg",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 457(b) Offset [Flag]",
        "terseLabel": "Rule 457(b) Offset",
        "documentation": "Checkbox indicating whether filer is claiming an offset under Rule 457(b) or 0-11(a)(2)."
       }
      }
     },
     "auth_ref": [
      "r5"
     ]
    },
    "ffd_Rule457fFlg": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "Rule457fFlg",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 457(f) [Flag]",
        "terseLabel": "Rule 457(f)",
        "documentation": "Checkbox indicating whether filer is using Rule 457(f) to calculate the registration fee due."
       }
      }
     },
     "auth_ref": [
      "r6"
     ]
    },
    "ffd_Rule457oFlg": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "Rule457oFlg",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 457(o) [Flag]",
        "terseLabel": "Rule 457(o)",
        "documentation": "Checkbox indicating whether filer is using Rule 457(o) to calculate the registration fee due."
       }
      }
     },
     "auth_ref": [
      "r7"
     ]
    },
    "ffd_Rule457pOffsetFlg": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "Rule457pOffsetFlg",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 457(p) Offset [Flag]",
        "terseLabel": "Rule 457(p) Offset",
        "documentation": "Checkbox indicating whether filer is claiming an offset under Rule 457(p)."
       }
      }
     },
     "auth_ref": [
      "r8"
     ]
    },
    "ffd_Rule457rFlg": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "Rule457rFlg",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 457(r) [Flag]",
        "terseLabel": "Rule 457(r)"
       }
      }
     },
     "auth_ref": [
      "r9"
     ]
    },
    "ffd_Rule457sFlg": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "Rule457sFlg",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 457(s) Flag",
        "terseLabel": "Rule 457(s)"
       }
      }
     },
     "auth_ref": [
      "r10"
     ]
    },
    "ffd_Rule457uFlg": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "Rule457uFlg",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 457(u) [Flag]",
        "terseLabel": "Rule 457(u)",
        "documentation": "Checkbox indicating whether filer is using Rule 457(u) to calculate the registration fee due."
       }
      }
     },
     "auth_ref": [
      "r11"
     ]
    },
    "ffd_Scties424iAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "Scties424iAxis",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/securities424iTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Securities, 424I [Axis]",
        "terseLabel": "Securities, 424I"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_Scties424iLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "Scties424iLineItems",
     "lang": {
      "en-us": {
       "role": {
        "label": "Securities, 424I [Line Items]",
        "terseLabel": "Securities, 424I:"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_Scties424iTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "Scties424iTable",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/securities424iTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Securities, 424I [Table]",
        "terseLabel": "Securities, 424I Table"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_Securities424iTableNa": {
     "xbrltype": "naItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "Securities424iNa",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Securities 424I [N/A]",
        "terseLabel": "Securities 424I N/A"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_SubmissionLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "SubmissionLineItems",
     "lang": {
      "en-us": {
       "role": {
        "label": "Submission [Line Items]",
        "terseLabel": "Items"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_SubmissnTp": {
     "xbrltype": "submissionTypeItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "SubmissnTp",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Submission Type",
        "terseLabel": "Submission Type"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_TermntnCmpltnWdrwl": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "TermntnCmpltnWdrwl",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Termination / Completion / Withdrawal Statement",
        "terseLabel": "Termination / Withdrawal Statement"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_TtlFeeAmt": {
     "xbrltype": "nonNegative1TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "TtlFeeAmt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesSummaryTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Total Fee Amount",
        "terseLabel": "Total Fee Amount"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_TtlFeeAndIntrstAmt": {
     "xbrltype": "nonNegativeDecimal2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "TtlFeeAndIntrstAmt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesSummaryTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Total Fee and Interest Amount",
        "terseLabel": "Total Fee and Interest Amount"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_TtlOfferingAmt": {
     "xbrltype": "nonNegative1TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "TtlOfferingAmt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesSummaryTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Total Offering Amount",
        "terseLabel": "Total Offering"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_TtlOffsetAmt": {
     "xbrltype": "nonNegative1TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "TtlOffsetAmt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesSummaryTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Total Offset Amount",
        "terseLabel": "Total Offset Amount"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_TtlPrevslyPdAmt": {
     "xbrltype": "nonNegative1TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "TtlPrevslyPdAmt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesSummaryTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Total Previously Paid Amount",
        "terseLabel": "Previously Paid Amount"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_TtlTxValtn": {
     "xbrltype": "nonNegative100TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "TtlTxValtn",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesSummaryTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Total Transaction Valuation",
        "terseLabel": "Total Transaction Valuation"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_TxValtn": {
     "xbrltype": "nonNegative100TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "TxValtn",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Transaction Valuation",
        "terseLabel": "Transaction Valuation"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_ValSctiesRcvd": {
     "xbrltype": "nonNegative100TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "ValSctiesRcvd",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Value of Securities Received",
        "terseLabel": "Value of Securities Received",
        "documentation": "Value of securities to be received by the registrant (or cancelled upon issuance of securities to be registered on the form)"
       }
      }
     },
     "auth_ref": [
      "r6"
     ]
    },
    "ffd_ValSctiesRcvdPerShr": {
     "xbrltype": "nonNegativeDecimal4lItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "ValSctiesRcvdPerShr",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Value of Securities Received, Per Share",
        "terseLabel": "Value of Securities Received, Per Share",
        "documentation": "Value per share of securities to be received by the registrant (or cancelled upon issuance of securities to be registered on the form). This is included in the explanation of 457(f) fee calculation."
       }
      }
     },
     "auth_ref": [
      "r6"
     ]
    }
   }
  }
 },
 "std_ref": {
  "r0": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b-2"
  },
  "r1": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230"
  },
  "r2": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "415",
   "Subsection": "a"
  },
  "r3": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "429"
  },
  "r4": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "457"
  },
  "r5": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "457",
   "Subsection": "b"
  },
  "r6": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "457",
   "Subsection": "f"
  },
  "r7": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "457",
   "Subsection": "o"
  },
  "r8": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "457",
   "Subsection": "p"
  },
  "r9": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "457",
   "Subsection": "r"
  },
  "r10": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "457",
   "Subsection": "s"
  },
  "r11": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "457",
   "Subsection": "u"
  },
  "r12": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Subsection": "f",
   "Section": "457"
  }
 }
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>21
<FILENAME>0000950103-25-013457-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0000950103-25-013457-xbrl.zip
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MGU3_ U!+ 0(4 Q0    ( -J 55MON/Z4LPH  (4W   9              "
M 0    !D<#(S-C Y-5]E>&9I;&EN9V9E97,N:'1M4$L%!@     !  $ 1P
' .H*      $!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>22
<FILENAME>dp236095_exfilingfees_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:dei="http://xbrl.sec.gov/dei/2025"
  xmlns:ffd="http://xbrl.sec.gov/ffd/2025"
  xmlns:iso4217="http://www.xbrl.org/2003/iso4217"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:xbrldi="http://xbrl.org/2006/xbrldi"
  xmlns:xlink="http://www.w3.org/1999/xlink"
  xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
    <link:schemaRef
      xlink:href="https://xbrl.sec.gov/ffd/2025/ffd-2025.xsd"
      xlink:type="simple"/>
    <context id="c_offering_1">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000312070</identifier>
            <segment>
                <xbrldi:typedMember dimension="ffd:OfferingAxis">
                    <dei:lineNo>1</dei:lineNo>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-10-21</startDate>
            <endDate>2025-10-21</endDate>
        </period>
    </context>
    <context id="c_report">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000312070</identifier>
        </entity>
        <period>
            <startDate>2025-10-21</startDate>
            <endDate>2025-10-21</endDate>
        </period>
    </context>
    <unit id="USD">
        <measure>iso4217:USD</measure>
    </unit>
    <unit id="pure">
        <measure>pure</measure>
    </unit>
    <unit id="shares">
        <measure>shares</measure>
    </unit>
    <ffd:SubmissnTp contextRef="c_report" id="fee_001">424B2</ffd:SubmissnTp>
    <ffd:FeeExhibitTp contextRef="c_report" id="fee_002">EX-FILING FEES</ffd:FeeExhibitTp>
    <dei:EntityCentralIndexKey contextRef="c_report" id="fee_003">0000312070</dei:EntityCentralIndexKey>
    <ffd:RegnFileNb contextRef="c_report" id="fee_004">333-287303</ffd:RegnFileNb>
    <ffd:OfferingTableNa contextRef="c_report" id="fee_005" xsi:nil="true"/>
    <ffd:OffsetTableNa contextRef="c_report" id="fee_006">N/A</ffd:OffsetTableNa>
    <ffd:CombinedProspectusTableNa contextRef="c_report" id="fee_007">N/A</ffd:CombinedProspectusTableNa>
    <ffd:FormTp contextRef="c_report" id="fee_008">F-3</ffd:FormTp>
    <dei:EntityRegistrantName contextRef="c_report" id="fee_009">BARCLAYS BANK PLC</dei:EntityRegistrantName>
    <ffd:PrevslyPdFlg contextRef="c_offering_1" id="fee_010">false</ffd:PrevslyPdFlg>
    <ffd:OfferingSctyTp contextRef="c_offering_1" id="fee_011">Debt</ffd:OfferingSctyTp>
    <ffd:OfferingSctyTitl contextRef="c_offering_1" id="fee_012">Global Medium-Term Notes, Series A</ffd:OfferingSctyTitl>
    <ffd:Rule457rFlg contextRef="c_offering_1" id="fee_013">true</ffd:Rule457rFlg>
    <ffd:AmtSctiesRegd
      contextRef="c_offering_1"
      decimals="0"
      id="fee_014"
      unitRef="shares">6962</ffd:AmtSctiesRegd>
    <ffd:MaxOfferingPricPerScty
      contextRef="c_offering_1"
      decimals="INF"
      id="fee_015"
      unitRef="USD">1000</ffd:MaxOfferingPricPerScty>
    <ffd:MaxAggtOfferingPric
      contextRef="c_offering_1"
      decimals="INF"
      id="fee_016"
      unitRef="USD">6962000</ffd:MaxAggtOfferingPric>
    <ffd:FeeRate
      contextRef="c_offering_1"
      decimals="INF"
      id="fee_017"
      unitRef="pure">0.0001381</ffd:FeeRate>
    <ffd:FeeAmt
      contextRef="c_offering_1"
      decimals="INF"
      id="ixv-223"
      unitRef="USD">961.45</ffd:FeeAmt>
    <ffd:TtlOfferingAmt
      contextRef="c_report"
      decimals="INF"
      id="ixv-224"
      unitRef="USD">6962000</ffd:TtlOfferingAmt>
    <ffd:TtlFeeAmt
      contextRef="c_report"
      decimals="INF"
      id="ixv-225"
      unitRef="USD">961.45</ffd:TtlFeeAmt>
    <ffd:TtlPrevslyPdAmt
      contextRef="c_report"
      decimals="INF"
      id="ixv-226"
      unitRef="USD">0.00</ffd:TtlPrevslyPdAmt>
    <ffd:TtlOffsetAmt
      contextRef="c_report"
      decimals="INF"
      id="ixv-227"
      unitRef="USD">0.00</ffd:TtlOffsetAmt>
    <ffd:NetFeeAmt
      contextRef="c_report"
      decimals="INF"
      id="ixv-228"
      unitRef="USD">961.45</ffd:NetFeeAmt>
    <ffd:OfferingNote contextRef="c_offering_1" id="ixv-229">The filing fee paid with this filing pursuant to Rule 457(r) under the Securities Act of 1933, as amended (the &#x201c;Securities Act&#x201d;), was originally deferred in accordance with Rule 456(b) under the Securities Act.</ffd:OfferingNote>
    <ffd:NrrtvMaxAggtOfferingPric
      contextRef="c_report"
      decimals="INF"
      id="ixv-230"
      unitRef="USD">6962000</ffd:NrrtvMaxAggtOfferingPric>
    <ffd:FnlPrspctsFlg contextRef="c_report" id="ixv-231">true</ffd:FnlPrspctsFlg>
</xbrl>
</XML>
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
